,words,labels,sentence_id,full sentence
72,Moreover,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
73,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
74,selenium,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
75,content,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
76,in,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
77,products,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
78,based,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
79,on,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
80,popular,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
81,gluten,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
82,-,I-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
83,free,I-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
84,cereals,I-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
85,like,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
86,corn,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
87,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
88,rice,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
89,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
90,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
91,buckwheat,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
92,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
93,in,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
94,relatively,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
95,new,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
96,or,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
97,less,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
98,popular,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
99,products,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
100,based,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
101,on,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
102,oat,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
103,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
104,amaranth,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
105,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
106,teff,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
107,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
108,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
109,quinoa,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
110,was,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
111,compared,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
112,.,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
200,Dairy,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
201,sheep,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
202,have,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
203,been,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
204,farmed,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
205,traditionally,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
206,in,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
207,the,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
208,Mediterranean,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
209,basin,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
210,in,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
211,southern,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
212,Europe,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
213,",",O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
214,central,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
215,Europe,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
216,",",O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
217,eastern,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
218,Europe,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
219,",",O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
220,and,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
221,in,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
222,Near,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
223,East,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
224,countries,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
225,.,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
1102,The,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1103,risk,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1104,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1105,specific,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1106,types,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1107,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1108,cancer,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1109,is,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1110,also,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1111,directly,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1112,influenced,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1113,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1114,regardless,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1115,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1116,the,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1117,magnitude,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1118,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1119,adiposity,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1120,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1121,by,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1122,physical,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1123,inactivity,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1124,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1125,consumption,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1126,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1127,red,B-AG.01.d,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1128,meat,I-AG.01.d,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1129,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1130,processed,B-AG.01.d,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1131,meat,I-AG.01.d,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1132,and,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1133,ultra,B-AG.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1134,-,I-AG.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1135,processed,I-AG.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1136,foods,I-AG.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1137,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1138,dairy,B-AG.01.e,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1139,products,I-AG.01.e,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1140,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1141,alcohol,B-AG.01.y.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1142,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1143,whole,B-AG.01.i,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1144,grain,I-AG.01.i,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1145,cereals,I-AG.01.i,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1146,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1147,nuts,B-AG.01.h.01.f,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1148,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1149,vegetables,B-AG.01.h.02,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1150,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1151,and,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1152,fruits,B-AG.01.h.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1153,.,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1590,From,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1591,these,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1592,observations,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1593,",",O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1594,it,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1595,is,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1596,suggested,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1597,that,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1598,the,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1599,beta,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1600,-,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1601,glycosyl,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1602,bond,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1603,of,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1604,genistin,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1605,is,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1606,cleaved,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1607,to,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1608,produce,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1609,genistein,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1610,by,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1611,microbes,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1612,during,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1613,fermentation,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1614,to,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1615,yield,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1616,miso,B-AG.01.n.02,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1617,and,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1618,natto,B-AG.01.n,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
1619,.,O,49.0,"From these observations , it is suggested that the beta - glycosyl bond of genistin is cleaved to produce genistein by microbes during fermentation to yield miso and natto ."
2303,After,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2304,16,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2305,weeks,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2306,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2307,ginger,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2308,supplementation,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2309,alleviated,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2310,the,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2311,HFD,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2312,-,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2313,induced,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2314,increases,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2315,in,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2316,body,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2317,weight,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2318,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2319,fat,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2320,accumulation,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2321,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2322,and,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2323,levels,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2324,of,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2325,serum,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2326,glucose,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2327,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2328,triglyceride,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2329,and,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2330,cholesterol,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2331,.,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2496,Intakes,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2497,of,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2498,dairy,B-AG.01.e,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2499,produce,I-AG.01.e,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2500,show,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2501,enormous,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2502,diversity,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2503,between,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2504,regions,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2505,",",O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2506,cultures,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2507,",",O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2508,and,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2509,individuals,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2510,around,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2511,the,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2512,world,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2513,.,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2578,For,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2579,people,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2580,lacking,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2581,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2582,LP,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2583,trait,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2584,",",O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2585,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2586,fermentation,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2587,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2588,milk,B-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2589,into,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2590,yogurt,B-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2591,and,I-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2592,related,I-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2593,products,I-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2594,(,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2595,a,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2596,process,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2597,known,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2598,for,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2599,≥8500,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2600,y,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2601,),O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2602,aids,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2603,milk,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2604,digestion,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2605,through,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2606,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2607,breakdown,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2608,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2609,some,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2610,lactose,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2611,and,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2612,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2613,provision,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2614,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2615,β,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2616,-,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2617,galactosidase,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2618,",",O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2619,which,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2620,remains,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2621,active,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2622,in,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2623,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2624,gastrointestinal,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2625,tract,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2626,.,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2745,Yogurt,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2746,has,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2747,been,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2748,part,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2749,of,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2750,the,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2751,human,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2752,diet,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2753,for,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2754,thousands,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2755,of,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2756,years,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2757,",",O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2758,and,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2759,during,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2760,that,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2761,time,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2762,a,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2763,number,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2764,of,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2765,health,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2766,benefits,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2767,have,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2768,been,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2769,associated,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2770,with,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2771,its,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2772,consumption,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2773,.,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
3428,In,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3429,food,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3430,groups,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3431,",",O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3432,increased,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3433,intake,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3434,of,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3435,soybean,B-AG.01.n,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3436,products,I-AG.01.n,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3437,was,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3438,associated,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3439,with,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3440,decreased,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3441,risk,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3442,of,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3443,GC,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3444,.,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3926,Canola,B-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3927,oil,I-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3928,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3929,relative,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3930,to,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3931,butter,B-AG.01.e.01,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3932,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3933,resulted,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3934,in,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3935,higher,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3936,exogenous,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3937,LCAT,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3938,activity,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3939,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3940,and,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3941,both,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3942,soybean,B-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3943,and,I-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3944,canola,I-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3945,oils,I-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3946,significantly,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3947,increased,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3948,hepatic,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3949,apo,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3950,A,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3951,-,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3952,I,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3953,and,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3954,SR,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3955,-,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3956,B1,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3957,mRNA,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3958,abundance,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3959,.,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
4380,It,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4381,would,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4382,be,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4383,important,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4384,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4385,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4386,future,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4387,to,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4388,investigate,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4389,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4390,origins,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4391,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4392,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4393,differences,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4394,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4395,wine,B-AG.01.y.01.a,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4396,stilbene,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4397,levels,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4398,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4399,relation,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4400,to,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4401,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4402,vine,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4403,varieties,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4404,",",O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4405,and,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4406,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4407,bioavailability,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4408,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4409,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4410,newly,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4411,extracted,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4412,stilbene,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4413,delta,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4414,-,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4415,viniferin,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4416,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4417,plasma,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4418,after,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4419,consumption,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4420,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4421,different,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4422,types,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4423,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4424,wines,B-AG.01.y.01.a,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4425,.,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
5303,Our,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5304,study,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5305,concludes,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5306,that,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5307,olive,B-AG.01.f,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5308,oil,I-AG.01.f,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5309,may,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5310,play,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5311,a,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5312,role,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5313,in,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5314,the,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5315,epigenetic,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5316,therapy,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5317,by,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5318,altering,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5319,NF,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5320,-,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5321,κB,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5322,and,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5323,apoptotic,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5324,pathways,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5325,via,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5326,targeting,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5327,noncoding,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5328,RNAs,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5329,and,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5330,methylation,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5331,machinery,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5332,that,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5333,affecting,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5334,epigenome,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5335,to,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5336,prevent,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5337,colon,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5338,carcinogenesis,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5339,.,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5443,Milk,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5444,peptides,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5445,may,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5446,also,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5447,have,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5448,other,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5449,additional,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5450,mechanisms,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5451,to,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5452,lower,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5453,blood,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5454,pressure,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5455,such,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5456,as,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5457,opioid,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5458,-,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5459,like,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5460,activities,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5461,and,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5462,mineral,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5463,-,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5464,binding,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5465,and,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5466,antithrombotic,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5467,properties,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5468,.,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
6090,Consumption,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6091,of,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6092,tomato,B-AG.01.h.02.f,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6093,and,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6094,tomato,B-AG.01.n.09,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6095,-,I-AG.01.n.09,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6096,based,I-AG.01.n.09,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6097,products,I-AG.01.n.09,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6098,contribute,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6099,to,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6100,the,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6101,absorption,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6102,of,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6103,carotenoids,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6104,and,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6105,lycopenes,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6106,in,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6107,human,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6108,serum,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6109,.,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6135,It,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6136,has,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6137,ability,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6138,for,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6139,adenosine,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6140,deaminase,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6141,inhibition,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6142,that,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6143,plays,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6144,important,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6145,role,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6146,in,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6147,the,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6148,regression,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6149,of,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6150,tumor,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6151,.,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6225,Latest,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6226,research,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6227,highlights,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6228,the,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6229,relationship,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6230,between,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6231,consuming,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6232,tomato,B-AG.01.h.02.f,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6233,and,I-AG.01.h.02.f,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6234,its,I-AG.01.h.02.f,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6235,products,I-AG.01.h.02.f,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6236,with,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6237,reduced,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6238,risk,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6239,of,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6240,various,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6241,maladies,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6242,like,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6243,obesity,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6244,",",O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6245,hyperglycemic,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6246,and,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6247,hypercholesterolemic,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6248,attributes,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6249,",",O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6250,cardiovascular,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6251,disorders,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6252,",",O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6253,and,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6254,cancer,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6255,insurgences,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6256,.,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6450,When,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6451,consumed,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6452,within,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6453,the,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6454,DGA,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6455,recommendations,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6456,",",O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6457,100,B-AG.01.ab,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6458,%,I-AG.01.ab,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6459,fruit,I-AG.01.ab,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6460,juice,I-AG.01.ab,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6461,is,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6462,not,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6463,associated,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6464,with,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6465,overweight,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6466,/,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6467,obesity,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6468,or,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6469,childhood,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6470,dental,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6471,caries,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6472,and,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6473,does,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6474,not,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6475,compromise,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6476,fiber,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6477,intake,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6478,.,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6560,Reducing,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6561,or,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6562,eliminating,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6563,100,B-AG.01.ab,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6564,%,I-AG.01.ab,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6565,fruit,I-AG.01.ab,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6566,juice,I-AG.01.ab,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6567,could,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6568,lead,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6569,to,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6570,unintended,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6571,consequences,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6572,such,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6573,as,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6574,reduced,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6575,daily,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6576,fruit,B-AG.01.h.01,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6577,intake,B-X,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6578,and,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6579,increased,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6580,consumption,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6581,of,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6582,less,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6583,nutritious,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6584,beverages,B-AG.01.y,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6585,(,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6586,for,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6587,example,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6588,",",O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6589,sugar,B-AG.01.y,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6590,-,I-AG.01.y,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6591,sweetened,I-AG.01.y,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6592,beverages,I-AG.01.y,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6593,),O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6594,.,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
7141,The,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7142,espresso,B-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7143,coffee,I-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7144,sample,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7145,was,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7146,found,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7147,to,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7148,contain,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7149,the,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7150,highest,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7151,level,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7152,of,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7153,MG,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7154,at,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7155,230.9,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7156,microM.,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7157,The,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7158,bold,B-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7159,coffee,I-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7160,roast,I-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7161,had,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7162,the,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7163,2nd,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7164,highest,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7165,amount,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7166,of,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7167,MG,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7168,",",O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7169,followed,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7170,by,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7171,the,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7172,mild,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7173,and,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7174,decaffeinated,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7175,varieties,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7176,.,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7516,The,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7517,contributions,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7518,of,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7519,food,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7520,items,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7521,and,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7522,food,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7523,groups,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7524,as,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7525,risk,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7526,factors,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7527,in,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7528,a,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7529,previously,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7530,reported,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7531,case,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7532,-,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7533,control,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7534,study,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7535,of,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7536,diet,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7537,and,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7538,colo,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7539,-,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7540,rectal,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7541,cancer,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7542,have,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7543,been,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7544,analyzed,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7545,.,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7947,Fifty,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7948,-,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7949,six,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7950,percent,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7951,of,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7952,the,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7953,GF,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7954,products,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7955,had,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7956,sucrose,B-AG.01.l.02,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7957,in,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7958,their,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7959,formulation,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
7960,.,O,265.0,Fifty - six percent of the GF products had sucrose in their formulation .
8503,Multivariate,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8504,odds,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8505,ratios,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8506,(,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8507,OR,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8508,),O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8509,were,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8510,obtained,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8511,after,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8512,allowance,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8513,for,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8514,energy,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8515,intake,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8516,and,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8517,other,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8518,major,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8519,confounding,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8520,factors,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8521,.,O,281.0,Multivariate odds ratios ( OR ) were obtained after allowance for energy intake and other major confounding factors .
8574,Poultry,B-AG.01.d.06,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8575,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8576,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8577,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8578,0.74,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8579,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8580,",",O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8581,processed,B-AG.01.d,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8582,meat,I-AG.01.d,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8583,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8584,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8585,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8586,0.64,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8587,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8588,and,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8589,vegetables,B-AG.01.h.02,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8590,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8591,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8592,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8593,0.65,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8594,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8595,were,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8596,inversely,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8597,associated,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8598,with,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8599,RCC,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8600,risk,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8601,.,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
9449,(,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9450,c,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9451,),O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9452,2007,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9453,Wiley,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9454,-,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9455,Liss,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9456,",",O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9457,Inc.,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9458,Soybean,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9459,(,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9460,Glycine,B-AG.01.h.02.g,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9461,max,I-AG.01.h.02.g,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9462,),O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9463,is,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9464,a,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9465,vital,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9466,oilseed,B-AG.01.h.02.g,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9467,legume,I-AG.01.h.02.g,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9468,crop,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9469,that,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9470,provides,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9471,protein,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9472,and,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9473,oil,B-AG.01.f,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9474,for,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9475,humans,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9476,and,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9477,feedstock,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9478,for,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9479,animals,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9480,.,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9594,Recent,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9595,deep,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9596,sequencing,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9597,data,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9598,revealed,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9599,that,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9600,six,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9601,FT,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9602,homologs,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9603,are,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9604,expressed,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9605,in,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9606,shoot,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9607,apical,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9608,meristem,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9609,and,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9610,leaves,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9611,during,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9612,floral,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9613,transition,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9614,.,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9628,Though,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9629,bioinformatic,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9630,analyses,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9631,revealed,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9632,that,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9633,GmFT7,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9634,had,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9635,high,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9636,similarity,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9637,with,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9638,GmFT2a,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9639,",",O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9640,ectopic,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9641,GmFT7,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9642,expression,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9643,in,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9644,Arabidopsis,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9645,could,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9646,not,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9647,promote,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9648,flowering,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9649,or,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9650,rescue,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9651,the,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9652,late,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9653,-,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9654,flowering,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9655,phenotype,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9656,of,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9657,Arabidopsis,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9658,ft-10,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9659,mutant,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9660,.,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9720,This,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9721,study,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9722,also,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9723,determined,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9724,the,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9725,potential,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9726,neuroprotective,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9727,effect,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9728,of,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9729,extracts,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9730,from,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9731,fruits,B-AG.01.h.01,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9732,and,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9733,leaves,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9734,against,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9735,glutamate,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9736,-,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9737,mediated,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9738,excitotoxicity,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9739,",",O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9740,which,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9741,is,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9742,believed,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9743,to,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9744,contribute,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9745,to,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9746,disorders,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9747,such,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9748,as,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9749,stroke,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9750,and,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9751,neurodegenerative,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9752,diseases,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9753,.,O,323.0,"This study also determined the potential neuroprotective effect of extracts from fruits and leaves against glutamate - mediated excitotoxicity , which is believed to contribute to disorders such as stroke and neurodegenerative diseases ."
9991,In,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9992,epidemiological,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9993,studies,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9994,frequent,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9995,consumption,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9996,of,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9997,certain,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9998,fruits,B-AG.01.h.01,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9999,and,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10000,vegetables,B-AG.01.h.02,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10001,and,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10002,in,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10003,laboratory,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10004,experiments,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10005,some,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10006,components,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10007,of,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10008,fruits,B-AG.01.h.01,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10009,and,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10010,vegetables,B-AG.01.h.02,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10011,",",O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10012,especially,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10013,cruciferous,B-AG.01.h.02.d,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10014,vegetables,I-AG.01.h.02.d,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10015,",",O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10016,appear,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10017,to,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10018,decrease,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10019,the,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10020,incidence,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10021,of,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10022,cancers,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10023,at,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10024,various,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10025,sites,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10026,.,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10027,In,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10028,contrast,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10029,",",O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10030,frequent,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10031,consumption,B-X,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10032,of,B-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10033,salt,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10034,-,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10035,cured,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10036,",",I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10037,salt,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10038,-,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10039,pickled,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10040,",",I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10041,or,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10042,smoked,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10043,foods,I-AG.01,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10044,",",O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10045,possibly,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10046,because,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10047,they,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10048,may,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10049,contain,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10050,nitrosamines,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10051,or,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10052,polycyclic,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10053,aromatic,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10054,hydrocarbons,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10055,",",O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10056,appears,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10057,to,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10058,increase,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10059,the,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10060,risk,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10061,of,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10062,esophageal,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10063,or,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10064,stomach,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10065,cancer,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10066,.,O,337.0,"In contrast , frequent consumption of salt - cured , salt - pickled , or smoked foods , possibly because they may contain nitrosamines or polycyclic aromatic hydrocarbons , appears to increase the risk of esophageal or stomach cancer ."
10095,Interim,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10096,dietary,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10097,guidelines,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10098,to,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10099,reduce,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10100,the,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10101,risk,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10102,of,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10103,cancer,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10104,were,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10105,proposed,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10106,in,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10107,accordance,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10108,with,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10109,these,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10110,conclusions,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10111,.,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10147,The,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10148,European,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10149,Commission,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10150,asked,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10151,EFSA,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10152,for,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10153,a,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10154,scientific,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10155,opinion,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10156,on,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10157,the,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10158,risks,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10159,for,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10160,animal,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10161,and,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10162,human,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10163,health,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10164,related,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10165,to,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10166,the,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10167,presence,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10168,of,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10169,glycoalkaloids,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10170,(,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10171,GAs,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10172,),O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10173,in,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10174,feed,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10175,and,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10176,food,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10177,.,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10275,In,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10276,humans,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10277,",",O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10278,no,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10279,evidence,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10280,of,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10281,health,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10282,problems,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10283,associated,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10284,with,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10285,repeated,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10286,or,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10287,long,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10288,-,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10289,term,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10290,intake,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10291,of,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10292,GAs,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10293,via,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10294,potatoes,B-AG.01.h.02.a,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10295,has,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10296,been,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10297,identified,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10298,.,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10352,Due,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10353,to,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10354,the,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10355,limited,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10356,data,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10357,available,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10358,",",O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10359,a,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10360,margin,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10361,of,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10362,exposure,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10363,(,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10364,MOE,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10365,),O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10366,approach,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10367,was,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10368,applied,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10369,.,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10370,The,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10371,MOEs,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10372,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10373,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10374,younger,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10375,age,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10376,groups,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10377,indicate,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10378,a,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10379,health,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10380,concern,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10381,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10382,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10383,food,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10384,consumption,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10385,surveys,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10386,with,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10387,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10388,highest,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10389,mean,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10390,exposure,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10391,",",O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10392,as,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10393,well,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10394,as,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10395,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10396,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10397,P95,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10398,exposure,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10399,in,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10400,all,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10401,surveys,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10402,.,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10490,Milk,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10491,beverages,B-AG.01,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10492,derived,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10493,from,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10494,plant,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10495,-,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10496,based,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10497,protein,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10498,have,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10499,attracted,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10500,the,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10501,interest,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10502,of,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10503,consumers,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10504,and,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10505,researchers,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10506,as,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10507,a,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10508,health,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10509,-,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10510,promoting,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10511,functional,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10512,food,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10513,.,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10535,The,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10536,plant,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10537,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10538,based,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10539,emulsions,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10540,are,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10541,directed,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10542,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10543,prevent,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10544,diet,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10545,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10546,related,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10547,chronic,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10548,diseases,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10549,including,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10550,diabetes,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10551,",",O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10552,cardiovascular,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10553,",",O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10554,obesity,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10555,and,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10556,other,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10557,disorders,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10558,due,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10559,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10560,the,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10561,presence,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10562,of,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10563,healthy,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10564,long,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10565,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10566,chain,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10567,unsaturated,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10568,fatty,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10569,acids,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10570,as,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10571,compared,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10572,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10573,bovine,B-AG.01.e,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10574,milk,I-AG.01.e,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10575,.,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10782,Through,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10783,principal,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10784,component,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10785,analysis,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10786,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10787,a,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10788,score,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10789,for,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10790,a,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10791,traditional,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10792,dietary,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10793,pattern,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10794,(,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10795,characterized,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10796,by,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10797,higher,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10798,intakes,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10799,of,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10800,high,B-AG.01,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10801,-,I-AG.01,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10802,fat,I-AG.01,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10803,sandwich,I-AG.01,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10804,spreads,I-AG.01,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10805,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10806,red,B-AG.01.d,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10807,meat,I-AG.01.d,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10808,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10809,potatoes,B-AG.01.h.02.a,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10810,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10811,butter,B-AG.01.e.01,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10812,and,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10813,lard,B-AG.01.f,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10814,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10815,low,B-AG.01.d.07,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10816,-,I-AG.01.d.07,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10817,fat,I-AG.01.d.07,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10818,fish,I-AG.01.d.07,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10819,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10820,sandwich,B-AG.01.d,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10821,meat,I-AG.01.d,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10822,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10823,and,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10824,sauces,B-AG.01.l.04,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10825,),O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10826,and,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10827,a,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10828,score,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10829,for,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10830,a,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10831,modern,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10832,dietary,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10833,pattern,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10834,(,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10835,characterized,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10836,by,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10837,higher,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10838,intakes,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10839,of,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10840,vegetables,B-AG.01.h.02,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10841,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10842,fruit,B-AG.01.h.01,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10843,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10844,vegetable,B-AG.01.l.04,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10845,oil,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10846,/,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10847,vinegar,B-AG.01.l.04,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10848,dressing,I-AG.01.l.04,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10849,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10850,poultry,B-AG.01.d.06,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10851,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10852,pasta,B-AG.01.i,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10853,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10854,rice,B-AG.01.i,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10855,",",O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10856,and,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10857,cereals,B-AG.01.i,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10858,),O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10859,were,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10860,estimated,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10861,for,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10862,each,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10863,person,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10864,at,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10865,baseline,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
10866,.,O,364.0,"Through principal component analysis , a score for a traditional dietary pattern ( characterized by higher intakes of high - fat sandwich spreads , red meat , potatoes , butter and lard , low - fat fish , sandwich meat , and sauces ) and a score for a modern dietary pattern ( characterized by higher intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ) were estimated for each person at baseline ."
11040,The,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11041,main,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11042,cause,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11043,of,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11044,obesity,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11045,is,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11046,energy,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11047,imbalance,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11048,",",O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11049,of,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11050,which,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11051,contributing,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11052,factors,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11053,include,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11054,a,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11055,sedentary,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11056,lifestyle,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11057,",",O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11058,epigenetic,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11059,factors,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11060,and,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11061,excessive,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11062,caloric,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11063,intake,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11064,through,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11065,food,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11066,and,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11067,beverages,B-AG.01.y,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11068,.,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11960,The,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11961,objective,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11962,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11963,this,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11964,study,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11965,was,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11966,to,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11967,determine,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11968,the,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11969,effect,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11970,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11971,substitution,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11972,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11973,20,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11974,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11975,split,B-AG.01.h.02.g,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11976,yellow,I-AG.01.h.02.g,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11977,pea,I-AG.01.h.02.g,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11978,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11979,SYP,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11980,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11981,flour,B-AG.01.h.02.g,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11982,treated,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11983,by,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11984,Revtech,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11985,thermal,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11986,processing,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11987,at,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11988,140,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11989, ,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11990,°,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11991,C,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11992,with,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11993,10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11994,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11995,steam,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11996,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11997,RT10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11998,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11999,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12000,and,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12001,without,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12002,steam,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12003,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12004,RT0,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12005,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12006,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12007,for,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12008,wheat,B-AG.01.k,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12009,flour,I-AG.01.k,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12010,in,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12011,bread,B-AG.01.n.11,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12012,on,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12013,the,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12014,sensory,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12015,attributes,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12016,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12017,acceptability,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12018,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12019,nutrient,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12020,composition,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12021,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12022,firmness,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12023,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12024,color,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12025,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12026,and,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12027,pH.,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12028,RT10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12029,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12030,was,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12031,more,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12032,acceptable,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12033,overall,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12034,than,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12035,bread,B-AG.01.n.11,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12036,with,I-AG.01.n.11,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12037,untreated,I-AG.01.n.11,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12038,pea,I-AG.01.n.11,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12039,flour,I-AG.01.n.11,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12040,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12041,USYP,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12042,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12043,or,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12044,RT0,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12045,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12046,as,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12047,assessed,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12048,by,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12049,110,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12050,consumers,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12051,.,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12619,Our,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12620,aim,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12621,was,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12622,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12623,review,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12624,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12625,epidemiological,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12626,literature,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12627,on,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12628,possible,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12629,cancer,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12630,-,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12631,preventive,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12632,effects,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12633,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12634,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12635,consumption,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12636,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12637,fruits,B-AG.01.h.01,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12638,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12639,vegetables,B-AG.01.h.02,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12640,in,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12641,humans,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12642,",",O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12643,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12644,quantify,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12645,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12646,effect,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12647,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12648,high,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12649,versus,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12650,low,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12651,consumption,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12652,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12653,fruits,B-AG.01.h.01,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12654,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12655,vegetables,B-AG.01.h.02,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12656,",",O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12657,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12658,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12659,give,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12660,an,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12661,overall,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12662,assessment,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12663,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12664,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12665,existing,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12666,evidence,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12667,.,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12668,We,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12669,based,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12670,our,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12671,work,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12672,on,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12673,an,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12674,expert,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12675,meeting,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12676,conducted,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12677,by,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12678,the,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12679,International,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12680,Agency,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12681,for,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12682,Research,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12683,on,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12684,Cancer,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12685,in,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12686,2003,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12687,.,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12850,Applying,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12851,this,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12852,range,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12853,of,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12854,risk,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12855,difference,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12856,to,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12857,the,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12858,range,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12859,of,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12860,prevalence,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12861,of,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12862,low,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12863,intake,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12864,",",O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12865,the,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12866,preventable,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12867,fraction,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12868,for,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12869,low,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12870,fruit,B-AG.01.h,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12871,and,I-AG.01.h,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12872,vegetable,I-AG.01.h,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12873,intake,B-X,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12874,would,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12875,fall,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12876,into,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12877,the,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12878,range,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12879,of,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12880,5,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12881,-,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12882,12,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12883,%,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12884,.,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12961,Extrapolating,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12962,to,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12963,a,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12964,random,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12965,community,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12966,population,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12967,showed,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12968,that,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12969,at,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12970,the,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12971,age,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12972,of,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12973,two,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12974,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12975,egg,B-AG.01.g,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12976,appears,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12977,the,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12978,most,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12979,frequent,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12980,food,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12981,allergen,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12982,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12983,3.2,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12984,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12985,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12986,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12987,while,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12988,cow,B-AG.01.e,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12989,milk,I-AG.01.e,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12990,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12991,2.0,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12992,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12993,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12994,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12995,and,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12996,peanut,B-AG.01.h.01.f,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12997,are,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12998,of,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12999,similar,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13000,frequency,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13001,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13002,1.9,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13003,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13004,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13005,.,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13111,Casein,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13112,is,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13113,the,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13114,major,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13115,protein,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13116,in,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13117,milk,B-AG.01.e,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13118,and,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13119,enhances,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13120,the,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13121,secretion,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13122,of,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13123,insulin,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13124,that,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13125,has,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13126,anti,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13127,-,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13128,inflammatory,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13129,activity,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13130,.,O,436.0,Casein is the major protein in milk and enhances the secretion of insulin that has anti - inflammatory activity .
13258,Plasma,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13259,IL-6,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13260,concentrations,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13261,increased,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13262,significantly,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13263,(,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13264,P,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13265, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13266,<,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13267, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13268,0·001,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13269,),O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13270,during,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13271,4,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13272, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13273,h,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13274,after,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13275,the,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13276,meals,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13277,.,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13440,We,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13441,determined,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13442,the,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13443,intake,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13444,of,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13445,gluten,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13446,from,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13447,wheat,B-AG.01.i,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13448,",",O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13449,barley,B-AG.01.i,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13450,",",O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13451,rye,B-AG.01.i,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13452,and,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13453,oats,B-AG.01.i,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13454,in,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13455,a,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13456,cross,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13457,-,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13458,sectional,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13459,National,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13460,Danish,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13461,Survey,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13462,of,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13463,Dietary,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13464,Habits,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13465,among,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13466,Infants,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13467,and,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13468,Young,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13469,Children,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13470,(,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13471,2006,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13472,-,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13473,2007,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13474,),O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13475,.,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13929,Foods,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13930,contain,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13931,a,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13932,wide,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13933,range,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13934,of,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13935,food,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13936,ingredients,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13937,that,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13938,serve,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13939,numerous,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13940,technical,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13941,functions,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13942,.,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
14082,A,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14083,few,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14084,food,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14085,ingredients,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14086,are,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14087,capable,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14088,of,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14089,eliciting,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14090,allergic,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14091,sensitization,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14092,",",O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14093,although,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14094,these,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14095,ingredients,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14096,would,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14097,be,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14098,classified,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14099,as,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14100,rarely,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14101,allergenic,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14102,.,O,470.0,"A few food ingredients are capable of eliciting allergic sensitization , although these ingredients would be classified as rarely allergenic ."
14287,The,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14288,prospective,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14289,part,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14290,of,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14291,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14292,study,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14293,was,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14294,performed,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14295,on,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14296,103,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14297,birch,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14298,pollen,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14299,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14300,hypersensitive,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14301,patients,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14302,who,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14303,were,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14304,OAS,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14305,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14306,free,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14307,at,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14308,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14309,time,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14310,of,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14311,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14312,first,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14313,visit,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14314,and,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14315,were,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14316,periodically,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14317,followed,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14318,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14319,up,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14320,for,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14321,OAS,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14322,.,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14500,Controls,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14501,(,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14502,n,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14503,=,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14504,641,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14505,),O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14506,matched,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14507,for,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14508,sex,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14509,and,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14510,age,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14511,were,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14512,selected,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14513,among,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14514,patients,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14515,undergoing,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14516,functional,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14517,reeducation,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14518,for,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14519,injury,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14520,or,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14521,trauma,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14522,in,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14523,one,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14524,of,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14525,five,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14526,hospital,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14527,centers,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14528,.,O,482.0,Controls ( n = 641 ) matched for sex and age were selected among patients undergoing functional reeducation for injury or trauma in one of five hospital centers .
14938,Importantly,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14939,",",O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14940,whereas,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14941,cell,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14942,-,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14943,autonomous,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14944,clocks,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14945,have,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14946,been,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14947,identified,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14948,in,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14949,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14950,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14951,",",O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14952,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14953,complete,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14954,circadian,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14955,programing,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14956,of,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14957,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14958,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14959,transcriptome,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14960,and,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14961,posttranslational,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14962,modifications,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14963,of,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14964,essential,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14965,metabolic,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14966,proteins,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14967,is,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14968,strongly,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14969,dependent,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14970,on,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14971,nutrient,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14972,flux,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14973,and,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14974,circadian,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14975,signals,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14976,from,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14977,outside,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14978,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14979,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14980,.,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
15319,An,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15320,understanding,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15321,of,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15322,food,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15323,cravings,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15324,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15325,aversions,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15326,may,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15327,lead,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15328,to,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15329,improved,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15330,methods,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15331,for,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15332,the,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15333,prevention,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15334,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15335,treatment,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15336,of,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15337,obesity,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15338,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15339,eating,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15340,disorders,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15341,.,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15406,The,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15407,purpose,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15408,of,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15409,this,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15410,study,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15411,was,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15412,to,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15413,evaluate,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15414,the,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15415,effect,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15416,of,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15417,AMF,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15418,naturally,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15419,enriched,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15420,with,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15421,CLA,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15422,and,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15423,VA,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15424,in,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15425,spontaneously,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15426,hypertensive,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15427,rats,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15428,(,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15429,SHR,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15430,),O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15431,",",O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15432,using,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15433,sterculic,B-AG.01.f,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15434,oil,I-AG.01.f,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15435,to,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15436,inhibit,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15437,the,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15438,conversion,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15439,of,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15440,VA,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15441,into,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15442,CLA,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15443,.,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
16099,The,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16100,RS,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16101,pattern,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16102,had,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16103,the,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16104,highest,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16105,contribution,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16106,of,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16107,alcohol,B-AG.01.y.01,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16108,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16109,9.4,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16110,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16111,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16112,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16113,soft,B-AG.01.y,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16114,drinks,I-AG.01.y,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16115,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16116,9.4,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16117,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16118,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16119,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16120,white,B-AG.01.n.11,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16121,bread,I-AG.01.n.11,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16122,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16123,7.7,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16124,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16125,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16126,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16127,fast,B-AG.01,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16128,food,I-AG.01,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16129,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16130,sweets,B-AG.01.n.17.a,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16131,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16132,and,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16133,snacks,B-AG.01,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16134,.,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16691,The,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16692,current,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16693,review,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16694,evaluates,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16695,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16696,available,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16697,literature,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16698,describing,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16699,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16700,relationships,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16701,between,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16702,metabolic,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16703,dysfunction,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16704,",",O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16705,postprandial,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16706,metabolism,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16707,",",O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16708,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16709,vascular,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16710,dysfunction,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16711,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16712,discusses,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16713,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16714,potential,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16715,role,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16716,of,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16717,milk,B-AG.01.e,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16718,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16719,dairy,B-AG.01.e,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16720,products,I-AG.01.e,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16721,in,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16722,attenuating,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16723,these,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16724,impairments,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16725,.,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16864,It,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16865,is,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16866,likely,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16867,that,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16868,the,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16869,coffee,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16870,paradox,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16871,or,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16872,caffeine,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16873,paradox,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16874,exists,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16875,the,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16876,association,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16877,of,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16878,coffee,B-AG.01.ad,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16879,intake,B-X,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16880,with,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16881,cardiovascular,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16882,diseases,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16883,",",O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16884,cardiovascular,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16885,outcomes,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16886,",",O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16887,and,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16888,endothelial,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16889,function,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
16890,.,O,562.0,"It is likely that the coffee paradox or caffeine paradox exists the association of coffee intake with cardiovascular diseases , cardiovascular outcomes , and endothelial function ."
17303,The,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17304,animals,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17305,were,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17306,fed,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17307,either,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17308,a,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17309,commercial,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17310,laboratory,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17311,chow,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17312,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17313,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17314,study,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17315,1,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17316,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17317,",",O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17318,containing,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17319,5,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17320,%,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17321,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17322,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17323,low,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17324,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17325,saturated,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17326,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17327,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17328,1.46,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17329,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17330,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17331,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17332,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17333,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17334,cholesterol,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17335,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17336,0.03,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17337,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17338,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17339,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17340,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17341,or,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17342,a,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17343,semi,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17344,-,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17345,synthetic,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17346,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17347,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17348,study,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17349,2,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17350,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17351,set,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17352,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17353,gelatine,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17354,",",O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17355,containing,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17356,10,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17357,%,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17358,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17359,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17360,high,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17361,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17362,saturated,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17363,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17364,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17365,4,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17366,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17367,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17368,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17369,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17370,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17371,cholesterol,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17372,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17373,0.5,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17374,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17375,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17376,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17377,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17378,.,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17461,For,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17462,serum,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17463,lipid,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17464,analysis,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17465,",",O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17466,blood,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17467,samples,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17468,were,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17469,obtained,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17470,on,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17471,days,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17472,0,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17473,",",O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17474,7,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17475,and,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17476,14,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17477,in,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17478,study,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17479,1,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17480,and,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17481,on,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17482,days,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17483,0,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17484,",",O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17485,7,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17486,",",O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17487,14,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17488,and,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17489,21,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17490,in,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17491,study,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17492,2,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17493,.,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17640,Excess,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17641,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17642,fat,B-AG.01.f,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17643,intake,B-X,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17644,leads,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17645,to,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17646,obesity,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17647,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17648,causes,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17649,a,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17650,variety,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17651,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17652,metabolic,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17653,diseases,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17654,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17655,cancer,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17656,.,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17722,Five,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17723,types,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17724,of,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17725,dietary,B-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17726,fat,I-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17727,were,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17728,divided,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17729,according,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17730,to,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17731,their,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17732,observed,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17733,effects,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17734,:,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17735,Obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17736,with,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17737,high,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17738,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17739,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17740,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17741,I,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17742,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17743,beef,B-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17744,tallow,I-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17745,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17746,lard,B-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17747,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17748,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17749,hydrogenated,B-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17750,coconut,I-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17751,oil,I-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17752,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17753,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17754,non,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17755,-,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17756,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17757,with,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17758,high,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17759,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17760,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17761,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17762,II,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17763,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17764,linseed,B-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17765,oil,I-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17766,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17767,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17768,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17769,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17770,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17771,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17772,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17773,III,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17774,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17775,corn,B-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17776,oil,I-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17777,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17778,olive,B-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17779,oil,I-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17780,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17781,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17782,non,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17783,-,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17784,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17785,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17786,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17787,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17788,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17789,IV,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17790,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17791,soybean,B-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17792,oil,I-AG.01.f,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17793,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17794,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17795,lean,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17796,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17797,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17798,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17799,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17800,V,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17801,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17802,cocoa,B-AG.01,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17803,butter,I-AG.01,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17804,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17805,.,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17897,The,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17898,Mediterranean,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17899,diet,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17900,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17901,one,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17902,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17903,the,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17904,most,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17905,widely,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17906,evaluated,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17907,dietary,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17908,patterns,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17909,in,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17910,scientific,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17911,literature,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17912,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17913,includes,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17914,in,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17915,its,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17916,nutrients,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17917,two,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17918,fluid,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17919,foods,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17920,:,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17921,olive,B-AG.01.f,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17922,oil,I-AG.01.f,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17923,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17924,as,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17925,the,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17926,main,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17927,source,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17928,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17929,fats,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17930,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17931,and,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17932,a,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17933,low,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17934,-,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17935,to,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17936,-,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17937,moderate,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17938,consumption,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17939,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17940,wine,B-AG.01.y.01.a,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17941,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17942,mainly,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17943,red,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17944,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17945,particularly,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17946,during,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17947,meals,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17948,.,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
18147,This,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18148,review,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18149,provides,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18150,an,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18151,overview,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18152,of,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18153,the,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18154,nutritional,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18155,value,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18156,of,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18157,potatoes,B-AG.01.h.02.a,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18158,and,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18159,examines,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18160,the,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18161,evidence,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18162,for,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18163,associations,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18164,between,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18165,potato,B-AG.01.h.02.a,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18166,consumption,B-X,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18167,and,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18168,non,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18169,-,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18170,communicable,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18171,diseases,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18172,.,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18173,Potatoes,B-AG.01.h.02.a,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18174,are,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18175,an,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18176,important,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18177,source,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18178,of,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18179,micronutrients,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18180,",",O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18181,such,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18182,as,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18183,vitamin,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18184,C,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18185,",",O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18186,vitamin,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18187,B6,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18188,",",O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18189,potassium,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18190,",",O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18191,folate,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18192,",",O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18193,and,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18194,iron,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18195,and,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18196,contribute,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18197,a,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18198,significant,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18199,amount,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18200,of,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18201,fibre,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18202,to,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18203,the,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18204,diet,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18205,.,O,608.0,"Potatoes are an important source of micronutrients , such as vitamin C , vitamin B6 , potassium , folate , and iron and contribute a significant amount of fibre to the diet ."
18361,Experimental,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18362,and,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18363,clinical,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18364,studies,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18365,provide,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18366,evidence,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18367,that,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18368,food,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18369,intake,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18370,restricted,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18371,to,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18372,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18373,normal,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18374,activity,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18375,phase,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18376,is,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18377,a,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18378,potent,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18379,synchronizer,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18380,for,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18381,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18382,circadian,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18383,system,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18384,and,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18385,can,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18386,prevent,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18387,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18388,detrimental,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18389,metabolic,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18390,effects,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18391,associated,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18392,with,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18393,circadian,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18394,disruption,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18395,.,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18396,As,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18397,an,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18398,alternative,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18399,",",O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18400,we,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18401,hypothesized,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18402,that,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18403,a,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18404,timed,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18405,piece,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18406,of,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18407,chocolate,B-AG.01.n.17.a,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18408,scheduled,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18409,to,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18410,the,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18411,onset,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18412,of,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18413,the,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18414,activity,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18415,phase,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18416,may,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18417,be,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18418,sufficient,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18419,stimulus,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18420,to,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18421,synchronize,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18422,circadian,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18423,rhythms,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18424,under,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18425,conditions,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18426,of,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18427,shift,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18428,-,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18429,work,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18430,or,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18431,jet,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18432,-,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18433,lag,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18434,.,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18984,FA,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18985,(,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18986,30,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18987,or,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18988,60,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18989,mg,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18990,/,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18991,kg,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18992,),O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18993,was,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18994,orally,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18995,administered,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18996,to,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18997,the,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18998,HCHF,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
18999,and,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19000,control,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19001,rats,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19002,during,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19003,the,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19004,last,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19005,six,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19006,weeks,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19007,of,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19008,the,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19009,study,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19010,.,O,632.0,FA ( 30 or 60 mg / kg ) was orally administered to the HCHF and control rats during the last six weeks of the study .
19302,Pickled,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19303,vegetables,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19304,increased,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19305,the,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19306,risk,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19307,",",O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19308,whereas,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19309,fresh,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19310,vegetables,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19311,did,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19312,not,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19313,.,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19337,Case,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19338,-,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19339,control,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19340,and,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19341,cohort,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19342,studies,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19343,have,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19344,reported,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19345,that,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19346,ginseng,B-AG.01.h.02.i,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19347,intake,B-X,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19348,decreased,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19349,the,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19350,risk,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19351,of,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19352,gastric,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19353,cancer,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19354,.,O,646.0,Case - control and cohort studies have reported that ginseng intake decreased the risk of gastric cancer .
19736,There,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19737,has,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19738,been,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19739,an,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19740,increased,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19741,focus,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19742,on,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19743,identifying,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19744,these,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19745,natural,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19746,components,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19747,of,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19748,foods,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19749,",",O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19750,describing,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19751,their,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19752,physiological,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19753,activities,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19754,and,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19755,mechanisms,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19756,of,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19757,actions,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
19758,.,O,660.0,"There has been an increased focus on identifying these natural components of foods , describing their physiological activities and mechanisms of actions ."
21003,The,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21004,beneficial,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21005,role,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21006,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21007,most,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21008,vegetables,B-AG.01.h.02,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21009,is,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21010,confirmed,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21011,",",O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21012,with,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21013,more,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21014,than,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21015,20,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21016,%,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21017,reduction,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21018,in,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21019,risk,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21020,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21021,colorectal,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21022,cancer,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21023,from,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21024,the,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21025,addition,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21026,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21027,one,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21028,daily,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21029,serving,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21030,.,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21102,Breed,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21103,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21104,milking,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21105,frequency,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21106,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21107,days,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21108,in,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21109,milk,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21110,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21111,seasonality,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21112,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21113,SCC,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21114,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21115,cumulative,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21116,months,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21117,with,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21118,SCC,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21119,greater,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21120,than,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21121,"100,000",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21122,cells,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21123,/,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21124,mL,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21125,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21126,lactation,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21127,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21128,and,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21129,herd,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21130,size,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21131,were,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21132,variables,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21133,included,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21134,in,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21135,the,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21136,regression,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21137,analysis,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21138,.,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21623,Due,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21624,to,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21625,popular,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21626,use,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21627,of,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21628,cinnamon,B-AG.01.l.03,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21629,and,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21630,several,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21631,human,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21632,reports,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21633,on,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21634,adverse,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21635,events,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21636,associated,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21637,with,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21638,short,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21639,or,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21640,long,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21641,term,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21642,use,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21643,of,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21644,cinnamon,B-AG.01.l.03,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21645,",",O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21646,we,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21647,aimed,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21648,to,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21649,systematically,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21650,review,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21651,its,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21652,human,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21653,reports,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21654,of,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21655,adverse,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21656,event,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21657,.,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
22007,Such,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22008,approaches,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22009,to,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22010,limit,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22011,microbial,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22012,growth,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22013,may,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22014,include,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22015,hydrostatic,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22016,pressures,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22017,",",O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22018,irradiation,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22019,",",O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22020,controlled,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22021,atmosphere,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22022,packaging,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22023,",",O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22024,or,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22025,the,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22026,use,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22027,of,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22028,food,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22029,additives,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22030,.,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22541,Milk,B-AG.01.e,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22542,and,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22543,fresh,B-AG.01.e,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22544,cream,I-AG.01.e,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22545,increased,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22546,the,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22547,activity,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22548,of,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22549,human,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22550,retinoid,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22551,X,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22552,receptor,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22553,(,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22554,RXR)alpha,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22555,as,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22556,well,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22557,as,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22558,PPARalpha,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22559,and,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22560,PPARdelta,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22561,",",O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22562,whereas,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22563,neither,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22564,affected,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22565,vitamin,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22566,D3,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22567,receptor,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22568,",",O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22569,estrogen,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22570,receptors,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22571,alpha,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22572,and,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22573,beta,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22574,",",O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22575,or,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22576,thyroid,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22577,receptors,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22578,alpha,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22579,and,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22580,beta,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22581,.,O,755.0,"Milk and fresh cream increased the activity of human retinoid X receptor ( RXR)alpha as well as PPARalpha and PPARdelta , whereas neither affected vitamin D3 receptor , estrogen receptors alpha and beta , or thyroid receptors alpha and beta ."
22582,Both,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22583,milk,B-AG.01.e,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22584,and,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22585,fresh,B-AG.01.e,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22586,cream,I-AG.01.e,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22587,were,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22588,shown,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22589,by,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22590,quantitative,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22591,real,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22592,-,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22593,time,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22594,PCR,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22595,to,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22596,increase,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22597,the,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22598,quantity,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22599,of,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22600,mRNA,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22601,for,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22602,uncoupling,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22603,protein,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22604,2,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22605,(,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22606,UCP2,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22607,),O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22608,",",O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22609,an,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22610,energy,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22611,expenditure,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22612,gene,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22613,",",O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22614,in,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22615,a,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22616,dose,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22617,-,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22618,dependent,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22619,manner,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22620,.,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22766,Slices,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22767,were,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22768,fried,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22769,using,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22770,equivalent,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22771,thermal,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22772,driving,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22773,forces,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22774,",",O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22775,maintaining,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22776,a,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22777,constant,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22778,difference,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22779,between,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22780,oil,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22781,temperature,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22782,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22783,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22784,boiling,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22785,point,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22786,of,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22787,water,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22788,at,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22789,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22790,working,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22791,pressure,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22792,(,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22793,ΔT,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22794,=,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22795,60,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22796,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22797,80,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22798,°,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22799,C,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22800,),O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22801,.,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22876,Carrot,B-AG.01.n.09,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22877,chips,I-AG.01.n.09,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22878,vacuum,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22879,fried,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22880,at,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22881,98,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22882,°,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22883,C,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22884,retained,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22885,about,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22886,90,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22887,%,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22888,of,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22889,total,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22890,carotenoids,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22891,",",O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22892,whereas,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22893,potato,B-AG.01.h.02.a,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22894,and,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22895,apple,B-AG.01.h.01.c,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22896,slices,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22897,vacuum,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22898,fried,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22899,at,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22900,98,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22901,°,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22902,C,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22903,",",O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22904,preserved,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22905,around,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22906,95,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22907,%,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22908,of,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22909,their,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22910,initial,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22911,AA,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22912,content,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
22913,.,O,766.0,"Carrot chips vacuum fried at 98 ° C retained about 90 % of total carotenoids , whereas potato and apple slices vacuum fried at 98 ° C , preserved around 95 % of their initial AA content ."
23567,In,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23568,addition,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23569,to,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23570,the,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23571,scientific,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23572,evidence,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23573,accumulated,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23574,from,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23575,individual,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23576,prospective,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23577,studies,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23578,",",O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23579,several,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23580,meta,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23581,-,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23582,analyses,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23583,have,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23584,shown,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23585,that,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23586,yogurt,B-AG.01.e,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23587,consumption,B-X,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23588,has,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23589,a,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23590,potential,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23591,role,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23592,in,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23593,diabetes,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23594,prevention,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23595,.,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
24103,Texture,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24104,profile,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24105,analysis,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24106,indicated,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24107,that,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24108,disruption,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24109,followed,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24110,by,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24111,pasteurization,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24112,improved,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24113,hardness,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24114,from,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24115,approximately,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24116,175,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24117, ,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24118,g,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24119,force,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24120,from,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24121,the,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24122,control,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24123,",",O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24124,to,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24125,approximately,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24126,325,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24127, ,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24128,g,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24129,force,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24130,for,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24131,disrupted,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24132,+,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24133,pasteurizated,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24134,samples,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24135,without,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24136,fat,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24137,addition,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24138,.,O,810.0,"Texture profile analysis indicated that disruption followed by pasteurization improved hardness from approximately 175   g force from the control , to approximately 325   g force for disrupted + pasteurizated samples without fat addition ."
24656,We,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24657,recruited,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24658,703,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24659,histologically,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24660,confirmed,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24661,cases,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24662,of,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24663,ESCC,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24664,and,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24665,1664,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24666,controls,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24667,individually,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24668,matched,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24669,to,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24670,cases,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24671,for,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24672,age,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24673,",",O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24674,sex,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24675,",",O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24676,and,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24677,district,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24678,of,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24679,residence,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24680,.,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
25209,In,O,852.0,In this there was no reduction of the rate of reinfarction .
25210,this,O,852.0,In this there was no reduction of the rate of reinfarction .
25211,there,O,852.0,In this there was no reduction of the rate of reinfarction .
25212,was,O,852.0,In this there was no reduction of the rate of reinfarction .
25213,no,O,852.0,In this there was no reduction of the rate of reinfarction .
25214,reduction,O,852.0,In this there was no reduction of the rate of reinfarction .
25215,of,O,852.0,In this there was no reduction of the rate of reinfarction .
25216,the,O,852.0,In this there was no reduction of the rate of reinfarction .
25217,rate,O,852.0,In this there was no reduction of the rate of reinfarction .
25218,of,O,852.0,In this there was no reduction of the rate of reinfarction .
25219,reinfarction,O,852.0,In this there was no reduction of the rate of reinfarction .
25220,.,O,852.0,In this there was no reduction of the rate of reinfarction .
25525,Specific,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25526,anti,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25527,-,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25528,wheat,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25529,",",O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25530,rye,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25531,and,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25532,barley,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25533,flour,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25534,IgE,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25535,antibodies,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25536,were,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25537,found,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25538,by,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25539,RAST,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25540,.,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25784,The,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25785,highest,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25786,flow,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25787,rates,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25788,of,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25789,fresh,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25790,matter,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25791,were,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25792,during,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25793,the,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25794,first,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25795,3,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25796,h,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25797,after,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25798,feeding,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25799,.,O,870.0,The highest flow rates of fresh matter were during the first 3 h after feeding .
25890,It,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25891,is,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25892,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25893,main,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25894,glycoside,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25895,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25896,olives,B-AG.01.h.01.e,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25897,",",O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25898,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25899,degradation,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25900,of,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25901,which,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25902,results,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25903,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25904,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25905,formation,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25906,of,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25907,hydroxytyrosol,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25908,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25909,olive,B-AG.01.f,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25910,oil,I-AG.01.f,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25911,.,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25954,They,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25955,down,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25956,regulate,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25957,the,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25958,expression,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25959,of,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25960,BCL-2,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25961,and,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25962,COX-2,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25963,proteins,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25964,",",O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25965,and,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25966,reduced,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25967,DNA,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25968,damage,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25969,.,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25970,Hydroxytyrosol,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25971,and,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25972,oleuropein,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25973,inhibited,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25974,the,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25975,multiple,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25976,stages,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25977,in,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25978,colon,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25979,carcinogenesis,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25980,;,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25981,initiation,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25982,",",O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25983,promotion,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25984,",",O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25985,and,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25986,metastasis,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25987,.,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
26428,Our,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26429,second,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26430,aim,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26431,was,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26432,to,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26433,describe,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26434,training,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26435,-,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26436,of,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26437,-,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26438,trainers,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26439,workshops,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26440,in,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26441,both,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26442,countries,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26443,as,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26444,an,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26445,initial,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26446,response,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26447,to,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26448,the,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26449,findings,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26450,from,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26451,the,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26452,first,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26453,objective,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26454,.,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26489,Many,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26490,farms,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26491,are,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26492,struggling,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26493,with,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26494,feed,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26495,quality,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26496,",",O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26497,reproduction,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26498,",",O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26499,and,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26500,health,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26501,of,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26502,dairy,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26503,cows,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26504,.,O,897.0,"Many farms are struggling with feed quality , reproduction , and health of dairy cows ."
26505,Milk,O,898.0,Milk production per cow and quality is often low .
26506,production,O,898.0,Milk production per cow and quality is often low .
26507,per,O,898.0,Milk production per cow and quality is often low .
26508,cow,O,898.0,Milk production per cow and quality is often low .
26509,and,O,898.0,Milk production per cow and quality is often low .
26510,quality,O,898.0,Milk production per cow and quality is often low .
26511,is,O,898.0,Milk production per cow and quality is often low .
26512,often,O,898.0,Milk production per cow and quality is often low .
26513,low,O,898.0,Milk production per cow and quality is often low .
26514,.,O,898.0,Milk production per cow and quality is often low .
26515,Fresh,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26516,milk,B-AG.01.e,899.0,Fresh milk is collected by milk collection and cooling centers .
26517,is,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26518,collected,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26519,by,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26520,milk,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26521,collection,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26522,and,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26523,cooling,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26524,centers,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26525,.,O,899.0,Fresh milk is collected by milk collection and cooling centers .
26742,Continued,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26743,improvements,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26744,in,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26745,the,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26746,dairy,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26747,value,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26748,chain,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26749,depend,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26750,on,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26751,available,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26752,resources,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26753,for,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26754,education,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26755,.,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
27238,Non,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27239,-,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27240,selective,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27241,use,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27242,of,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27243,pesticide,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27244,to,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27245,increase,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27246,productivity,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27247,leaves,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27248,residues,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27249,on,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27250,crops,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27251,.,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27252,These,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27253,pesticides,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27254,after,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27255,consumption,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27256,have,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27257,a,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27258,detrimental,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27259,effect,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27260,on,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27261,human,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27262,health,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27263,and,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27264,their,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27265,intake,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27266,can,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27267,lead,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27268,to,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27269,various,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27270,diseases,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27271,such,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27272,as,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27273,kidney,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27274,damage,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27275,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27276,neurological,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27277,disorders,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27278,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27279,cardiovascular,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27280,diseases,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27281,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27282,circulatory,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27283,and,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27284,reproductive,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27285,problems,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27286,.,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
28923,This,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28924,review,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28925,describes,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28926,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28927,current,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28928,milk,B-AG.01.e,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28929,consumption,B-X,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28930,trends,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28931,among,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28932,children,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28933,;,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28934,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28935,structure,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28936,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28937,basic,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28938,requirements,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28939,of,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28940,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28941,school,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28942,lunch,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28943,program,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28944,in,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28945,total,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28946,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28947,for,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28948,milk,B-AG.01.e,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28949,;,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28950,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28951,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28952,intrinsic,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28953,",",O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28954,extrinsic,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28955,",",O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28956,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28957,environmental,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28958,factors,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28959,that,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28960,influence,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28961,child,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28962,perception,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28963,",",O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28964,preference,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28965,",",O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28966,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28967,consumption,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28968,of,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28969,fluid,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28970,milk,B-AG.01.e,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28971,in,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28972,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28973,US,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28974,school,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28975,system,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28976,.,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
29054,For,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29055,certain,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29056,individual,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29057,cancer,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29058,sites,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29059,:,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29060,endometrial,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29061,",",O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29062,lung,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29063,",",O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29064,oral,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29065,and,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29066,ovarian,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29067,cancer,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29068,",",O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29069,and,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29070,non,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29071,-,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29072,Hodgkins,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29073,lymphoma,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29074,the,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29075,majority,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29076,of,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29077,meta,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29078,-,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29079,analyses,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29080,observed,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29081,an,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29082,inverse,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29083,association,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29084,with,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29085,green,B-AG.01.ac,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29086,tea,I-AG.01.ac,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29087,.,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29288,Among,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29289,the,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29290,spices,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29291,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29292,black,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29293,pepper,I-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29294,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29295,capsicums,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29296,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29297,cumin,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29298,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29299,cinnamon,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29300,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29301,nutmeg,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29302,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29303,ginger,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29304,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29305,turmeric,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29306,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29307,saffron,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29308,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29309,coriander,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29310,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29311,cloves,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29312,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29313,dill,B-AG.01.h.02.i,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29314,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29315,mint,B-AG.01.h.02.i,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29316,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29317,thyme,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29318,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29319,sesame,B-AG.01,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29320,seed,I-AG.01,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29321,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29322,mustard,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29323,seed,I-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29324,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29325,and,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29326,curry,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29327,powder,I-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29328,are,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29329,the,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29330,most,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29331,popular,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29332,spices,B-AG.01.l.03,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29333,worldwide,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29334,.,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29483,Subjects,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29484,rated,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29485,their,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29486,liking,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29487,of,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29488,French,B-AG.01.n,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29489,toast,I-AG.01.n,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29490,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29491,sausage,B-AG.01.n.05,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29492,and,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29493,the,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29494,overall,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29495,meal,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29496,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29497,or,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29498,chicken,B-AG.01.d.06,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29499,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29500,vegetables,B-AG.01.h.02,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29501,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29502,pasta,B-AG.01.i,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29503,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29504,and,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29505,the,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29506,overall,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29507,meal,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29508,on,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29509,a,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29510,9,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29511,-,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29512,point,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29513,hedonic,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29514,Likert,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29515,scale,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29516,.,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29603,FF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29604,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29605,RFS,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29606,conditions,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29607,were,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29608,liked,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29609,more,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29610,than,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29611,RF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29612,for,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29613,the,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29614,breakfast,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29615,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29616,lunch,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29617,meals,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29618,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29619,French,B-AG.01.n,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29620,toast,I-AG.01.n,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29621,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29622,chicken,B-AG.01.d.06,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29623,entrée,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29624,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29625,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29626,vegetables,B-AG.01.h.02,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29627,.,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29732,The,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29733,objective,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29734,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29735,this,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29736,work,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29737,was,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29738,to,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29739,identify,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29740,the,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29741,effect,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29742,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29743,tomato,B-AG.01.y,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29744,juice,I-AG.01.y,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29745,on,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29746,the,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29747,expression,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29748,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29749,genes,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29750,and,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29751,levels,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29752,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29753,metabolites,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29754,related,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29755,to,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29756,steatosis,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29757,in,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29758,rats,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29759,.,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
30568,The,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30569,results,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30570,show,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30571,that,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30572,COVID-19,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30573,confinement,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30574,did,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30575,influence,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30576,their,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30577,dietary,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30578,habits,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30579,.,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30632,Understanding,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30633,the,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30634,adolescents,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30635,',O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30636,nutrition,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30637,behavior,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30638,during,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30639,COVID-19,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30640,lockdown,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30641,will,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30642,help,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30643,public,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30644,health,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30645,authorities,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30646,reshape,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30647,future,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30648,policies,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30649,on,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30650,their,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30651,nutritional,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30652,recommendations,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30653,",",O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30654,in,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30655,preparation,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30656,for,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30657,future,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30658,pandemics,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30659,.,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
31226,More,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31227,human,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31228,studies,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31229,are,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31230,needed,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31231,to,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31232,provide,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31233,clear,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31234,evidence,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31235,of,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31236,their,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31237,health,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31238,protective,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31239,effects,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31240,and,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31241,to,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31242,better,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31243,evaluate,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31244,the,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31245,risks,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31246,possibly,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31247,resulting,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31248,from,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31249,too,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31250,high,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31251,a,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31252,polyphenol,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31253,consumption,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31254,.,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31376,Comparison,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31377,between,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31378,olive,B-AG.01.f,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31379,and,I-AG.01.f,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31380,seed,I-AG.01.f,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31381,oils,I-AG.01.f,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31382,supports,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31383,the,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31384,superiority,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31385,of,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31386,olive,B-AG.01.f,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31387,oil,I-AG.01.f,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31388,as,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31389,high,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31390,levels,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31391,of,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31392,platelet,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31393,activating,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31394,factor,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31395,(,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31396,PAF,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31397,),O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31398,antagonists,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31399,have,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31400,been,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31401,detected,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31402,",",O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31403,mainly,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31404,in,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31405,TPL,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31406,.,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31558,A,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31559,protective,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31560,effect,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31561,of,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31562,green,B-AG.01.ac,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31563,tea,I-AG.01.ac,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31564,on,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31565,the,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31566,development,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31567,of,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31568,colon,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31569,cancer,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31570,is,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31571,suggested,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31572,.,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31573,The,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31574,evidence,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31575,regarding,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31576,black,B-AG.01.ac,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31577,tea,I-AG.01.ac,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31578,is,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31579,less,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31580,clear,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31581,",",O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31582,with,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31583,some,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31584,indication,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31585,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31586,a,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31587,risk,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31588,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31589,colon,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31590,or,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31591,rectal,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31592,cancer,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31593,associated,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31594,with,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31595,regular,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31596,use,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31597,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31598,black,B-AG.01.ac,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31599,tea,I-AG.01.ac,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31600,.,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31618,The,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31619,range,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31620,and,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31621,crude,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31622,categorization,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31623,of,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31624,tea,B-AG.01.ac,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31625,consumption,B-X,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31626,",",O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31627,choice,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31628,of,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31629,control,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31630,groups,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31631,",",O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31632,and,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31633,inadequate,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31634,control,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31635,for,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31636,confounding,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31637,might,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31638,have,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31639,obscured,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31640,possible,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31641,relationships,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
31642,.,O,1072.0,"The range and crude categorization of tea consumption , choice of control groups , and inadequate control for confounding might have obscured possible relationships ."
32314,In,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32315,this,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32316,review,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32317,we,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32318,focus,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32319,on,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32320,works,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32321,related,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32322,to,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32323,the,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32324,development,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32325,of,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32326,functional,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32327,foods,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32328,from,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32329,common,B-AG.01.i,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32330,buckwheat,I-AG.01.i,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32331,",",O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32332,Fagopyrum,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32333,esculentum,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32334,Moench,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32335,.,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32436,The,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32437,allergenic,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32438,proteins,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32439,existing,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32440,in,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32441,the,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32442,buckwheat,B-AG.01.i,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32443,seeds,I-AG.01.i,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32444,and,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32445,their,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32446,derivatives,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32447,were,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32448,reviewed,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32449,with,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32450,respect,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32451,to,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32452,their,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32453,chemical,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32454,and,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32455,biochemical,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32456,characteristics,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32457,as,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32458,well,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32459,as,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32460,the,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32461,physiological,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32462,reactions,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32463,after,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32464,digestion,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32465,.,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
33122,We,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33123,developed,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33124,a,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33125,',O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33126,dietary,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33127,gap,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33128,assessment,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33129,',O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33130,to,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33131,evaluate,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33132,the,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33133,degree,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33134,to,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33135,which,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33136,a,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33137,nation,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33138,'s,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33139,food,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33140,supply,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33141,could,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33142,support,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33143,healthy,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33144,diets,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33145,at,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33146,the,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33147,population,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33148,level,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33149,.,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33233,For,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33234,each,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33235,of,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33236,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33237,seven,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33238,food,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33239,groups,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33240,in,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33241,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33242,',O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33243,healthy,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33244,',O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33245,diet,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33246,",",O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33247,we,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33248,calculated,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33249,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33250,difference,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33251,between,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33252,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33253,estimated,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33254,national,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33255,supply,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33256,(,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33257,in,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33258,kcal,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33259,",",O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33260,edible,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33261,portion,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33262,only,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33263,),O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33264,and,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33265,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33266,target,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33267,amounts,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33268,.,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33368,Change,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33369,in,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33370,nutritional,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33371,composition,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33372,of,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33373,different,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33374,species,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33375,of,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33376,bamboo,B-AG.01,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33377,shoots,I-AG.01,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33378,with,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33379,processing,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33380,has,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33381,also,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33382,been,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33383,reviewed,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33384,.,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33479,Using,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33480,the,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33481,traditional,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33482,knowledge,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33483,",",O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33484,pharmaceutical,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33485,preparations,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33486,of,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33487,bamboo,B-AG.01,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33488,shoots,I-AG.01,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33489,like,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33490,bamboo,B-AG.01.l.01,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33491,salt,I-AG.01.l.01,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33492,",",O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33493,bamboo,B-AG.01.ae.01,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33494,vinegar,I-AG.01.ae.01,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33495,",",O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33496,bamboo,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33497,extracts,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33498,for,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33499,diabetes,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33500,and,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33501,cholesterol,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33502,control,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33503,",",O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33504,etc,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33505,.,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33557,Male,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33558,BHE,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33559,weanling,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33560,rats,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33561,were,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33562,fed,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33563,a,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33564,65,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33565,%,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33566,starch,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33567,diet,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33568,containing,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33569,5,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33570,%,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33571,corn,B-AG.01.f,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33572,or,I-AG.01.f,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33573,coconut,I-AG.01.f,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33574,oil,I-AG.01.f,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33575,.,O,1144.0,Male BHE weanling rats were fed a 65 % starch diet containing 5 % corn or coconut oil .
33821,The,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33822,amount,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33823,and,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33824,source,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33825,of,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33826,fat,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33827,was,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33828,varied,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33829,in,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33830,diets,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33831,fed,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33832,to,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33833,anemic,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33834,rats,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33835,for,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33836,assaying,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33837,the,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33838,bioavailability,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33839,of,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33840,iron,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33841,from,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33842,turkey,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33843,meat,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33844,.,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
34359,A,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34360,partial,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34361,life,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34362,cycle,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34363,assessment,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34364,detailed,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34365,flows,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34366,of,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34367,milk,B-AG.01.e,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34368,from,I-AG.01.e,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34369,cow,I-AG.01.e,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34370,to,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34371,farm,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34372,gate,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34373,and,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34374,captured,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34375,farm,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34376,inputs,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34377,such,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34378,as,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34379,imported,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34380,feeds,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34381,and,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34382,fertilizers,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34383,.,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34642,Therefore,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34643,",",O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34644,continuous,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34645,modifications,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34646,are,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34647,ongoing,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34648,either,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34649,to,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34650,develop,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34651,new,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34652,cultivars,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34653,for,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34654,different,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34655,purposes,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34656,",",O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34657,or,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34658,novel,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34659,processing,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34660,methods,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34661,to,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34662,improve,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34663,its,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34664,organoleptic,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34665,characters,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34666,.,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34667,In,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34668,this,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34669,review,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34670,",",O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34671,we,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34672,provide,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34673,a,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34674,comprehensive,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34675,overview,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34676,of,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34677,the,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34678,macroconstituents,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34679,and,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34680,microconstituents,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34681,of,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34682,barley,B-AG.01.i,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34683,",",O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34684,its,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34685,nutritional,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34686,value,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34687,and,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34688,prebiotic,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34689,effects,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
34690,.,O,1183.0,"In this review , we provide a comprehensive overview of the macroconstituents and microconstituents of barley , its nutritional value and prebiotic effects ."
35244,The,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35245,walnut,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35246,ELISA,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35247,has,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35248,a,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35249,detection,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35250,limit,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35251,of,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35252,1,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35253,ppm,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35254,(,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35255,1,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35256,microg,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35257,/,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35258,g,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35259,),O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35260,walnut,B-AG.01.h.01.f,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35261,in,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35262,several,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35263,food,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35264,matrices,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35265,.,O,1201.0,The walnut ELISA has a detection limit of 1 ppm ( 1 microg / g ) walnut in several food matrices .
35330,Researchers,O,1204.0,Researchers do not understand what causes ovarian cancer .
35331,do,O,1204.0,Researchers do not understand what causes ovarian cancer .
35332,not,O,1204.0,Researchers do not understand what causes ovarian cancer .
35333,understand,O,1204.0,Researchers do not understand what causes ovarian cancer .
35334,what,O,1204.0,Researchers do not understand what causes ovarian cancer .
35335,causes,O,1204.0,Researchers do not understand what causes ovarian cancer .
35336,ovarian,O,1204.0,Researchers do not understand what causes ovarian cancer .
35337,cancer,O,1204.0,Researchers do not understand what causes ovarian cancer .
35338,.,O,1204.0,Researchers do not understand what causes ovarian cancer .
35339, ,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35340,Some,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35341,studies,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35342,find,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35343,galactose,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35344,to,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35345,be,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35346,toxic,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35347,to,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35348,oocytes,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35349,which,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35350,renders,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35351,ovaries,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35352,susceptible,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35353,to,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35354,cancer,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35355,.,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35734,A,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35735,recent,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35736,study,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35737,established,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35738,that,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35739,milk,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35740,perchlorate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35741,concentrations,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35742,in,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35743,cattle,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35744,highly,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35745,correlate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35746,with,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35747,perchlorate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35748,intake,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35749,.,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35837,Over,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35838,a,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35839,12,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35840,-,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35841,d,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35842,period,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35843,",",O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35844,cows,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35845,were,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35846,ruminally,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35847,infused,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35848,with,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35849,1,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35850,L,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35851,/,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35852,d,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35853,of,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35854,water,B-AG.01.z,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35855,or,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35856,water,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35857,containing,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35858,8,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35859,mg,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35860,of,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35861,perchlorate,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35862,.,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
36612,Patterns,O,1252.0,Patterns of cancer are also changing .
36613,of,O,1252.0,Patterns of cancer are also changing .
36614,cancer,O,1252.0,Patterns of cancer are also changing .
36615,are,O,1252.0,Patterns of cancer are also changing .
36616,also,O,1252.0,Patterns of cancer are also changing .
36617,changing,O,1252.0,Patterns of cancer are also changing .
36618,.,O,1252.0,Patterns of cancer are also changing .
37319,Reference,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37320,Doses,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37321,were,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37322,established,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37323,for,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37324,11,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37325,allergenic,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37326,foods,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37327,ranging,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37328,from,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37329,0.03,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37330,mg,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37331,for,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37332,egg,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37333,protein,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37334,to,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37335,10,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37336,mg,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37337,for,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37338,shrimp,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37339,protein,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37340,.,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37465,Against,O,1282.0,"Against this background , emerging data on potassium are presented ."
37466,this,O,1282.0,"Against this background , emerging data on potassium are presented ."
37467,background,O,1282.0,"Against this background , emerging data on potassium are presented ."
37468,",",O,1282.0,"Against this background , emerging data on potassium are presented ."
37469,emerging,O,1282.0,"Against this background , emerging data on potassium are presented ."
37470,data,O,1282.0,"Against this background , emerging data on potassium are presented ."
37471,on,O,1282.0,"Against this background , emerging data on potassium are presented ."
37472,potassium,O,1282.0,"Against this background , emerging data on potassium are presented ."
37473,are,O,1282.0,"Against this background , emerging data on potassium are presented ."
37474,presented,O,1282.0,"Against this background , emerging data on potassium are presented ."
37475,.,O,1282.0,"Against this background , emerging data on potassium are presented ."
37802,Tested,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37803,meats,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37804,were,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37805,bacon,B-AG.01.d.05,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37806,",",O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37807,pork,B-AG.01.d.05,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37808,",",O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37809,chicken,B-AG.01.d.06,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37810,",",O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37811,and,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37812,beef,B-AG.01.d.03,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37813,.,O,1296.0,"Tested meats were bacon , pork , chicken , and beef ."
37886,Rats,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37887,fed,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37888,a,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37889,diet,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37890,based,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37891,on,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37892,beef,B-AG.01.d.03,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37893,",",O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37894,pork,B-AG.01.d.05,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37895,",",O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37896,or,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37897,chicken,B-AG.01.d.06,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37898,meat,I-AG.01.d.06,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37899,had,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37900,less,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37901,fecal,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37902,NOC,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37903,than,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37904,controls,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37905,(,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37906,most,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37907,p,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37908,<,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37909,0.01,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37910,),O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37911,.,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
38209,A,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38210,possible,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38211,supportive,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38212,action,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38213,may,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38214,be,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38215,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38216,modulation,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38217,of,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38218,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38219,gut,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38220,microbiota,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38221,by,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38222,non,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38223,-,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38224,digested,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38225,prebiotic,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38226,constituents,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38227,of,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38228,coffee,B-AG.01.ad,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38229,",",O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38230,but,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38231,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38232,available,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38233,data,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38234,are,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38235,still,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38236,scarce,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38237,.,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38665,It,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38666,is,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38667,not,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38668,clear,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38669,whether,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38670,alcohol,B-AG.01.y.01,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38671,consumption,B-X,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38672,is,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38673,associated,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38674,with,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38675,lung,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38676,cancer,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38677,risk,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
38678,.,O,1330.0,It is not clear whether alcohol consumption is associated with lung cancer risk .
39219,Only,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39220,with,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39221,comprehensive,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39222,food,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39223,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39224,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39225,strategies,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39226,based,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39227,on,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39228,fiscal,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39229,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39230,regulatory,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39231,measures,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39232,(,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39233,including,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39234,a,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39235,minimum,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39236,unit,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39237,price,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39238,for,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39239,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39240,",",O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39241,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39242,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39243,duty,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39244,escalator,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39245,",",O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39246,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39247,an,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39248,extension,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39249,of,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39250,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39251,sugar,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39252,levy,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39253,on,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39254,food,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39255,content,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39256,),O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39257,can,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39258,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39259,disease,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39260,burden,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39261,be,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39262,curtailed,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39263,.,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39365,We,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39366,propose,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39367,a,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39368,plan,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39369,based,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39370,around,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39371,specialist,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39372,hospital,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39373,centres,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39374,that,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39375,are,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39376,linked,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39377,to,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39378,district,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39379,general,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39380,hospitals,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39381,by,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39382,operational,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39383,delivery,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39384,networks,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39385,.,O,1353.0,We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks .
39522,The,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39523,Lancet,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39524,Commission,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39525,has,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39526,serious,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39527,doubts,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39528,about,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39529,whether,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39530,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39531,initiatives,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39532,described,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39533,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39534,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39535,Prevention,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39536,Green,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39537,Paper,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39538,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39539,with,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39540,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39541,onus,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39542,placed,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39543,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39544,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39545,individual,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39546,based,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39547,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39548,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39549,use,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39550,of,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39551,information,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39552,technology,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39553,and,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39554,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39555,latest,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39556,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39557,behavioural,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39558,science,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39559,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39560,will,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39561,be,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39562,effective,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39563,.,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39695,The,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39696,serum,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39697,lipid,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39698,profiles,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39699,of,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39700,these,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39701,animals,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39702,showed,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39703,a,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39704,dose,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39705,dependent,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39706,decrease,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39707,in,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39708,total,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39709,cholesterol,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39710,",",O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39711,low,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39712,density,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39713,lipoproteins,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39714,and,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39715,very,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39716,low,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39717,density,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39718,lipoproteins,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39719,cholesterol,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39720,",",O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39721,and,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39722,triglyceride,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39723,levels,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39724,when,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39725,ghee,B-AG.01.e.01,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39726,was,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39727,present,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39728,at,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39729,levels,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39730,greater,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39731,than,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39732,2.5,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39733,%,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39734,in,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39735,the,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39736,diet,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39737,.,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39749,When,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39750,ghee,B-AG.01.e.01,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39751,was,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39752,included,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39753,as,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39754,a,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39755,sole,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39756,source,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39757,of,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39758,fat,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39759,at,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39760,a,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39761,10,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39762,%,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39763,level,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39764,",",O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39765,polyunsaturated,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39766,fatty,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39767,acids,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39768,in,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39769,the,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39770,serum,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39771,and,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39772,liver,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39773,lipids,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39774,were,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39775,reduced,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39776,significantly,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39777,.,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
40279,The,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40280,National,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40281,Institutes,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40282,of,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40283,Health,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40284,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40285,AARP,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40286,(,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40287,NIH,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40288,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40289,AARP,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40290,),O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40291,Diet,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40292,and,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40293,Health,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40294,Study,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40295,recruited,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40296,"566,398",O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40297,individuals,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40298,aged,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40299,50,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40300,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40301,71,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40302,at,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40303,baseline,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40304,in,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40305,1995,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40306,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40307,1996,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40308,.,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40676,Overweight,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40677,teen,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40678,-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40679,agers,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40680,appear,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40681,to,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40682,be,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40683,more,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40684,conscious,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40685,of,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40686,their,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40687,food,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40688,intake,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40689,than,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40690,under-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40691,and,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40692,normal,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40693,-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40694,weight,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40695,children,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40696,.,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40850,The,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40851,concentrations,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40852,of,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40853,fatty,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40854,acids,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40855,as,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40856,well,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40857,as,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40858,bile,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40859,acids,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40860,in,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40861,fecal,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40862,water,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40863,were,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40864,",",O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40865,however,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40866,",",O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40867,significantly,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40868,lowered,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40869,by,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40870,calcium,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40871,phosphate,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40872,supplementation,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40873,in,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40874,rats,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40875,fed,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40876,all,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40877,types,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40878,of,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40879,dietary,B-AG.01.f,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40880,fat,I-AG.01.f,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40881,.,O,1400.0,"The concentrations of fatty acids as well as bile acids in fecal water were , however , significantly lowered by calcium phosphate supplementation in rats fed all types of dietary fat ."
40899,The,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40900,concentration,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40901,of,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40902,surfactants,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40903,in,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40904,fecal,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40905,water,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40906,and,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40907,cytotoxicity,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40908,were,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40909,correlated,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40910,by,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40911,multiple,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40912,regression,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40913,analysis,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40914,(,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40915,R,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40916,=,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40917,0.89,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40918,),O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40919,.,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
41337,We,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41338,therefore,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41339,assessed,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41340,the,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41341,effect,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41342,of,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41343,decreasing,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41344,postprandial,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41345,glucose,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41346,excursions,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41347,on,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41348,measures,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41349,of,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41350,oxidative,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41351,damage,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41352,.,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
42491,A,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42492,multi,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42493,-,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42494,centre,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42495,case,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42496,-,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42497,control,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42498,study,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42499,of,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42500,diet,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42501,and,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42502,gastric,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42503,cancer,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42504,was,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42505,carried,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42506,out,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42507,in,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42508,4,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42509,regions,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42510,of,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42511,Spain,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42512,(,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42513,Aragon,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42514,",",O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42515,Castile,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42516,",",O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42517,Catalonia,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42518,and,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42519,Galicia,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42520,),O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42521,.,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42591,The,O,1459.0,The results regarding consumption of food items are presented here .
42592,results,O,1459.0,The results regarding consumption of food items are presented here .
42593,regarding,O,1459.0,The results regarding consumption of food items are presented here .
42594,consumption,O,1459.0,The results regarding consumption of food items are presented here .
42595,of,O,1459.0,The results regarding consumption of food items are presented here .
42596,food,O,1459.0,The results regarding consumption of food items are presented here .
42597,items,O,1459.0,The results regarding consumption of food items are presented here .
42598,are,O,1459.0,The results regarding consumption of food items are presented here .
42599,presented,O,1459.0,The results regarding consumption of food items are presented here .
42600,here,O,1459.0,The results regarding consumption of food items are presented here .
42601,.,O,1459.0,The results regarding consumption of food items are presented here .
42751,A,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42752,dietary,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42753,food,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42754,pattern,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42755,naturally,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42756,rich,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42757,in,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42758,polyphenols,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42759,is,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42760,the,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42761,Mediterranean,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42762,diet,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42763,and,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42764,evidence,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42765,suggests,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42766,those,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42767,of,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42768,Mediterranean,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42769,descent,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42770,have,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42771,a,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42772,lower,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42773,breast,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42774,cancer,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42775,incidence,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42776,.,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
43119,Spinach,B-AG.01.h.02.c,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43120,showed,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43121,the,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43122,highest,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43123,inhibitory,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43124,effect,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43125,",",O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43126,followed,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43127,by,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43128,cabbage,B-AG.01.h.02.d,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43129,",",O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43130,red,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43131,pepper,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43132,",",O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43133,onion,B-AG.01.h.02.e,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43134,",",O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43135,and,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43136,broccoli,B-AG.01.h.02.d,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43137,.,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43298,The,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43299,published,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43300,data,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43301,interventions,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43302,reported,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43303,are,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43304,diverse,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43305,and,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43306,vary,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43307,widely,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43308,in,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43309,quality,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43310,",",O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43311,including,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43312,poor,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43313,selection,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43314,of,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43315,control,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43316,products,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43317,or,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43318,inadequate,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43319,blinding,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43320,procedures,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43321,.,O,1487.0,"The published data interventions reported are diverse and vary widely in quality , including poor selection of control products or inadequate blinding procedures ."
43739,Understanding,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43740,the,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43741,role,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43742,of,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43743,low,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43744,-,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43745,level,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43746,arsenic,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43747,as,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43748,it,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43749,relates,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43750,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43751,subclinical,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43752,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43753,may,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43754,contribute,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43755,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43756,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43757,prevention,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43758,and,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43759,control,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43760,.,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43960,We,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43961,observed,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43962,that,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43963,the,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43964,hazard,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43965,ratio,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43966,for,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43967,total,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43968,death,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43969,rates,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43970,showed,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43971,a,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43972,U,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43973,-,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43974,shaped,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43975,association,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43976,with,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43977,nut,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43978,/,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43979,peanut,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43980,butter,B-AG.01.e.01,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43981,consumption,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
43982,.,O,1514.0,We observed that the hazard ratio for total death rates showed a U - shaped association with nut / peanut butter consumption .
44548,By,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44549,ELISA,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44550,",",O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44551,specific,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44552,IgE,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44553,antibodies,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44554,to,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44555,paprika,B-AG.01.l.03,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44556,",",O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44557,coriander,B-AG.01.l.03,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44558,",",O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44559,and,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44560,mace,B-AG.01.l.03,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44561,were,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44562,demonstrated,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44563,.,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44587,The,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44588,immunoblot,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44589,analysis,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44590,showed,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44591,two,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44592,IgE,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44593,-,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44594,reactive,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44595,protein,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44596,bands,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44597,able,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44598,to,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44599,bind,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44600,to,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44601,IgE,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44602,from,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44603,mace,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44604,of,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44605,20,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44606,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44607,40,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44608,kDa,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44609,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44610,two,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44611,other,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44612,bands,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44613,from,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44614,coriander,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44615,extract,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44616,of,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44617,50,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44618,and,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44619,56,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44620,kDa,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44621,.,O,1537.0,The immunoblot analysis showed two IgE - reactive protein bands able to bind to IgE from mace of 20 and 40 kDa and two other bands from coriander extract of 50 and 56 kDa .
44733,In,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44734,contrast,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44735,",",O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44736,consumption,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44737,of,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44738,white,B-AG.01.d.06,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44739,meat,I-AG.01.d.06,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44740,(,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44741,chicken,B-AG.01.d.06,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44742,),O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44743,is,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44744,not,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44745,associated,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44746,with,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44747,risk,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44748,and,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44749,might,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44750,even,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44751,reduce,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44752,the,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44753,occurrence,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44754,of,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44755,colorectal,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44756,cancer,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44757,.,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44758,We,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44759,speculated,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44760,that,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44761,a,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44762,diet,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44763,containing,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44764,beef,B-AG.01.d.03,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44765,or,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44766,bacon,B-AG.01.d.05,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44767,would,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44768,increase,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44769,and,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44770,a,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44771,diet,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44772,containing,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44773,chicken,B-AG.01.d.06,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44774,would,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44775,decrease,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44776,colon,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44777,carcinogenesis,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44778,in,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44779,rats,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44780,.,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44922,The,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44923,ACF,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44924,multiplicity,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44925,was,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44926,nearly,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44927,the,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44928,same,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44929,in,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44930,all,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44931,groups,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44932,",",O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44933,except,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44934,bacon,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44935,-,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44936,fed,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44937,rats,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44938,",",O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44939,with,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44940,no,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44941,effect,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44942,of,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44943,fat,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44944,and,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44945,protein,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44946,level,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44947,or,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44948,source,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44949,(,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44950,p,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44951,=,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44952,0.7,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44953,between,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44954,8,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44955,groups,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44956,by,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44957,analysis,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44958,of,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44959,variance,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44960,),O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44961,.,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
45173,Domestic,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45174,use,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45175,of,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45176,kefir,B-AG.01.e,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45177,is,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45178,straightforward,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45179,and,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45180,the,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45181,eggshell,B-AG.01,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45182,is,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45183,a,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45184,natural,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45185,discarded,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45186,source,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45187,of,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45188,Ca,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45189,.,O,1559.0,Domestic use of kefir is straightforward and the eggshell is a natural discarded source of Ca .
45497,",",O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45498,(,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45499,OR,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45500,=,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45501,1.51,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45502,;,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45503,95,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45504,%,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45505,CI,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45506,1.09,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45507,-,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45508,2.09,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45509,),O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45510,and,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45511,cabbages,B-AG.01.h.02.d,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45512,(,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45513,OR,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45514,=,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45515,1.51,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45516,;,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45517,95,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45518,%,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45519,CI,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45520,1.09,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45521,-,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45522,2.09,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45523,),O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45524,.,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45607,Our,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45608,results,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45609,suggest,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45610,potentially,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45611,adverse,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45612,effects,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45613,on,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45614,melanoma,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45615,risk,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45616,of,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45617,foods,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45618,characterized,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45619,by,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45620,high,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45621,contents,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45622,of,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45623,refined,B-AG.01.k,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45624,flours,I-AG.01.k,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45625,and,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45626,sugars,B-AG.01.l.02,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45627,",",O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45628,while,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45629,suggesting,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45630,a,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45631,protective,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45632,role,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45633,for,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45634,eggs,B-AG.01.g,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45635,and,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45636,two,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45637,key,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45638,components,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45639,of,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45640,the,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45641,Mediterranean,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45642,diet,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45643,",",O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45644,legumes,B-AG.01.h.02.g,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45645,and,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45646,olive,B-AG.01.f,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45647,oil,I-AG.01.f,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45648,.,O,1577.0,"Our results suggest potentially adverse effects on melanoma risk of foods characterized by high contents of refined flours and sugars , while suggesting a protective role for eggs and two key components of the Mediterranean diet , legumes and olive oil ."
45799,Spinach,B-AG.01.h.02.c,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45800,had,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45801,the,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45802,strongest,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45803,inhibitory,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45804,effect,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45805,on,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45806,pol,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45807,alpha,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45808,activity,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45809,and,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45810,human,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45811,cancer,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45812,cell,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45813,proliferation,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45814,.,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45829,Therefore,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45830,",",O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45831,the,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45832,inhibition,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45833,of,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45834,pol,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45835,alpha,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45836,activity,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45837,by,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45838,SQDG,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45839,may,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45840,lead,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45841,to,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45842,cell,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45843,growth,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45844,suppression,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45845,.,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
46327,Other,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46328,contributions,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46329,have,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46330,included,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46331,the,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46332,value,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46333,of,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46334,nut,B-AG.01.h.01.f,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46335,consumption,B-X,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46336,for,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46337,prevention,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46338,of,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46339,coronary,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46340,artery,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46341,disease,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46342,",",O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46343,and,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46344,the,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46345,roles,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46346,of,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46347,red,B-AG.01.d,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46348,meat,I-AG.01.d,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46349,and,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46350,dairy,B-AG.01.e,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46351,products,I-AG.01.e,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46352,in,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46353,the,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46354,etiologies,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46355,of,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46356,cardiovascular,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46357,disease,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46358,and,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46359,cancer,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46360,.,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46649,In,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46650,order,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46651,to,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46652,increase,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46653,the,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46654,sustainability,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46655,of,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46656,a,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46657,cardio,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46658,-,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46659,protective,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46660,diet,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46661,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46662,consumers,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46663,can,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46664,choose,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46665,nuts,B-AG.01.h.01.f,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46666,(,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46667,e.g.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46668,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46669,walnuts,B-AG.01.h.01.f,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46670,),O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46671,and,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46672,oils,B-AG.01.f,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46673,(,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46674,e.g.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46675,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46676,sunflower,B-AG.01.f,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46677,),O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46678,with,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46679,lower,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46680,water,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46681,footprints,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46682,and,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46683,sustainably,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46684,produced,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46685,fish,B-AG.01.d.07,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46686,.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
47001,The,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47002,flavonoids,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47003,are,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47004,polyphenols,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47005,which,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47006,in,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47007,vitro,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47008,exhibit,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47009,antioxidant,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47010,properties,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47011,.,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47149,Similarly,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47150,consumption,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47151,of,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47152,milky,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47153,tea,B-AG.01.ac,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47154,produced,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47155,no,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47156,change,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47157,in,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47158,FRAP,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47159,between,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47160,9.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47161,a.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47162,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47163,12.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47164,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47165,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47166,the,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47167,50,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47168,%,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47169,increase,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47170,in,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47171,FRAP,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47172,noted,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47173,between,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47174,12.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47175,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47176,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47177,15.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47178,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47179,was,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47180,not,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47181,statistically,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47182,significant,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47183,.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47798,Avoiding,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47799,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47800,high,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47801,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47802,fat,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47803,/,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47804,low,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47805,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47806,fibre,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47807,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47808,and,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47809,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47810,high,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47811,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47812,sugar,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47813,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47814,dietary,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47815,components,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47816,may,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47817,reduce,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47818,the,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47819,risk,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47820,of,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47821,cardiovascular,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47822,events,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47823,and,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47824,all,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47825,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47826,cause,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47827,mortality,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47828,in,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47829,older,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47830,adults,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47831,.,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47832,Test,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47833,meals,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47834,with,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47835,25,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47836,g,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47837,protein,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47838,in,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47839,the,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47840,form,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47841,of,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47842,cottage,B-AG.01.e,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47843,cheese,I-AG.01.e,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47844,or,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47845,egg,B-AG.01.g,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47846,white,I-AG.01.g,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47847,were,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47848,given,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47849,with,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47850,or,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47851,without,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47852,50,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47853,g,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47854,glucose,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47855,to,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47856,male,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47857,subjects,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47858,with,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47859,mild,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47860,to,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47861,moderately,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47862,severe,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47863,",",O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47864,untreated,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47865,",",O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47866,type,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47867,II,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47868,diabetes,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
47869,.,O,1653.0,"Test meals with 25 g protein in the form of cottage cheese or egg white were given with or without 50 g glucose to male subjects with mild to moderately severe , untreated , type II diabetes ."
48249,Two,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48250,hundred,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48251,eight,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48252,cases,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48253,and,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48254,399,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48255,controls,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48256,",",O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48257,all,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48258,males,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48259,",",O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48260,were,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48261,interviewed,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48262,about,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48263,their,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48264,eating,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48265,",",O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48266,drinking,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48267,and,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48268,smoking,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48269,habits,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48270,.,O,1668.0,"Two hundred eight cases and 399 controls , all males , were interviewed about their eating , drinking and smoking habits ."
48589,For,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48590,potato,B-AG.01.n.09,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48591,chips,I-AG.01.n.09,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48592,",",O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48593,consumers,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48594,liked,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48595,samples,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48596,characterized,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48597,by,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48598,meaty,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48599,aftertaste,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48600,",",O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48601,aroma,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48602,",",O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48603,aroma,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48604,-,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48605,by,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48606,-,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48607,mouth,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48608,",",O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48609,and,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48610,umami,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48611,aftertaste,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48612,.,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48613,Consumers,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48614,disliked,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48615,samples,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48616,with,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48617,a,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48618,strong,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48619,raw,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48620,potato,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48621,aroma,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48622,.,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48786,This,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48787,has,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48788,led,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48789,to,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48790,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48791,creation,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48792,of,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48793,a,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48794,"""",O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48795,glycemic,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48796,index,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48797,",",O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48798,"""",O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48799,a,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48800,classification,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48801,of,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48802,dietary,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48803,carbohydrates,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48804,on,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48805,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48806,basis,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48807,of,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48808,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48809,relative,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48810,rise,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48811,in,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48812,plasma,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48813,glucose,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48814,after,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48815,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48816,administration,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48817,of,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48818,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48819,food,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48820,in,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48821,question,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48822,as,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48823,compared,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48824,to,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48825,a,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48826,standard,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48827,glucose,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48828,challenge,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48829,.,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
49128,Their,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49129,common,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49130,central,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49131,feature,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49132,is,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49133,the,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49134,usage,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49135,of,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49136,olive,B-AG.01.f,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49137,oil,I-AG.01.f,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49138,as,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49139,the,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49140,main,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49141,source,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49142,of,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49143,fat,B-AG.01.f,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49144,.,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49145,The,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49146,health,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49147,benefits,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49148,attributed,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49149,to,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49150,olive,B-AG.01.f,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49151,oil,I-AG.01.f,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49152,are,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49153,specifically,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49154,related,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49155,to,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49156,extra,B-AG.01.f,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49157,virgin,I-AG.01.f,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49158,olive,I-AG.01.f,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49159,oil,I-AG.01.f,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49160,(,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49161,EVOO,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49162,),O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49163,intake,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49164,with,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49165,its,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49166,high,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49167,nutritional,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49168,quality,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49169,and,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49170,multiple,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49171,positive,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49172,effects,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49173,on,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49174,health,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49175,.,O,1698.0,The health benefits attributed to olive oil are specifically related to extra virgin olive oil ( EVOO ) intake with its high nutritional quality and multiple positive effects on health .
49441,Overall,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49442,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49443,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49444,IMI,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49445,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49446,early,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49447,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49448,caused,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49449,only,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49450,a,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49451,slight,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49452,but,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49453,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49454,increase,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49455,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49456,qSCC,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49457,compared,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49458,with,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49459,milk,B-AG.01.e,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49460,from,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49461,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49462,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49463,during,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49464,the,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49465,first,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49466,4,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49467,mo,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49468,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49469,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49470,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49471,whereas,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49472,no,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49473,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49474,difference,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49475,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49476,daily,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49477,qMY,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49478,was,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49479,present,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49480,between,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49481,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49482,-,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49483,infected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49484,and,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49485,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49486,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49487,.,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49729,The,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49730,results,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49731,showed,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49732,a,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49733,positive,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49734,impact,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49735,of,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49736,the,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49737,new,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49738,technology,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49739,on,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49740,the,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49741,oil,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49742,yield,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49743,",",O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49744,with,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49745,an,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49746,increase,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49747,ranging,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49748,from,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49749,2.3,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49750,to,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49751,6,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49752,%,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49753,",",O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49754,and,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49755,on,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49756,the,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49757,concentration,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49758,of,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49759,hydrophilic,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49760,phenols,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49761,",",O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49762,with,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49763,an,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49764,increase,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49765,ranging,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49766,from,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49767,3.2,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49768,to,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49769,14.3,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49770,%,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49771,",",O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49772,with,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49773,respect,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49774,to,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49775,the,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49776,control,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49777,tests,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49778,.,O,1716.0,"The results showed a positive impact of the new technology on the oil yield , with an increase ranging from 2.3 to 6 % , and on the concentration of hydrophilic phenols , with an increase ranging from 3.2 to 14.3 % , with respect to the control tests ."
49882,The,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49883,objective,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49884,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49885,this,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49886,study,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49887,was,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49888,to,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49889,evaluate,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49890,the,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49891,effects,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49892,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49893,fat,B-AG.01.k,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49894,free,I-AG.01.k,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49895,peanut,I-AG.01.k,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49896,flour,I-AG.01.k,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49897,(,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49898,FFPF,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49899,),O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49900,",",O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49901,peanuts,B-AG.01.h.01.f,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49902,",",O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49903,and,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49904,peanut,B-AG.01.f,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49905,oil,I-AG.01.f,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49906,on,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49907,cardiovascular,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49908,disease,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49909,(,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49910,CVD,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49911,),O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49912,risk,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49913,factors,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49914,and,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49915,the,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49916,development,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49917,of,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49918,atherosclerosis,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49919,in,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49920,male,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49921,Syrian,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49922,golden,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49923,hamsters,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49924,.,O,1720.0,"The objective of this study was to evaluate the effects of fat free peanut flour ( FFPF ) , peanuts , and peanut oil on cardiovascular disease ( CVD ) risk factors and the development of atherosclerosis in male Syrian golden hamsters ."
49961,Tissues,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49962,were,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49963,collected,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49964,at,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49965,week,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49966,0,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49967,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49968,12,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49969,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49970,18,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49971,",",O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49972,and,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49973,24,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
49974,.,O,1722.0,"Tissues were collected at week 0 , 12 , 18 , and 24 ."
50154,It,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50155,has,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50156,been,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50157,reported,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50158,that,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50159,miso,B-AG.01.n.02,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50160,soup,I-AG.01.n.02,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50161,was,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50162,one,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50163,of,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50164,the,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50165,major,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50166,sources,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50167,of,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50168,daily,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50169,salt,B-AG.01.l.01,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50170,intake,B-X,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50171,in,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50172,Japanese,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50173,people,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50174,.,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50175,Adding,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50176,salt,B-AG.01.l.01,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50177,is,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50178,indispensable,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50179,to,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50180,make,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50181,miso,B-AG.01.n.02,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50182,",",O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50183,and,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50184,therefore,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50185,",",O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50186,in,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50187,some,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50188,cases,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50189,",",O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50190,refraining,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50191,from,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50192,miso,B-AG.01.n.02,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50193,soup,I-AG.01.n.02,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50194,is,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50195,recommended,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50196,to,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50197,reduce,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50198,dietary,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50199,salt,B-AG.01.l.01,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50200,intake,B-X,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50201,.,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50247,In,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50248,addition,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50249,",",O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50250,many,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50251,clinical,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50252,observational,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50253,studies,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50254,have,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50255,demonstrated,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50256,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50257,absence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50258,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50259,a,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50260,relationship,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50261,between,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50262,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50263,frequency,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50264,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50265,miso,B-AG.01.n.02,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50266,soup,I-AG.01.n.02,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50267,intake,B-X,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50268,and,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50269,blood,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50270,pressure,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50271,levels,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50272,or,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50273,hypertension,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50274,incidence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50275,.,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50607,The,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50608,present,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50609,study,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50610,demonstrates,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50611,that,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50612,there,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50613,was,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50614,considerable,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50615,variation,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50616,in,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50617,the,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50618,trends,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50619,in,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50620,reported,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50621,food,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50622,PS,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50623,over,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50624,this,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50625,period,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50626,.,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
51169,The,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51170,major,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51171,components,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51172,of,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51173,the,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51174,"""",O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51175,cold,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51176,foods,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51177,"""",O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51178,pattern,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51179,were,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51180,fruit,B-AG.01.h.01,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51181,",",O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51182,fruit,B-AG.01.ab,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51183,juice,I-AG.01.ab,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51184,and,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51185,cold,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51186,breakfast,B-AG.01.n.10,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51187,cereals,I-AG.01.n.10,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51188,.,O,1757.0,"The major components of the "" cold foods "" pattern were fruit , fruit juice and cold breakfast cereals ."
51223,After,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51224,adjustment,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51225,for,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51226,daily,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51227,energy,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51228,intake,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51229,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51230,the,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51231,"""",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51232,meat,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51233,"""",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51234,pattern,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51235,was,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51236,positively,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51237,associated,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51238,with,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51239,body,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51240,mass,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51241,index,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51242,(,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51243,r,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51244,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51245,0.17,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51246,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51247,P,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51248,:,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51249,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51250,0.0001,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51251,),O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51252,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51253,whereas,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51254,the,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51255,other,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51256,three,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51257,patterns,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51258,showed,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51259,negative,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51260,relationships,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51261,to,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51262,body,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51263,mass,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51264,index,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51265,(,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51266,r,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51267,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51268,-0.076,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51269,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51270,P,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51271,:,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51272,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51273,0.084,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51274,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51275,r,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51276,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51277,-0.13,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51278,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51279,P,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51280,:,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51281,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51282,0.003,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51283,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51284,and,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51285,r,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51286,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51287,-0.13,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51288,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51289,P,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51290,:,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51291,=,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51292,0.003,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51293,),O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51294,for,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51295,vegetables,B-AG.01.h.02,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51296,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51297,beans,B-AG.01.h.02.g,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51298,and,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51299,cold,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51300,foods,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51301,",",O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51302,respectively,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51303,.,O,1759.0,"After adjustment for daily energy intake , the "" meat "" pattern was positively associated with body mass index ( r = 0.17 , P : = 0.0001 ) , whereas the other three patterns showed negative relationships to body mass index ( r = -0.076 , P : = 0.084 , r = -0.13 , P : = 0.003 , and r = -0.13 , P : = 0.003 ) for vegetables , beans and cold foods , respectively ."
51317,The,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51318,study,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51319,results,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51320,support,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51321,the,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51322,ideas,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51323,that,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51324,choosing,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51325,the,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51326,right,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51327,foods,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51328,may,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51329,be,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51330,important,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51331,in,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51332,weight,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51333,control,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51334,and,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51335,that,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51336,food,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51337,-,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51338,based,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51339,dietary,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51340,patterns,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51341,may,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51342,be,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51343,useful,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51344,in,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51345,dietary,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51346,counseling,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51347,.,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51735,Between,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51736,days,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51737,7,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51738,and,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51739,11,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51740,and,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51741,days,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51742,28,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51743,and,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51744,32,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51745,complete,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51746,5,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51747,d,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51748,faecal,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51749,collections,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51750,were,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51751,made,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51752,for,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51753,the,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51754,measurement,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51755,of,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51756,neutral,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51757,",",O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51758,acidic,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51759,and,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51760,conjugated,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51761,steroids,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51762,.,O,1774.0,"Between days 7 and 11 and days 28 and 32 complete 5 d faecal collections were made for the measurement of neutral , acidic and conjugated steroids ."
51837,The,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51838,results,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51839,suggest,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51840,that,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51841,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51842,mechanism,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51843,for,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51844,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51845,hypocholesterolaemic,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51846,effect,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51847,does,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51848,not,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51849,involve,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51850,increased,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51851,hepatic,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51852,bile,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51853,acid,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51854,synthesis,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51855,and,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51856,thereby,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51857,increased,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51858,cholesterol,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51859,clearance,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51860,via,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51861,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51862,intestinal,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51863,route,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51864,.,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51958,The,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51959,prefortification,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51960,folate,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51961,status,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51962,of,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51963,751,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51964,healthy,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51965,women,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51966,of,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51967,reproductive,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51968,age,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51969,was,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51970,assessed,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51971,.,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
52178,The,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52179,effect,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52180,of,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52181,the,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52182,FA,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52183,fortification,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52184,program,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52185,on,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52186,the,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52187,occurrence,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52188,of,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52189,NTD,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52190,is,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52191,currently,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52192,being,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52193,assessed,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52194,.,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52863,Spice,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52864,extracts,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52865,exhibited,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52866,high,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52867,antioxidant,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52868,capacity,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52869,that,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52870,correlated,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52871,with,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52872,the,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52873,total,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52874,amount,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52875,of,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52876,major,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52877,chemicals,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52878,.,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52879,All,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52880,spice,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52881,extracts,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52882,",",O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52883,with,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52884,the,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52885,exception,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52886,of,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52887,turmeric,B-AG.01.l.03,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52888,",",O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52889,enhanced,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52890,the,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52891,growth,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52892,of,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52893,Bifidobacterium,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52894,spp,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52895,.,O,1815.0,"All spice extracts , with the exception of turmeric , enhanced the growth of Bifidobacterium spp ."
52896,and,O,1816.0,and Lactobacillus spp .
52897,Lactobacillus,O,1816.0,and Lactobacillus spp .
52898,spp,O,1816.0,and Lactobacillus spp .
52899,.,O,1816.0,and Lactobacillus spp .
53029,Potatoes,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53030,",",O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53031,especially,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53032,mashed,B-AG.01.n,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53033,potatoes,I-AG.01.n,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53034,",",O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53035,are,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53036,known,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53037,to,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53038,result,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53039,in,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53040,high,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53041,glycaemic,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53042,and,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53043,insulinaemic,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53044,responses,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53045,.,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53137,Capillary,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53138,blood,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53139,samples,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53140,were,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53141,then,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53142,drawn,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53143,for,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53144,2,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53145,h,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53146,",",O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53147,and,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53148,glucose,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53149,and,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53150,insulin,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53151,were,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53152,analysed,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53153,.,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53243,Chicken,B-AG.01.d.06,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53244,breast,I-AG.01.d.06,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53245,in,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53246,the,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53247,meal,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53248,increased,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53249,the,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53250,insulinaemic,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53251,response,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53252,",",O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53253,and,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53254,rapeseed,B-AG.01.f,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53255,oil,I-AG.01.f,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53256,diminished,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53257,it,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53258,.,O,1831.0,"Chicken breast in the meal increased the insulinaemic response , and rapeseed oil diminished it ."
53259,However,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53260,",",O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53261,the,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53262,insulinaemic,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53263,response,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53264,to,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53265,mashed,B-AG.01.n,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53266,potato,I-AG.01.n,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53267,with,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53268,chicken,B-AG.01.d.06,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53269,breast,I-AG.01.d.06,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53270,and,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53271,rapeseed,B-AG.01.f,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53272,oil,I-AG.01.f,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53273,was,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53274,lower,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53275,than,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53276,that,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53277,to,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53278,mashed,B-AG.01.n,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53279,potato,I-AG.01.n,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53280,alone,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53281,.,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53356,The,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53357,aim,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53358,of,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53359,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53360,study,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53361,was,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53362,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53363,investigate,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53364,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53365,nutritional,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53366,status,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53367,and,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53368,adherence,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53369,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53370,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53371,Mediterranean,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53372,Diet,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53373,(,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53374,MD,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53375,),O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53376,in,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53377,GEP,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53378,-,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53379,NET,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53380,patients,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53381,and,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53382,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53383,correlate,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53384,them,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53385,with,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53386,tumor,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53387,aggressiveness,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53388,.,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53653,However,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53654,",",O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53655,rates,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53656,of,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53657,obesity,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53658,and,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53659,diabetes,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53660,rose,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53661,markedly,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53662,throughout,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53663,this,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53664,period,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53665,",",O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53666,with,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53667,potentially,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53668,catastrophic,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53669,implications,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53670,for,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53671,public,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53672,health,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53673,and,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53674,the,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53675,economy,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
53676,.,O,1847.0,"However , rates of obesity and diabetes rose markedly throughout this period , with potentially catastrophic implications for public health and the economy ."
54174,Intakes,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54175,of,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54176,cabbage,B-AG.01.h.02.d,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54177,",",O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54178,lettuce,B-AG.01.h.02.c,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54179,",",O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54180,green,B-AG.01.h.02.c,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54181,leafy,I-AG.01.h.02.c,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54182,vegetables,I-AG.01.h.02.c,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54183,",",O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54184,carrots,B-AG.01.h.02.a,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54185,",",O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54186,squash,B-AG.01.h.02.f,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54187,",",O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54188,tomatoes,B-AG.01.h.02.f,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54189,",",O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54190,and,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54191,oranges,B-AG.01.h.01.a,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54192,were,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54193,not,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54194,significantly,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54195,associated,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54196,with,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54197,the,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54198,risk,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
54199,.,O,1870.0,"Intakes of cabbage , lettuce , green leafy vegetables , carrots , squash , tomatoes , and oranges were not significantly associated with the risk ."
55017,Positively,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55018,tested,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55019,edibles,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55020,were,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55021,staple,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55022,foods,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55023,such,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55024,as,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55025,maize,B-AG.01.i,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55026,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55027,rice,B-AG.01.i,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55028,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55029,wheat,B-AG.01.k,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55030,flour,I-AG.01.k,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55031,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55032,millet,B-AG.01.i,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55033,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55034,potato,B-AG.01.h.02.a,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55035,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55036,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55037,milk,B-AG.01.e,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55038,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55039,also,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55040,cocoa,B-AG.01,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55041,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55042,popcorn,B-AG.01,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55043,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55044,tomato,B-AG.01.h.02.f,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55045,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55046,carrot,B-AG.01.h.02.a,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55047,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55048,pineapple,B-AG.01.h.01,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55049,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55050,kiwi,B-AG.01.h.01,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55051,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55052,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55053,apples,B-AG.01.h.01.c,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55054,.,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55136,This,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55137,review,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55138,summarizes,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55139,human,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55140,studies,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55141,and,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55142,clinical,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55143,trials,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55144,of,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55145,polyphenols,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55146,as,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55147,anti,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55148,-,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55149,diabetic,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55150,agents,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55151,.,O,1906.0,This review summarizes human studies and clinical trials of polyphenols as anti - diabetic agents .
55152,Polyphenols,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55153,from,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55154,coffee,B-AG.01.ad,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55155,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55156,guava,B-AG.01.h.01,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55157,tea,B-AG.01.ac,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55158,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55159,whortleberry,B-AG.01.h.01.b,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55160,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55161,olive,B-AG.01.f,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55162,oil,I-AG.01.f,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55163,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55164,propolis,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55165,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55166,chocolate,B-AG.01.n.17.a,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55167,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55168,red,B-AG.01.y.01.a,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55169,wine,I-AG.01.y.01.a,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55170,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55171,grape,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55172,seed,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55173,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55174,and,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55175,cocoa,B-AG.01,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55176,have,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55177,been,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55178,reported,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55179,to,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55180,show,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55181,anti,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55182,-,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55183,diabetic,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55184,effects,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55185,in,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55186,T2D,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55187,patients,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55188,through,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55189,increasing,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55190,glucose,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55191,metabolism,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55192,",",O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55193,improving,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55194,vascular,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55195,function,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55196,as,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55197,well,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55198,as,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55199,reducing,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55200,insulin,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55201,resistance,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55202,and,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55203,HbA1c,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55204,level,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55205,.,O,1907.0,"Polyphenols from coffee , guava tea , whortleberry , olive oil , propolis , chocolate , red wine , grape seed , and cocoa have been reported to show anti - diabetic effects in T2D patients through increasing glucose metabolism , improving vascular function as well as reducing insulin resistance and HbA1c level ."
55896,This,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55897,review,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55898,aims,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55899,to,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55900,characterize,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55901,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55902,assess,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55903,food,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55904,consumption,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55905,patterns,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55906,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55907,nutrient,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55908,intakes,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55909,amongst,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55910,school,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55911,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55912,aged,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55913,children,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55914,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55915,5,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55916,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55917,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55918,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55919,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55920,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55921,adolescents,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55922,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55923,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55924,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55925,19,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55926,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55927,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55928,in,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55929,countries,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55930,of,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55931,the,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55932,EMR,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55933,.,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55934,Electronic,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55935,databases,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55936,(,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55937,MedLine,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55938,",",O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55939,PubMed,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55940,",",O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55941,Scopus,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55942,",",O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55943,and,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55944,Google,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55945,Scholar,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55946,),O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55947,were,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55948,searched,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55949,for,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55950,relevant,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55951,articles,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55952,published,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55953,between,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55954,2005,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55955,and,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55956,2020,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55957,;,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55958,international,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55959,organizations,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55960,and,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55961,governmental,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55962,websites,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55963,were,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55964,also,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55965,searched,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55966,.,O,1933.0,"Electronic databases ( MedLine , PubMed , Scopus , and Google Scholar ) were searched for relevant articles published between 2005 and 2020 ; international organizations and governmental websites were also searched ."
55967,Available,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55968,studies,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55969,documented,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55970,low,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55971,intakes,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55972,of,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55973,fruits,B-AG.01.h.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55974,",",O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55975,vegetables,B-AG.01.h.02,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55976,and,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55977,fiber,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55978,",",O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55979,inadequate,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55980,consumption,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55981,of,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55982,water,B-AG.01.z,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55983,",",O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55984,milk,B-AG.01.e,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55985,and,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55986,dairy,B-AG.01.e,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55987,products,I-AG.01.e,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55988,",",O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55989,coupled,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55990,with,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55991,high,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55992,intakes,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55993,of,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55994,fat,B-AG.01.f,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55995,",",O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55996,saturated,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55997,fat,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55998,",",O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
55999,and,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56000,sugar,B-AG.01.y,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56001,sweetened,I-AG.01.y,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56002,beverages,I-AG.01.y,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56003,",",O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56004,as,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56005,well,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56006,as,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56007,a,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56008,frequent,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56009,consumption,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56010,of,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56011,energy,B-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56012,-,I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56013,dense,I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56014,",",I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56015,nutrient,I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56016,poor,I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56017,foods,I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56018,such,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56019,as,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56020,sweet,B-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56021,and,I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56022,savory,I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56023,snacks,I-AG.01,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56024,.,O,1934.0,"Available studies documented low intakes of fruits , vegetables and fiber , inadequate consumption of water , milk and dairy products , coupled with high intakes of fat , saturated fat , and sugar sweetened beverages , as well as a frequent consumption of energy - dense , nutrient poor foods such as sweet and savory snacks ."
56127,The,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56128,aim,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56129,of,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56130,this,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56131,study,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56132,was,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56133,to,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56134,determine,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56135,the,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56136,effect,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56137,of,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56138,pomegranate,B-AG.01.ab,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56139,juice,I-AG.01.ab,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56140,consumption,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56141,on,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56142,serum,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56143,levels,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56144,of,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56145,estradiol,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56146,",",O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56147,estrone,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56148,",",O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56149,testosterone,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56150,",",O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56151,androstenedione,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56152,",",O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56153,and,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56154,sex,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56155,hormone,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56156,binding,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56157,globulin,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56158,(,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56159,SHBG,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56160,),O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56161,.,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56818,Dietary,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56819,proteins,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56820,are,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56821,important,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56822,nutrients,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56823,and,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56824,are,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56825,classified,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56826,into,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56827,:,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56828,1,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56829,),O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56830,animal,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56831,proteins,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56832,(,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56833,meat,B-AG.01.d,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56834,",",O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56835,fish,B-AG.01.d.07,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56836,",",O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56837,poultry,B-AG.01.d.06,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56838,",",O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56839,eggs,B-AG.01.g,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56840,and,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56841,dairy,B-AG.01.e,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56842,),O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56843,",",O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56844,and,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56845,",",O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56846,2,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56847,),O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56848,plant,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56849,proteins,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56850,(,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56851,legumes,B-AG.01.h.02.g,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56852,",",O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56853,nuts,B-AG.01.h.01.f,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56854,and,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56855,soy,B-AG.01.h.02.g,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56856,),O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
56857,.,O,1961.0,"Dietary proteins are important nutrients and are classified into : 1 ) animal proteins ( meat , fish , poultry , eggs and dairy ) , and , 2 ) plant proteins ( legumes , nuts and soy ) ."
57127,Thus,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57128,",",O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57129,it,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57130,is,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57131,recommended,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57132,to,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57133,substitute,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57134,red,B-AG.01.d,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57135,meat,I-AG.01.d,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57136,with,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57137,poultry,B-AG.01.d.06,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57138,or,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57139,fish,B-AG.01.d.07,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57140,in,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57141,order,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57142,to,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57143,lower,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57144,CVD,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57145,risk,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57146,.,O,1973.0,"Thus , it is recommended to substitute red meat with poultry or fish in order to lower CVD risk ."
57147,Specific,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57148,amino,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57149,acids,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57150,have,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57151,favourable,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57152,results,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57153,in,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57154,modifying,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57155,major,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57156,risk,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57157,factors,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57158,for,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57159,CVD,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57160,",",O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57161,such,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57162,as,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57163,hypertension,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57164,.,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57316,Post,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57317,-,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57318,course,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57319,evaluation,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57320,data,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57321,were,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57322,collected,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57323,at,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57324,a,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57325,reunion,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57326,session,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57327,held,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57328,2,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57329,months,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57330,after,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57331,course,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57332,completion,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57333,.,O,1981.0,Post - course evaluation data were collected at a reunion session held 2 months after course completion .
57479,Diabetes,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57480,is,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57481,one,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57482,of,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57483,the,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57484,main,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57485,health,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57486,problems,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57487,among,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57488,Saharawi,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57489,refugees,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57490,living,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57491,in,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57492,Algerian,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57493,camps,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57494,",",O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57495,especially,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57496,for,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57497,women,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57498,.,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57809,The,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57810,postprandial,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57811,PG,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57812,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57813,SI,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57814,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57815,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57816,CP,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57817,responses,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57818,to,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57819,two,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57820,of,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57821,the,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57822,test,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57823,breakfasts,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57824,(,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57825,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57826,A,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57827,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57828,eggs,B-AG.01.g,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57829,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57830,toasted,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57831,wholemeal,B-AG.01.n.11,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57832,bread,I-AG.01.n.11,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57833,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57834,orange,B-AG.01.ab,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57835,juice,I-AG.01.ab,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57836,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57837,margarine,B-AG.01.f,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57838,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57839,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57840,milk,B-AG.01.e,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57841,;,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57842,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57843,B,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57844,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57845,wheatflake,B-AG.01.n.14,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57846,biscuits,I-AG.01.n.14,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57847,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57848,toasted,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57849,wholemeal,B-AG.01.n.11,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57850,bread,I-AG.01.n.11,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57851,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57852,milk,B-AG.01.e,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57853,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57854,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57855,margarine,B-AG.01.f,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57856,),O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57857,were,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57858,similar,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57859,(,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57860,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57861,A,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57862,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57863,104.3,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57864,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57865,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57866,23.0,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57867,mg,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57868,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57869,h,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57870,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57871,dl-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57872,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57873,5996,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57874,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57875,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57876,1108,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57877,microU,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57878,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57879,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57880,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57881,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57882,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57883,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57884,89.8,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57885,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57886,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57887,25.4,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57888,pmol,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57889,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57890,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57891,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57892,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57893,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57894,respectively,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57895,;,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57896,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57897,B,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57898,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57899,104.9,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57900,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57901,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57902,21.6,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57903,mg,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57904,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57905,h,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57906,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57907,dl-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57908,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57909,6268,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57910,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57911,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57912,1161,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57913,microU,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57914,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57915,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57916,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57917,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57918,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57919,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57920,99.8,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57921,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57922,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57923,26.4,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57924,pmol,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57925,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57926,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57927,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57928,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57929,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57930,respectively,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57931,),O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57932,.,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57933,Meal,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57934,C,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57935,",",O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57936,consisting,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57937,of,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57938,toasted,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57939,muesli,B-AG.01.n.10,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57940,and,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57941,skim,B-AG.01.e,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57942,milk,I-AG.01.e,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57943,",",O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57944,produced,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57945,smaller,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57946,glycemic,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57947,and,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57948,insulin,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57949,responses,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57950,(,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57951,46.8,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57952,+,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57953,/-,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57954,8.8,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57955,mg,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57956,X,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57957,h,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57958,X,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57959,dl-1,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57960,;,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57961,P,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57962,less,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57963,than,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57964,.02,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57965,",",O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57966,and,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57967,4369,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57968,+,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57969,/-,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57970,700,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57971,microU,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57972,X,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57973,min,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57974,X,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57975,ml-1,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57976,;,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57977,P,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57978,less,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57979,than,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57980,.05,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57981,",",O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57982,respectively,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57983,),O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57984,than,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57985,meals,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57986,A,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57987,and,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57988,B,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57989,and,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57990,less,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57991,endogenous,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57992,insulin,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57993,secretion,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57994,(,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57995,CP,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57996,response,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57997,62.8,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57998,+,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
57999,/-,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58000,19.9,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58001,pmol,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58002,X,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58003,min,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58004,X,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58005,ml-1,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58006,;,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58007,P,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58008,less,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58009,than,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58010,.05,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58011,compared,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58012,with,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58013,meal,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58014,A,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58015,",",O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58016,NS,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58017,compared,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58018,with,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58019,meal,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58020,B).(ABSTRACT,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58021,TRUNCATED,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58022,AT,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58023,250,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58024,WORDS,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58025,),O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58026,Asians,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58027,typically,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58028,consume,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58029,carbohydrate,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58030,-,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58031,rich,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58032,and,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58033,high,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58034,-,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58035,glycaemic,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58036,-,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58037,index,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58038,diets,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58039,that,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58040,have,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58041,been,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58042,associated,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58043,with,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58044,an,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58045,increased,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58046,risk,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58047,of,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58048,developing,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58049,type,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58050,2,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58051,diabetes,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58052,.,O,2001.0,"Meal C , consisting of toasted muesli and skim milk , produced smaller glycemic and insulin responses ( 46.8 + /- 8.8 mg X h X dl-1 ; P less than .02 , and 4369 + /- 700 microU X min X ml-1 ; P less than .05 , respectively ) than meals A and B and less endogenous insulin secretion ( CP response 62.8 + /- 19.9 pmol X min X ml-1 ; P less than .05 compared with meal A , NS compared with meal B).(ABSTRACT TRUNCATED AT 250 WORDS ) Asians typically consume carbohydrate - rich and high - glycaemic - index diets that have been associated with an increased risk of developing type 2 diabetes ."
58435,UPF,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58436,and,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58437,UPF,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58438,subgroups,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58439,were,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58440,categorised,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58441,according,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58442,to,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58443,the,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58444,distribution,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58445,of,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58446,their,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58447,contribution,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58448,to,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58449,total,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58450,energy,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58451,intake,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58452,.,O,2016.0,UPF and UPF subgroups were categorised according to the distribution of their contribution to total energy intake .
58894,We,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58895,tested,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58896,the,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58897,GI,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58898,of,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58899,beer,B-AG.01.y.01.b,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58900,and,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58901,estimated,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58902,its,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58903,contribution,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58904,to,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58905,dietary,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58906,GI,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58907,and,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58908,GL,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58909,in,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58910,the,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58911,Netherlands,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58912,.,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58992,Stepwise,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58993,linear,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58994,regression,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58995,identified,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58996,contribution,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58997,to,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58998,inter,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58999,-,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59000,individual,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59001,variation,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59002,in,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59003,dietary,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59004,GI,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59005,and,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59006,GL,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59007,.,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59234,Both,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59235,diets,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59236,were,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59237,low,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59238,glycemic,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59239,",",O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59240,low,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59241,fat,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59242,",",O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59243,and,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59244,high,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59245,plant,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59246,protein,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59247,diets,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59248,;,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59249,the,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59250,diet,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59251,for,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59252,the,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59253,TD,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59254,group,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59255,contained,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59256,an,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59257,additional,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59258,0.5,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59259,servings,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59260,of,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59261,protein,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59262,.,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59517,In,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59518,addition,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59519,",",O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59520,olives,B-AG.01.h.01.e,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59521,(,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59522,Olea,B-AG.01.h.01.e,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59523,europaea,I-AG.01.h.01.e,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59524,L.,I-AG.01.h.01.e,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59525,),O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59526,and,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59527,olive,B-AG.01.f,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59528,oils,I-AG.01.f,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59529,provide,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59530,a,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59531,rich,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59532,source,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59533,of,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59534,natural,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59535,antioxidants,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59536,.,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59818,To,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59819,examine,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59820,these,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59821,relations,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59822,",",O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59823,the,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59824,authors,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59825,performed,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59826,a,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59827,cohort,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59828,study,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59829,of,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59830,participants,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59831,in,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59832,a,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59833,large,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59834,Northern,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59835,California,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59836,prepaid,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59837,health,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59838,care,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59839,program,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59840,.,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
60285,We,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60286,used,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60287,Cox,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60288,models,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60289,to,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60290,estimate,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60291,the,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60292,effect,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60293,of,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60294,red,B-AG.01.y.01.a,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60295,wine,I-AG.01.y.01.a,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60296,on,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60297,prostate,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60298,cancer,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60299,risk,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60300,",",O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60301,adjusting,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60302,for,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60303,potential,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60304,confounders,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60305,.,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
61122,Thus,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61123,",",O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61124,in,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61125,this,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61126,study,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61127,",",O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61128,the,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61129,potential,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61130,anti,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61131,-,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61132,diabetic,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61133,properties,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61134,of,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61135,cocoa,B-AG.01,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61136,on,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61137,glucose,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61138,homeostasis,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61139,and,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61140,insulin,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61141,signaling,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61142,were,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61143,evaluated,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61144,in,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61145,type,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61146,2,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61147,diabetic,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61148,Zucker,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61149,diabetic,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61150,fatty,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61151,(,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61152,ZDF,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61153,),O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61154,rats,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61155,.,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61217,Cocoa,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61218,-,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61219,rich,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61220,diet,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61221,further,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61222,ameliorated,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61223,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61224,hepatic,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61225,insulin,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61226,resistance,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61227,by,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61228,abolishing,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61229,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61230,increased,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61231,serine,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61232,-,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61233,phosphorylated,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61234,levels,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61235,of,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61236,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61237,insulin,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61238,receptor,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61239,substrate,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61240,1,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61241,and,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61242,preventing,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61243,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61244,inactivation,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61245,of,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61246,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61247,glycogen,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61248,synthase,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61249,kinase,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61250,3,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61251,/,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61252,glycogen,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61253,synthase,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61254,pathway,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61255,in,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61256,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61257,liver,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61258,of,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61259,cocoa,B-AG.01,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61260,-,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61261,fed,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61262,ZDF,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61263,rats,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61264,.,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61326,These,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61327,findings,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61328,suggest,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61329,that,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61330,cocoa,B-AG.01,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61331,has,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61332,the,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61333,potential,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61334,to,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61335,alleviate,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61336,both,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61337,hyperglycemia,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61338,and,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61339,hepatic,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61340,insulin,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61341,resistance,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61342,in,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61343,type,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61344,2,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61345,diabetic,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61346,ZDF,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61347,rats,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61348,.,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61512,The,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61513,evidence,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61514,for,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61515,colorectal,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61516,cancer,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61517,suggested,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61518,an,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61519,association,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61520,with,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61521,sugar,B-AG.01.l.02,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61522,",",O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61523,but,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61524,this,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61525,appeared,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61526,to,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61527,have,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61528,been,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61529,confounded,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61530,by,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61531,energy,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61532,intake,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61533,and,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61534,glycemic,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61535,load,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61536,.,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61603,Ginger,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61604,(,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61605,Zingiber,B-AG.01.l.03,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61606,officinale,I-AG.01.l.03,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61607,Roscoe,I-AG.01.l.03,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61608,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61609,Zingiberacae,B-AG.01.l.03,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61610,),O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61611,is,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61612,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61613,medicinal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61614,plant,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61615,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61616,has,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61617,been,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61618,widely,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61619,used,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61620,in,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61621,Chinese,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61622,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61623,Ayurvedic,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61624,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61625,Tibb,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61626,-,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61627,Unani,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61628,herbal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61629,medicines,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61630,all,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61631,over,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61632,the,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61633,world,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61634,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61635,since,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61636,antiquity,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61637,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61638,for,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61639,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61640,wide,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61641,array,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61642,of,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61643,unrelated,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61644,ailments,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61645,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61646,include,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61647,arthritis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61648,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61649,rheumatism,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61650,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61651,sprains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61652,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61653,muscular,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61654,aches,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61655,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61656,pains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61657,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61658,sore,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61659,throats,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61660,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61661,cramps,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61662,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61663,constipation,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61664,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61665,indigestion,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61666,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61667,vomiting,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61668,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61669,hypertension,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61670,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61671,dementia,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61672,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61673,fever,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61674,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61675,infectious,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61676,diseases,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61677,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61678,helminthiasis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61679,.,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61824,More,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61825,studies,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61826,are,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61827,required,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61828,in,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61829,animals,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61830,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61831,humans,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61832,on,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61833,the,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61834,kinetics,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61835,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61836,ginger,B-AG.01.l.03,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61837,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61838,its,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61839,constituents,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61840,and,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61841,on,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61842,the,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61843,effects,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61844,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61845,their,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61846,consumption,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61847,over,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61848,a,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61849,long,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61850,period,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61851,of,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61852,time,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
61853,.,O,2145.0,More studies are required in animals and humans on the kinetics of ginger and its constituents and on the effects of their consumption over a long period of time .
62836,Since,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62837,all,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62838,parameters,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62839,were,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62840,tested,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62841,in,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62842,model,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62843,experiments,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62844,with,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62845,either,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62846,human,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62847,or,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62848,murine,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62849,IgE,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62850,",",O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62851,their,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62852,relevance,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62853,has,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62854,to,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62855,be,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62856,proven,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62857,in,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62858,further,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62859,clinical,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62860,investigations,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62861,.,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
63171,Although,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63172,associations,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63173,between,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63174,fruit,B-AG.01.h,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63175,and,I-AG.01.h,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63176,vegetable,I-AG.01.h,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63177,intake,B-X,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63178,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63179,both,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63180,ESCC,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63181,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63182,EAC,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63183,have,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63184,been,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63185,found,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63186,in,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63187,multiple,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63188,ecological,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63189,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63190,case,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63191,-,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63192,control,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63193,studies,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63194,",",O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63195,few,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63196,prospective,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63197,studies,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63198,have,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63199,investigated,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63200,these,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63201,associations,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63202,.,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63647,The,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63648,microstructure,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63649,of,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63650,instant,B-AG.01.i,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63651,rice,I-AG.01.i,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63652,kernels,I-AG.01.i,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63653,after,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63654,cooking,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63655,at,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63656,higher,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63657,temperature,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63658,or,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63659,lower,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63660,volumes,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63661,of,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63662,water,B-AG.01.z,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63663,showed,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63664,larger,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63665,voids,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63666,and,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63667,a,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63668,less,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63669,compact,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63670,surface,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63671,",",O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63672,which,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63673,facilitated,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63674,enzymatic,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63675,accessibility,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63676,and,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63677,increased,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63678,starch,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63679,digestibility,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
63680,.,O,2209.0,"The microstructure of instant rice kernels after cooking at higher temperature or lower volumes of water showed larger voids and a less compact surface , which facilitated enzymatic accessibility and increased starch digestibility ."
64001,Small,O,2223.0,Small differences were observed between patterns identified for women and men .
64002,differences,O,2223.0,Small differences were observed between patterns identified for women and men .
64003,were,O,2223.0,Small differences were observed between patterns identified for women and men .
64004,observed,O,2223.0,Small differences were observed between patterns identified for women and men .
64005,between,O,2223.0,Small differences were observed between patterns identified for women and men .
64006,patterns,O,2223.0,Small differences were observed between patterns identified for women and men .
64007,identified,O,2223.0,Small differences were observed between patterns identified for women and men .
64008,for,O,2223.0,Small differences were observed between patterns identified for women and men .
64009,women,O,2223.0,Small differences were observed between patterns identified for women and men .
64010,and,O,2223.0,Small differences were observed between patterns identified for women and men .
64011,men,O,2223.0,Small differences were observed between patterns identified for women and men .
64012,.,O,2223.0,Small differences were observed between patterns identified for women and men .
64069,The,O,2227.0,The reproducibility was better for women than for men .
64070,reproducibility,O,2227.0,The reproducibility was better for women than for men .
64071,was,O,2227.0,The reproducibility was better for women than for men .
64072,better,O,2227.0,The reproducibility was better for women than for men .
64073,for,O,2227.0,The reproducibility was better for women than for men .
64074,women,O,2227.0,The reproducibility was better for women than for men .
64075,than,O,2227.0,The reproducibility was better for women than for men .
64076,for,O,2227.0,The reproducibility was better for women than for men .
64077,men,O,2227.0,The reproducibility was better for women than for men .
64078,.,O,2227.0,The reproducibility was better for women than for men .
64145,Current,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64146,scientific,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64147,evidence,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64148,also,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64149,suggests,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64150,a,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64151,protective,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64152,role,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64153,for,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64154,fruits,B-AG.01.h.01,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64155,and,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64156,vegetables,B-AG.01.h.02,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64157,in,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64158,prevention,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64159,of,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64160,coronary,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64161,heart,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64162,disease,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64163,",",O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64164,and,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64165,evidence,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64166,is,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64167,accumulating,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64168,for,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64169,a,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64170,protective,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64171,role,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64172,in,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64173,stroke,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64174,.,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64343,At,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64344,birth,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64345,",",O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64346,calves,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64347,are,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64348,functionally,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64349,monogastric,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64350,and,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64351,remain,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64352,so,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64353,for,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64354,the,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64355,first,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64356,weeks,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64357,of,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64358,life,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64359,.,O,2236.0,"At birth , calves are functionally monogastric and remain so for the first weeks of life ."
64360,Milk,B-AG.01.e,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64361,in,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64362,the,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64363,rumen,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64364,may,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64365,cause,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64366,indigestion,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64367,",",O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64368,diarrhea,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64369,",",O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64370,and,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64371,reduced,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64372,growth,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64373,.,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64374,Calves,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64375,are,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64376,often,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64377,fed,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64378,cold,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64379,milk,B-AG.01.e,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64380,from,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64381,a,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64382,large,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64383,-,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64384,aperture,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64385,teat,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64386,",",O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64387,but,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64388,warm,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64389,milk,B-AG.01.e,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64390,and,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64391,sucking,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64392,behavior,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64393,are,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64394,believed,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64395,to,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64396,trigger,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64397,the,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64398,esophageal,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64399,reflex,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64400,.,O,2238.0,"Calves are often fed cold milk from a large - aperture teat , but warm milk and sucking behavior are believed to trigger the esophageal reflex ."
64814,In,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64815,control,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64816,and,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64817,ISWs,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64818,-,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64819,treated,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64820,soils,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64821,",",O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64822,dry,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64823,matter,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64824,yield,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64825,of,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64826,tomato,B-AG.01.h.02.f,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64827,grown,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64828,in,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64829,the,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64830,presence,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64831,of,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64832,wheat,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64833,straw,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64834,was,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64835,significantly,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64836,restricted,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64837,",",O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64838,while,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64839,the,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64840,application,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64841,of,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64842,rice,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64843,husk,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64844,increased,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64845,tomato,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64846,shoot,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64847,and,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64848,root,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64849,dry,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64850,weight,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64851,.,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64962,A,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64963,case,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64964,-,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64965,control,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64966,study,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64967,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64968,cancer,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64969,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64970,the,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64971,colon,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64972,and,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64973,rectum,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64974,was,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64975,conducted,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64976,in,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64977,the,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64978,Marseilles,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64979,region,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64980,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64981,southern,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64982,France,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64983,.,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
65024,A,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65025,dietary,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65026,history,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65027,questionnaire,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65028,was,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65029,used,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65030,to,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65031,determine,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65032,the,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65033,usual,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65034,eating,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65035,habits,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65036,during,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65037,the,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65038,year,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65039,preceding,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65040,diagnosis,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65041,for,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65042,cases,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65043,",",O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65044,or,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65045,preceding,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65046,interview,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65047,for,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65048,controls,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65049,.,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65079,The,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65080,intake,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65081,of,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65082,several,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65083,nutrients,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65084,",",O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65085,particularly,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65086,vitamins,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65087,B2,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65088,",",O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65089,B6,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65090,",",O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65091,C,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65092,",",O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65093,potassium,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65094,",",O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65095,iron,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65096,",",O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65097,magnesium,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65098,and,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65099,vegetable,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65100,fibre,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65101,",",O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65102,was,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65103,lower,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65104,among,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65105,cases,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65106,.,O,2265.0,"The intake of several nutrients , particularly vitamins B2 , B6 , C , potassium , iron , magnesium and vegetable fibre , was lower among cases ."
65220,We,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65221,assessed,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65222,wine,B-AG.01.y.01.a,2271.0,"We assessed wine , beer , and spirits intake separately ."
65223,",",O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65224,beer,B-AG.01.y.01.b,2271.0,"We assessed wine , beer , and spirits intake separately ."
65225,",",O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65226,and,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65227,spirits,B-AG.01.y.01,2271.0,"We assessed wine , beer , and spirits intake separately ."
65228,intake,B-X,2271.0,"We assessed wine , beer , and spirits intake separately ."
65229,separately,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65230,.,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
79608,The,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79609,countries,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79610,around,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79611,the,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79612,Mediterranean,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79613,basin,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79614,have,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79615,different,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79616,diets,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79617,",",O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79618,religions,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79619,and,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79620,cultures,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79621,.,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79835,These,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79836,findings,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79837,should,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79838,serve,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79839,as,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79840,a,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79841,strong,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79842,incentive,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79843,for,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79844,the,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79845,initiation,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79846,of,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79847,intervention,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79848,trials,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79849,that,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79850,will,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79851,test,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79852,the,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79853,effect,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79854,of,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79855,specific,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79856,dietary,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79857,patterns,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79858,in,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79859,the,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79860,prevention,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79861,and,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79862,management,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79863,of,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79864,patients,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79865,with,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79866,cancer,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79867,.,O,2764.0,These findings should serve as a strong incentive for the initiation of intervention trials that will test the effect of specific dietary patterns in the prevention and management of patients with cancer .
79930,Red,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79931,foods,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79932,contain,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79933,lycopene,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79934,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79935,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79936,pigment,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79937,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79938,tomatoes,B-AG.01.h.02.f,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79939,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79940,which,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79941,is,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79942,localized,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79943,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79944,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79945,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79946,gland,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79947,and,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79948,may,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79949,be,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79950,involved,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79951,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79952,maintaining,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79953,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79954,health,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79955,.,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79956,Yellow,B-AG.01.h.02,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79957,-,I-AG.01.h.02,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79958,green,I-AG.01.h.02,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79959,vegetables,I-AG.01.h.02,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79960,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79961,such,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79962,as,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79963,corn,B-AG.01.i,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79964,and,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79965,leafy,B-AG.01.h.02.c,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79966,greens,I-AG.01.h.02.c,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79967,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79968,contain,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79969,lutein,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79970,and,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79971,zeaxanthin,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79972,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79973,which,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79974,are,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79975,localized,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79976,in,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79977,the,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79978,retina,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79979,where,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79980,age,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79981,-,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79982,related,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79983,macular,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79984,degeneration,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79985,occurs,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79986,.,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
80044,Green,B-AG.01,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80045,foods,I-AG.01,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80046,",",O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80047,including,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80048,broccoli,B-AG.01.h.02.d,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80049,",",O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80050,Brussels,B-AG.01.h.02.d,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80051,sprouts,I-AG.01.h.02.d,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80052,and,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80053,kale,B-AG.01.h.02.d,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80054,",",O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80055,contain,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80056,glucosinolates,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80057,.,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80497,A,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80498,case,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80499,-,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80500,control,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80501,study,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80502,was,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80503,conducted,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80504,including,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80505,"1,170",O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80506,histologically,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80507,confirmed,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80508,cases,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80509,and,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80510,"2,525",O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80511,group,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80512,-,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80513,matched,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80514,visitor,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80515,controls,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80516,from,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80517,the,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80518,largest,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80519,cancer,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80520,hospital,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80521,in,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80522,India,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80523,.,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80709,A,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80710,protective,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80711,association,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80712,was,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80713,observed,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80714,with,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80715,consumption,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80716,of,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80717,leafy,B-AG.01.h.02.c,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80718,vegetables,I-AG.01.h.02.c,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80719,",",O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80720,fruits,B-AG.01.h.01,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80721,",",O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80722,onion,B-AG.01.h.02.e,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80723,and,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80724,garlic,B-AG.01.h.02.e,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
80725,.,O,2793.0,"A protective association was observed with consumption of leafy vegetables , fruits , onion and garlic ."
81083,However,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81084,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81085,mechanisms,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81086,including,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81087,low,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81088,-,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81089,density,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81090,lipoproteins,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81091,oxidation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81092,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81093,inhibition,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81094,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81095,platelet,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81096,aggregation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81097,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81098,modification,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81099,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81100,eicosanoid,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81101,metabolism,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81102,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81103,and,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81104,endothelium,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81105,-,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81106,dependent,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81107,relaxation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81108,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81109,blood,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81110,vessels,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81111,are,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81112,recognized,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81113,as,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81114,contributory,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81115,.,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81933,Well,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81934,-,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81935,planned,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81936,vegetarian,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81937,diets,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81938,are,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81939,appropriate,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81940,for,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81941,individuals,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81942,during,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81943,all,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81944,stages,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81945,of,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81946,the,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81947,life,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81948,cycle,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81949,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81950,including,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81951,pregnancy,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81952,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81953,lactation,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81954,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81955,infancy,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81956,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81957,childhood,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81958,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81959,and,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81960,adolescence,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81961,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81962,and,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81963,for,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81964,athletes,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81965,.,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
83396,Ginger,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83397,(,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83398,Zingiber,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83399,officinale,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83400,Roscoe,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83401,),O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83402,continues,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83403,to,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83404,be,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83405,used,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83406,as,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83407,an,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83408,important,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83409,cooking,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83410,spice,B-AG.01.l.03,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83411,and,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83412,herbal,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83413,medicine,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83414,around,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83415,the,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83416,world,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83417,.,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83617,This,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83618,study,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83619,aimed,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83620,to,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83621,determine,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83622,both,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83623,sensory,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83624,and,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83625,nonsensory,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83626,factors,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83627,that,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83628,might,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83629,affect,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83630,U.S.,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83631,consumers,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83632,',O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83633,acceptability,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83634,of,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83635,Seolgitteok,B-AG.01.n.13,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83636,.,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83670,Nonsensory,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83671,factors,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83672,such,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83673,as,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83674,demographic,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83675,profile,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83676,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83677,innovativeness,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83678,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83679,social,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83680,representation,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83681,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83682,sensation,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83683,-,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83684,seeking,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83685,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83686,and,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83687,personality,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83688,traits,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83689,were,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83690,also,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83691,assessed,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83692,.,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83832,However,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83833,",",O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83834,the,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83835,removal,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83836,of,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83837,fat,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83838,often,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83839,impairs,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83840,the,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83841,sensory,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83842,and,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83843,textural,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83844,properties,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83845,of,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83846,foods,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83847,",",O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83848,leading,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83849,to,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83850,low,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83851,consumer,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83852,acceptance,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83853,.,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83962,A,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83963,similar,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83964,effect,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83965,was,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83966,also,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83967,shown,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83968,for,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83969,rennet,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83970,casein,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83971,",",O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83972,whereas,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83973,inulin,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83974,and,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83975,polydextrose,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83976,had,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83977,little,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83978,or,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83979,no,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83980,effect,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83981,on,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83982,these,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83983,rheological,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83984,parameters,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83985,.,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
84042,Our,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84043,results,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84044,indicate,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84045,the,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84046,different,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84047,concentrations,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84048,and,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84049,combinations,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84050,of,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84051,fat,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84052,replacers,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84053,and,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84054,rennet,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84055,casein,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84056,that,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84057,can,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84058,be,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84059,included,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84060,in,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84061,reduced,B-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84062,-,I-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84063,fat,I-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84064,processed,I-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84065,cheese,I-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84066,to,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84067,develop,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84068,products,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84069,with,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84070,specific,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84071,rheological,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84072,properties,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84073,",",O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84074,thus,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84075,meeting,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84076,future,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84077,demand,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84078,for,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84079,reduced,B-AG.01,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84080,-,I-AG.01,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84081,fat,I-AG.01,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84082,products,I-AG.01,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84083,with,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84084,attractive,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84085,sensory,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84086,attributes,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84087,.,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84165,According,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84166,to,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84167,national,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84168,and,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84169,European,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84170,reference,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84171,values,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84172,",",O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84173,the,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84174,children,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84175,had,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84176,an,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84177,adequate,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84178,nutrient,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84179,intake,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84180,with,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84181,exception,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84182,of,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84183,low,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84184,intakes,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84185,of,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84186,total,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84187,fat,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84188,",",O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84189,n-3,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84190,fatty,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84191,acids,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84192,from,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84193,fish,B-AG.01.d.07,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84194,and,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84195,possibly,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84196,iron,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84197,.,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84279,In,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84280,young,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84281,children,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84282,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84283,low,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84284,intakes,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84285,of,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84286,n-3,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84287,fatty,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84288,acids,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84289,and,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84290,iron,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84291,are,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84292,a,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84293,potential,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84294,matter,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84295,of,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84296,concern,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84297,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84298,as,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84299,are,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84300,the,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84301,high,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84302,intakes,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84303,of,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84304,energy,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84305,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84306,protein,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84307,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84308,sugared,B-AG.01.y,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84309,beverages,I-AG.01.y,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84310,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84311,and,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84312,milk,B-AG.01.e,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84313,",",O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84314,since,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84315,these,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84316,may,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84317,increase,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84318,the,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84319,risk,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84320,of,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84321,becoming,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84322,overweight,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84323,.,O,2923.0,"In young children , low intakes of n-3 fatty acids and iron are a potential matter of concern , as are the high intakes of energy , protein , sugared beverages , and milk , since these may increase the risk of becoming overweight ."
84415,Intervention,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84416,periods,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84417,were,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84418,preceded,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84419,by,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84420,2,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84421,-,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84422,week,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84423,depletion,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84424,phases,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84425,.,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84426,At,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84427,the,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84428,end,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84429,of,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84430,each,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84431,study,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84432,period,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84433,",",O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84434,faeces,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84435,of,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84436,twelve,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84437,volunteers,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84438,were,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84439,collected,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84440,for,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84441,chemical,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84442,analyses,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84443,and,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84444,use,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84445,in,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84446,cell,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84447,-,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84448,culture,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84449,systems,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84450,.,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84660,The,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84661,analyses,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84662,included,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84663,"2,381",O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84664,postmenopausal,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84665,invasive,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84666,breast,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84667,cancer,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84668,cases,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84669,diagnosed,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84670,during,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84671,a,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84672,median,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84673,9.7,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84674,-,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84675,year,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84676,follow,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84677,-,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84678,up,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84679,period,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84680,(,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84681,1993,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84682,-,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84683,2005,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84684,),O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84685,among,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84686,"65,374",O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84687,women,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84688,from,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84689,the,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84690,E3N,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84691,-,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84692,EPIC,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84693,cohort,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
84694,.,O,2938.0,"The analyses included 2,381 postmenopausal invasive breast cancer cases diagnosed during a median 9.7 - year follow - up period ( 1993 - 2005 ) among 65,374 women from the E3N - EPIC cohort ."
85347,Specifically,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85348,",",O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85349,nutritional,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85350,recommendations,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85351,for,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85352,children,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85353,with,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85354,diabetes,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85355,focus,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85356,on,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85357,limiting,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85358,the,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85359,intake,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85360,of,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85361,foods,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85362,of,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85363,animal,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85364,origin,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85365,(,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85366,red,B-AG.01.d,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85367,meat,I-AG.01.d,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85368,",",O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85369,cheese,B-AG.01.e.02,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85370,",",O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85371,cold,B-AG.01.d,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85372,cuts,I-AG.01.d,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85373,),O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85374,",",O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85375,moderating,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85376,fat,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85377,intake,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85378,and,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85379,promoting,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85380,the,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85381,intake,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85382,of,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85383,foods,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85384,that,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85385,naturally,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85386,contain,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85387,fibre,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85388,(,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85389,mainly,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85390,vegetables,B-AG.01.h.02,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85391,",",O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85392,legumes,B-AG.01.h.02.g,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85393,",",O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85394,fruit,B-AG.01.h.01,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85395,),O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
85396,.,O,2958.0,"Specifically , nutritional recommendations for children with diabetes focus on limiting the intake of foods of animal origin ( red meat , cheese , cold cuts ) , moderating fat intake and promoting the intake of foods that naturally contain fibre ( mainly vegetables , legumes , fruit ) ."
86172,We,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86173,previously,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86174,have,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86175,shown,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86176,that,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86177,ingested,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86178,beef,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86179,protein,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86180,is,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86181,just,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86182,as,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86183,potent,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86184,as,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86185,glucose,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86186,in,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86187,stimulating,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86188,a,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86189,rise,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86190,in,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86191,insulin,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86192,concentration,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86193,in,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86194,type,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86195,II,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86196,diabetic,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86197,patients,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86198,.,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86427,The,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86428,alpha,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86429,amino,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86430,nitrogen,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86431,concentration,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86432,varied,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86433,considerably,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86434,.,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86691,Lowered,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86692,risk,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86693,was,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86694,also,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86695,related,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86696,to,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86697,consumption,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86698,of,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86699,spices,B-AG.01.l.03,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86700,",",O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86701,olive,B-AG.01.f,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86702,oil,I-AG.01.f,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86703,and,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86704,garlic,B-AG.01.h.02.e,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86705,.,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
87375,The,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87376,triacylglycerol,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87377,response,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87378,increased,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87379,in,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87380,a,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87381,dose,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87382,-,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87383,dependent,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87384,manner,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87385,with,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87386,the,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87387,fat,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87388,content,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87389,of,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87390,the,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87391,meals,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87392,irrespective,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87393,of,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87394,the,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87395,type,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87396,of,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87397,fat,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87398,.,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87508,Micronutrient,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87509,",",O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87510,protein,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87511,",",O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87512,and,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87513,energy,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87514,intakes,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87515,were,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87516,compared,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87517,to,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87518,European,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87519,Society,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87520,for,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87521,Parenteral,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87522,and,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87523,Enteral,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87524,Nutrition,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87525,guidelines,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87526,for,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87527,cancer,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87528,patients,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87529,.,O,3029.0,"Micronutrient , protein , and energy intakes were compared to European Society for Parenteral and Enteral Nutrition guidelines for cancer patients ."
87740,In,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87741,a,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87742,cross,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87743,-,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87744,sectional,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87745,design,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87746,",",O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87747,we,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87748,compared,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87749,IGF,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87750,-,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87751,I,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87752,levels,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87753,between,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87754,women,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87755,with,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87756,high,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87757,and,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87758,low,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87759,soy,B-AG.01.h.02.g,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87760,intake,B-X,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87761,.,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87953,Inclusion,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87954,of,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87955,total,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87956,energy,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87957,",",O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87958,total,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87959,protein,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87960,",",O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87961,meat,B-AG.01.d,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87962,",",O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87963,and,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87964,dairy,B-AG.01.e,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87965,intake,B-X,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87966,did,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87967,not,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87968,materially,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87969,alter,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87970,the,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87971,association,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87972,between,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87973,tofu,B-AG.01.n,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87974,consumption,B-X,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87975,and,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87976,IGF,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87977,-,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87978,I,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87979,levels,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
87980,.,O,3045.0,"Inclusion of total energy , total protein , meat , and dairy intake did not materially alter the association between tofu consumption and IGF - I levels ."
88072,Flavanols,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88073,have,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88074,been,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88075,described,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88076,to,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88077,exert,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88078,favorable,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88079,effects,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88080,on,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88081,endothelium,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88082,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88083,derived,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88084,vasodilation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88085,via,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88086,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88087,stimulation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88088,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88089,nitric,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88090,oxide,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88091,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88092,synthase,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88093,",",O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88094,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88095,increased,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88096,availability,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88097,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88098,l,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88099,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88100,arginine,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88101,",",O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88102,and,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88103,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88104,decreased,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88105,degradation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88106,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88107,NO,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88108,.,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88256,This,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88257,paper,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88258,summarizes,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88259,new,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88260,findings,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88261,concerning,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88262,cocoa,B-AG.01,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88263,effects,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88264,on,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88265,blood,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88266,pressure,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88267,and,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88268,cardiovascular,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88269,health,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88270,",",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88271,focusing,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88272,on,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88273,putative,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88274,mechanisms,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88275,of,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88276,action,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88277,and,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88278,"""",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88279,nutraceutical,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88280,"""",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88281,viewpoints,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88282,.,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88420,Meat,B-AG.01.d,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88421,and,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88422,grains,B-AG.01.i,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88423,contained,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88424,the,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88425,greatest,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88426,quantities,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88427,of,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88428,minerals,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88429,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88430,but,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88431,milk,B-AG.01.e,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88432,provided,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88433,a,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88434,relatively,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88435,good,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88436,proportion,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88437,of,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88438,potassium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88439,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88440,calcium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88441,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88442,magnesium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88443,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88444,and,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88445,phosphorus,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88446,.,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88447,Anemia,O,3065.0,Anemia was not related to the incidence of toxemia .
88448,was,O,3065.0,Anemia was not related to the incidence of toxemia .
88449,not,O,3065.0,Anemia was not related to the incidence of toxemia .
88450,related,O,3065.0,Anemia was not related to the incidence of toxemia .
88451,to,O,3065.0,Anemia was not related to the incidence of toxemia .
88452,the,O,3065.0,Anemia was not related to the incidence of toxemia .
88453,incidence,O,3065.0,Anemia was not related to the incidence of toxemia .
88454,of,O,3065.0,Anemia was not related to the incidence of toxemia .
88455,toxemia,O,3065.0,Anemia was not related to the incidence of toxemia .
88456,.,O,3065.0,Anemia was not related to the incidence of toxemia .
88924,Ten,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88925,Murciano,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88926,-,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88927,Granadina,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88928,dairy,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88929,goats,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88930,(,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88931,n,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88932,=,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88933,5,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88934,per,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88935,group,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88936,),O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88937,in,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88938,mid,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88939,-,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88940,lactation,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88941,were,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88942,used,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88943,in,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88944,a,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88945,crossover,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88946,design,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88947,experiment,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88948,(,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88949,2,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88950,treatments,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88951,across,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88952,2,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88953,periods,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88954,),O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
88955,.,O,3081.0,Ten Murciano - Granadina dairy goats ( n = 5 per group ) in mid - lactation were used in a crossover design experiment ( 2 treatments across 2 periods ) .
89042,After,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89043,14,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89044,d,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89045,on,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89046,their,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89047,respective,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89048,treatments,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89049,",",O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89050,goats,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89051,were,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89052,allocated,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89053,to,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89054,individual,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89055,metabolism,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89056,cages,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89057,for,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89058,another,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89059,7,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89060,d.,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89061,Subsequently,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89062,",",O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89063,feed,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89064,intake,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89065,",",O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89066,total,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89067,fecal,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89068,and,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89069,urine,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89070,output,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89071,",",O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89072,and,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89073,milk,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89074,yield,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89075,were,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89076,recorded,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89077,daily,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89078,over,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89079,the,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89080,first,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89081,5,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89082,d.,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89083,During,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89084,the,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89085,last,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89086,2,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89087,d,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89088,",",O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89089,ruminal,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89090,fluid,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89091,and,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89092,blood,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89093,samples,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89094,were,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89095,collected,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89096,",",O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89097,along,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89098,with,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89099,individual,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89100,gas,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89101,exchange,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89102,measurements,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89103,recorded,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89104,by,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89105,a,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89106,mobile,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89107,open,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89108,-,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89109,circuit,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89110,indirect,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89111,calorimetry,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89112,system,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89113,using,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89114,a,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89115,head,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89116,box,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89117,.,O,3084.0,"After 14 d on their respective treatments , goats were allocated to individual metabolism cages for another 7 d. Subsequently , feed intake , total fecal and urine output , and milk yield were recorded daily over the first 5 d. During the last 2 d , ruminal fluid and blood samples were collected , along with individual gas exchange measurements recorded by a mobile open - circuit indirect calorimetry system using a head box ."
89398,After,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89399,adjustment,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89400,for,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89401,other,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89402,food,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89403,constituents,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89404,",",O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89405,only,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89406,increased,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89407,vitamin,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89408,C,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89409,consumption,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89410,showed,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89411,an,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89412,inverse,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89413,relation,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89414,to,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89415,risk,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89416,.,O,3093.0,"After adjustment for other food constituents , only increased vitamin C consumption showed an inverse relation to risk ."
89865,Some,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89866,relationships,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89867,between,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89868,dough,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89869,rheology,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89870,and,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89871,bread,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89872,characteristics,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89873,were,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89874,established,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89875,to,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89876,identify,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89877,possible,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89878,predictor,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89879,parameters,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89880,.,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
90198,As,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90199,anticipated,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90200,",",O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90201,the,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90202,group,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90203,containing,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90204,individuals,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90205,who,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90206,prefer,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90207,milk,B-AG.01.n.17.a,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90208,chocolate,I-AG.01.n.17.a,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90209,had,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90210,a,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90211,much,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90212,lower,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90213,tolerance,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90214,for,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90215,bitterness,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90216,in,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90217,their,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90218,chocolate,B-AG.01.n.17.b,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90219,ice,I-AG.01.n.17.b,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90220,cream,I-AG.01.n.17.b,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90221,compared,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90222,with,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90223,the,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90224,group,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90225,of,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90226,individuals,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90227,who,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90228,prefer,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90229,dark,B-AG.01.n.17.a,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90230,chocolate,I-AG.01.n.17.a,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90231,;,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90232,indeed,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90233,",",O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90234,the,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90235,dark,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90236,chocolate,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90237,group,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90238,tolerated,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90239,almost,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90240,twice,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90241,as,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90242,much,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90243,added,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90244,bitterant,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90245,in,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90246,the,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90247,ice,B-AG.01.n.17.b,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90248,cream,I-AG.01.n.17.b,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90249,before,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90250,indicating,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90251,a,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90252,significant,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90253,preference,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90254,for,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90255,the,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90256,unspiked,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90257,(,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90258,control,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90259,),O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90260,ice,B-AG.01.n.17.b,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90261,cream,I-AG.01.n.17.b,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90262,.,O,3126.0,"As anticipated , the group containing individuals who prefer milk chocolate had a much lower tolerance for bitterness in their chocolate ice cream compared with the group of individuals who prefer dark chocolate ; indeed , the dark chocolate group tolerated almost twice as much added bitterant in the ice cream before indicating a significant preference for the unspiked ( control ) ice cream ."
90366,Eighteen,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90367,observational,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90368,studies,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90369,were,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90370,reviewed,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90371,",",O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90372,the,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90373,results,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90374,of,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90375,which,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90376,indicate,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90377,that,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90378,total,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90379,dairy,B-AG.01.e,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90380,intake,B-X,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90381,does,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90382,not,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90383,contribute,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90384,to,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90385,cardiovascular,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90386,disease,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90387,incidence,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90388,or,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90389,death,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90390,.,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
91200,In,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91201,the,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91202,fourteen,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91203,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91204,week,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91205,study,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91206,",",O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91207,an,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91208,adjustment,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91209,period,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91210,of,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91211,three,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91212,weeks,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91213,was,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91214,followed,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91215,by,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91216,two,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91217,consecutive,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91218,experimental,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91219,periods,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91220,of,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91221,four,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91222,weeks,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91223,each,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91224,",",O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91225,then,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91226,by,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91227,a,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91228,three,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91229,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91230,week,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91231,follow,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91232,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91233,up,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91234,period,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91235,.,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91734,Energy,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91735,and,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91736,sugar,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91737,(,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91738,%,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91739,of,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91740,total,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91741,energy,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91742,),O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91743,intakes,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91744,were,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91745,not,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91746,significantly,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91747,different,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91748,across,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91749,all,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91750,fat,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91751,intakes,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91752,;,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91753,energy,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91754,density,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91755,decreased,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91756,with,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91757,decreasing,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91758,fat,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91759,quartile,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91760,.,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91820,Information,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91821,about,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91822,constituents,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91823,of,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91824,milk,B-AG.01.e,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91825,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91826,visual,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91827,alterations,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91828,can,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91829,be,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91830,used,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91831,for,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91832,management,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91833,support,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91834,in,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91835,improving,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91836,mastitis,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91837,detection,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91838,",",O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91839,monitoring,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91840,fertility,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91841,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91842,reproduction,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91843,",",O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91844,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91845,adapting,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91846,individual,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91847,diets,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91848,.,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
92128,Growing,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92129,evidence,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92130,suggests,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92131,the,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92132,crucial,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92133,role,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92134,of,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92135,diet,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92136,on,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92137,cancer,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92138,prevention,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92139,and,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92140,treatment,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92141,.,O,3194.0,Growing evidence suggests the crucial role of diet on cancer prevention and treatment .
92354,Skin,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92355,reactions,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92356,among,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92357,other,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92358,atopics,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92359,were,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92360,rare,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92361,",",O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92362,and,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92363,non,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92364,-,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92365,atopic,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92366,patients,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92367,showed,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92368,no,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92369,reactions,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92370,to,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92371,fresh,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92372,fruits,B-AG.01.h.01,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92373,and,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92374,vegetables,B-AG.01.h.02,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92375,.,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92393,Two,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92394,major,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92395,fractions,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92396,were,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92397,obtained,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92398,",",O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92399,one,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92400,with,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92401,sugar,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92402,and,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92403,proteins,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92404,",",O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92405,and,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92406,one,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92407,with,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92408,proteins,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92409,",",O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92410,the,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92411,latter,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92412,giving,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92413,skin,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92414,reactions,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92415,more,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92416,often,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92417,than,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92418,the,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92419,former,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92420,.,O,3203.0,"Two major fractions were obtained , one with sugar and proteins , and one with proteins , the latter giving skin reactions more often than the former ."
92618,While,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92619,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92620,evidence,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92621,suggests,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92622,that,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92623,yogurt,B-AG.01.e,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92624,consumption,B-X,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92625,is,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92626,beneficial,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92627,for,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92628,obese,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92629,individuals,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92630,",",O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92631,randomized,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92632,-,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92633,controlled,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92634,trials,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92635,are,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92636,needed,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92637,to,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92638,further,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92639,support,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92640,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92641,hypothesis,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92642,.,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
93038,Modes,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93039,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93040,their,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93041,actions,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93042,include,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93043,boosting,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93044,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93045,functioning,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93046,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93047,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93048,system,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93049,",",O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93050,activation,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93051,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93052,suppression,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93053,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93054,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93055,specialized,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93056,cells,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93057,",",O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93058,interfering,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93059,in,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93060,several,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93061,pathways,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93062,that,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93063,eventually,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93064,led,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93065,to,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93066,improvement,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93067,in,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93068,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93069,responses,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93070,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93071,defense,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93072,system,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93073,.,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93393,The,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93394,purpose,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93395,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93396,this,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93397,study,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93398,was,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93399,to,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93400,determine,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93401,the,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93402,effects,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93403,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93404,consumption,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93405,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93406,different,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93407,cocoa,B-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93408,-,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93409,derived,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93410,products,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93411,on,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93412,uric,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93413,acid,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93414,crystallization,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93415,in,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93416,urine,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93417,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93418,20,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93419,healthy,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93420,volunteers,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93421,.,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93536,Urine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93537,volume,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93538,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93539,pH,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93540,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93541,oxalate,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93542,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93543,creatinine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93544,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93545,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93546,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93547,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93548,theobromine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93549,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93550,and,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93551,a,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93552,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93553,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93554,crystallization,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93555,test,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93556,were,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93557,determined,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93558,for,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93559,each,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93560,sample,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93561,.,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93674,Skin,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93675,prick,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93676,tests,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93677,with,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93678,carrot,B-AG.01.h.02.a,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93679,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93680,celery,B-AG.01.h.02.a,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93681,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93682,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93683,olive,B-AG.01.h.01.e,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93684,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93685,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93686,birch,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93687,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93688,grass,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93689,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93690,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93691,mugwort,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93692,pollens,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93693,were,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93694,positive,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93695,.,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
94254,Furthermore,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94255,",",O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94256,in,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94257,animals,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94258,fed,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94259,on,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94260,olive,B-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94261,oil,I-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94262,in,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94263,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94264,absence,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94265,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94266,added,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94267,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94268,",",O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94269,plasma,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94270,LDL,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94271,-,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94272,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94273,concentrations,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94274,were,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94275,lower,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94276,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94277,P,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94278,<,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94279,0.05,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94280,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94281,and,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94282,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94283,extent,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94284,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94285,atherosclerotic,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94286,lesions,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94287,was,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94288,reduced,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94289,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94290,P,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94291,<,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94292,0.001,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94293,for,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94294,both,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94295,regions,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94296,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94297,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94298,aorta,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94299,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94300,compared,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94301,with,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94302,animals,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94303,fed,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94304,on,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94305,coconut,B-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94306,oil,I-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94307,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94308,with,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94309,no,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94310,added,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94311,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94312,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94313,.,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94388,In,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94389,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94390,aortic,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94391,arch,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94392,",",O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94393,lesion,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94394,size,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94395,decreased,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94396,linearly,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94397,(,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94398,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94399,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94400,0.05,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94401,",",O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94402,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94403,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94404,0.001,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94405,for,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94406,coconut,B-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94407,oil,I-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94408,and,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94409,olive,B-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94410,oil,I-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94411,respectively,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94412,),O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94413,with,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94414,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94415,greatest,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94416,reduction,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94417,being,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94418,seen,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94419,in,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94420,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94421,olive,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94422,-,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94423,oil,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94424,-,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94425,fed,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94426,animals,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94427,(,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94428,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94429,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94430,0.05,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94431,),O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94432,.,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94531,Therefore,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94532,",",O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94533,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94534,aim,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94535,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94536,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94537,present,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94538,study,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94539,was,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94540,to,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94541,evaluate,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94542,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94543,TG,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94544,response,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94545,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94546,hypertriglyceridemic,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94547,patients,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94548,to,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94549,a,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94550,similar,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94551,amount,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94552,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94553,calories,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94554,deriving,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94555,from,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94556,different,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94557,sources,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94558,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94559,CHO,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94560,and,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94561,fat,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94562,.,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94578,In,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94579,1,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94580,group,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94581,(,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94582,the,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94583,fat,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94584,group,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94585,),O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94586,",",O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94587,patients,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94588,were,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94589,given,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94590,a,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94591,standard,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94592,meal,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94593,plus,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94594,a,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94595,fat,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94596,supplement,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94597,of,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94598,300,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94599,kcal,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94600,derived,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94601,from,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94602,different,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94603,types,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94604,of,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94605,fat,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94606,(,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94607,butter,B-AG.01.e.01,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94608,",",O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94609,sunflower,B-AG.01.f,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94610,margarine,I-AG.01.f,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94611,",",O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94612,olive,B-AG.01.f,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94613,oil,I-AG.01.f,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94614,),O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94615,for,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94616,dinner,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94617,",",O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94618,once,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94619,a,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94620,week,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94621,for,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94622,3,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94623,weeks,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94624,.,O,3281.0,"In 1 group ( the fat group ) , patients were given a standard meal plus a fat supplement of 300 kcal derived from different types of fat ( butter , sunflower margarine , olive oil ) for dinner , once a week for 3 weeks ."
94625,In,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94626,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94627,other,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94628,group,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94629,(,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94630,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94631,CHO,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94632,group,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94633,),O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94634,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94635,patients,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94636,consumed,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94637,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94638,same,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94639,standard,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94640,meal,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94641,plus,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94642,a,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94643,supplement,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94644,of,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94645,300,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94646,kcal,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94647,derived,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94648,from,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94649,different,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94650,types,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94651,of,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94652,CHO,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94653,(,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94654,bread,B-AG.01.n.11,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94655,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94656,coke,B-AG.01.aa,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94657,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94658,fruit,B-AG.01.h.01,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94659,),O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94660,.,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
95138,Because,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95139,these,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95140,foods,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95141,are,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95142,a,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95143,major,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95144,source,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95145,of,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95146,calcium,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95147,",",O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95148,low,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95149,intake,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95150,of,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95151,them,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95152,can,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95153,compromise,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95154,calcium,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95155,nutriture,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95156,.,O,3298.0,"Because these foods are a major source of calcium , low intake of them can compromise calcium nutriture ."
95775,There,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95776,was,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95777,no,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95778,association,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95779,between,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95780,total,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95781,or,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95782,specific,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95783,vegetables,B-AG.01.h.02,3318.0,There was no association between total or specific vegetables intake and GC risk .
95784,intake,B-X,3318.0,There was no association between total or specific vegetables intake and GC risk .
95785,and,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95786,GC,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95787,risk,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95788,.,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95955,Intact,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95956,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95957,pepsin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95958,-,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95959,trypsin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95960,(,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95961,PT)-digested,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95962,prolamin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95963,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95964,glutelin,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95965,fractions,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95966,were,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95967,used,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95968,to,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95969,assess,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95970,their,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95971,immunoreactivity,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95972,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95973,gluten,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95974,recovery,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95975,by,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95976,three,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95977,sandwich,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95978,and,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95979,two,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95980,competitive,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95981,ELISA,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95982,kits,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
95983,.,O,3327.0,Intact and pepsin - trypsin ( PT)-digested prolamin and glutelin fractions were used to assess their immunoreactivity and gluten recovery by three sandwich and two competitive ELISA kits .
96659,Moderate,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96660,ethanol,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96661,intake,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96662,from,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96663,any,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96664,type,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96665,of,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96666,beverage,B-AG.01.y,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96667,improves,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96668,lipoprotein,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96669,metabolism,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96670,and,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96671,lowers,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96672,cardiovascular,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96673,mortality,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96674,risk,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96675,.,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
97020,The,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97021,consumption,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97022,of,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97023,yogurt,B-AG.01.e,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97024,seems,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97025,to,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97026,be,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97027,associated,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97028,with,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97029,a,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97030,lower,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97031,risk,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97032,of,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97033,developing,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97034,type,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97035,2,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97036,diabetes,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97037,.,O,3360.0,The consumption of yogurt seems to be associated with a lower risk of developing type 2 diabetes .
97675,A,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97676,relationship,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97677,has,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97678,also,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97679,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97680,observed,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97681,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97682,certain,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97683,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97684,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97685,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97686,such,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97687,as,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97688,constituents,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97689,of,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97690,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97691,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97692,Mediterranean,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97693,diet,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97694,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97695,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97696,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97697,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97698,metabolic,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97699,syndrome,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97700,;,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97701,similar,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97702,associations,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97703,have,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97704,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97705,noted,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97706,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97707,these,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97708,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97709,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97710,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97711,dementia,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97712,.,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97771,The,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97772,benefits,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97773,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97774,fruit,B-AG.01.n.08,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97775,products,I-AG.01.n.08,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97776,are,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97777,thought,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97778,to,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97779,be,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97780,a,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97781,result,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97782,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97783,its,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97784,polyphenol,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97785,content,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97786,.,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
98099,Avoidance,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98100,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98101,saturated,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98102,fat,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98103,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98104,cholesterol,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98105,by,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98106,"1,210",O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98107,Mexican,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98108,Americans,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98109,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98110,866,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98111,non,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98112,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98113,Hispanic,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98114,whites,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98115,was,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98116,assessed,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98117,as,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98118,part,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98119,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98120,a,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98121,population,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98122,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98123,based,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98124,survey,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98125,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98126,diabetes,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98127,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98128,cardiovascular,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98129,risk,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98130,factors,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98131,.,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98612,Food,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98613,sources,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98614,of,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98615,nutrients,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98616,in,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98617,Mexican,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98618,children,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98619,are,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98620,not,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98621,well,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98622,known,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98623,.,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98645,All,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98646,reported,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98647,foods,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98648,and,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98649,beverages,B-AG.01.y,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98650,were,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98651,assigned,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98652,to,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98653,one,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98654,of,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98655,76,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98656,food,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98657,groups,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98658,.,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
99547,Supplementation,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99548,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99549,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99550,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99551,increased,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99552,plasma,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99553,concentrations,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99554,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99555,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99556,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99557,at,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99558,calving,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99559,",",O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99560,but,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99561,no,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99562,differences,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99563,were,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99564,observed,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99565,in,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99566,samples,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99567,taken,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99568,24,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99569,h,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99570,postinfusion,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99571,.,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99659,Supplemental,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99660,vitamin,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99661,C,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99662,had,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99663,no,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99664,effect,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99665,on,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99666,neutrophil,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99667,phagocytosis,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99668,or,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99669,bacterial,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99670,kill,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99671,.,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
100778,Incident,O,3495.0,Incident stroke cases were identified in national registers .
100779,stroke,O,3495.0,Incident stroke cases were identified in national registers .
100780,cases,O,3495.0,Incident stroke cases were identified in national registers .
100781,were,O,3495.0,Incident stroke cases were identified in national registers .
100782,identified,O,3495.0,Incident stroke cases were identified in national registers .
100783,in,O,3495.0,Incident stroke cases were identified in national registers .
100784,national,O,3495.0,Incident stroke cases were identified in national registers .
100785,registers,O,3495.0,Incident stroke cases were identified in national registers .
100786,.,O,3495.0,Incident stroke cases were identified in national registers .
101190,Therefore,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101191,",",O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101192,interventions,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101193,to,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101194,reduce,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101195,levels,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101196,of,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101197,smoking,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101198,",",O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101199,improve,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101200,diet,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101201,",",O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101202,and,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101203,increase,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101204,physical,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101205,activity,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101206,must,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101207,become,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101208,much,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101209,higher,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101210,priorities,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101211,in,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101212,the,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101213,general,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101214,population,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101215,'s,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101216,health,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101217,and,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101218,health,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101219,care,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101220,systems,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101221,.,O,3512.0,"Therefore , interventions to reduce levels of smoking , improve diet , and increase physical activity must become much higher priorities in the general population 's health and health care systems ."
101537,We,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101538,could,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101539,conclude,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101540,that,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101541,these,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101542,foods,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101543,could,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101544,play,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101545,a,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101546,significant,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101547,role,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101548,in,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101549,the,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101550,etiology,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101551,of,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101552,lymphoid,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101553,malignancies,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101554,.,O,3521.0,We could conclude that these foods could play a significant role in the etiology of lymphoid malignancies .
101662,About,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101663,50,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101664,%,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101665,of,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101666,total,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101667,dietary,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101668,calcium,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101669,was,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101670,supplied,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101671,by,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101672,milk,B-AG.01.e,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101673,and,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101674,milk,B-AG.01.e,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101675,products,I-AG.01.e,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101676,.,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101868,After,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101869,all,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101870,testing,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101871,procedures,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101872,",",O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101873,participants,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101874,completed,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101875,the,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101876,Binge,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101877,Eating,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101878,Scale,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101879,(,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101880,BES,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101881,),O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101882,while,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101883,left,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101884,alone,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101885,and,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101886,allowed,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101887,to,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101888,eat,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101889,as,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101890,much,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101891,as,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101892,they,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101893,wanted,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101894,of,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101895,each,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101896,of,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101897,the,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101898,different,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101899,chocolates,B-AG.01.n.17.a,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101900,.,O,3535.0,"After all testing procedures , participants completed the Binge Eating Scale ( BES ) while left alone and allowed to eat as much as they wanted of each of the different chocolates ."
101901,We,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101902,found,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101903,a,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101904,measurable,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101905,psychoactive,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101906,dose⁻effect,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101907,relationship,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101908,with,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101909,each,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101910,incremental,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101911,increase,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101912,in,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101913,the,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101914,chocolate,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101915,'s,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101916,sugar,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101917,content,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101918,.,O,3536.0,We found a measurable psychoactive dose⁻effect relationship with each incremental increase in the chocolate 's sugar content .
101993,These,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101994,results,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101995,suggest,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101996,that,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101997,each,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101998,incremental,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101999,increase,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102000,in,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102001,chocolate,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102002,'s,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102003,sugar,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102004,content,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102005,enhances,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102006,its,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102007,psychoactive,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102008,effects,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102009,.,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102031,Recent,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102032,reports,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102033,on,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102034,cocoa,B-AG.01,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102035,are,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102036,appealing,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102037,in,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102038,that,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102039,a,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102040,food,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102041,commonly,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102042,consumed,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102043,for,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102044,pure,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102045,pleasure,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102046,might,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102047,also,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102048,bring,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102049,tangible,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102050,benefits,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102051,for,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102052,human,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102053,health,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102054,.,O,3541.0,Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health .
102638,The,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102639,survey,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102640,included,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102641,588,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102642,participants,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102643,aged,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102644,25,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102645,to,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102646,65,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102647,years,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102648,who,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102649,were,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102650,selected,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102651,using,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102652,convenience,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102653,samples,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102654,in,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102655,the,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102656,urban,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102657,areas,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102658,of,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102659,Benin,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102660,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102661,Guinea,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102662,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102663,Kenya,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102664,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102665,Mozambique,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102666,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102667,and,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102668,Seychelles,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102669,.,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
103140,Dietary,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103141,intakes,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103142,of,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103143,nutrients,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103144,were,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103145,estimated,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103146,at,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103147,baseline,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103148,(,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103149,1990,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103150,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103151,1994,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103152,),O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103153,using,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103154,a,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103155,121,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103156,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103157,item,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103158,food,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103159,frequency,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103160,questionnaire,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103161,.,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103553,Flavonoids,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103554,represent,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103555,a,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103556,large,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103557,class,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103558,of,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103559,phenolic,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103560,compounds,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103561,found,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103562,in,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103563,fruits,B-AG.01.h.01,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103564,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103565,vegetables,B-AG.01.h.02,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103566,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103567,nuts,B-AG.01.h.01.f,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103568,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103569,grains,B-AG.01.i,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103570,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103571,cocoa,B-AG.01,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103572,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103573,tea,B-AG.01.ac,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103574,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103575,and,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103576,other,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103577,beverages,B-AG.01.y,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103578,.,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103622,This,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103623,is,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103624,the,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103625,first,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103626,comprehensive,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103627,review,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103628,summarizing,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103629,the,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103630,current,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103631,research,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103632,progress,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103633,on,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103634,the,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103635,inhibition,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103636,of,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103637,inflammation,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103638,and,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103639,alleviation,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103640,of,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103641,insulin,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103642,resistance,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103643,by,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103644,flavonoids,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103645,as,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103646,well,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103647,as,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103648,the,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103649,mechanistic,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103650,link,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103651,between,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103652,these,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103653,disorders,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103654,.,O,3597.0,This is the first comprehensive review summarizing the current research progress on the inhibition of inflammation and alleviation of insulin resistance by flavonoids as well as the mechanistic link between these disorders .
103986,Treatment,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103987,of,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103988,linoleic,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103989,acid,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103990,-,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103991,rich,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103992,oils,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103993,such,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103994,as,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103995,safflower,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103996,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103997,",",O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103998,soybean,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103999,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104000,",",O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104001,or,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104002,maize,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104003,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104004,with,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104005,base,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104006,and,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104007,heat,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104008,will,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104009,result,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104010,in,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104011,the,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104012,formation,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104013,of,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104014,CLA,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104015,.,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104112,Since,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104113,CLA,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104114,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104115,derived,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104116,from,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104117,the,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104118,milk,B-AG.01.e,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104119,of,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104120,ruminant,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104121,animals,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104122,and,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104123,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104124,found,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104125,primarily,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104126,in,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104127,their,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104128,meat,B-AG.01.d,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104129,and,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104130,in,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104131,products,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104132,derived,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104133,from,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104134,their,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104135,milk,B-AG.01.e,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104136,there,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104137,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104138,a,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104139,concerted,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104140,world,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104141,-,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104142,wide,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104143,effort,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104144,to,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104145,increase,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104146,CLA,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104147,content,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104148,of,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104149,milk,B-AG.01.e,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104150,by,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104151,dietary,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104152,means,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104153,.,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104388,The,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104389,Dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104390,Quality,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104391,Index,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104392,was,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104393,reduced,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104394,from,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104395,42.4,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104396,±,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104397,4.1,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104398,to,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104399,37.8,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104400,±,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104401,4.7,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104402,(,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104403,Low,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104404,dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104405,fat,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104406,intake,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104407,may,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104408,reduce,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104409,the,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104410,risk,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104411,of,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104412,developing,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104413,atherosclerosis,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104414,.,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104529,Sensory,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104530,scores,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104531,for,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104532,color,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104533,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104534,smell,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104535,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104536,flavor,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104537,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104538,aftertaste,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104539,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104540,moistness,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104541,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104542,and,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104543,overall,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104544,acceptability,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104545,for,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104546,fresh,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104547,cookies,B-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104548,were,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104549,acceptable,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104550,",",O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104551,yet,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104552,lower,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104553,for,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104554,flavor,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104555,and,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104556,aftertaste,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104557,in,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104558,fat,B-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104559,-,I-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104560,free,I-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104561,cookies,I-AG.01.n.14,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104562,than,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104563,CTL,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104564,(,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104565,P<.01,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104566,),O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104567,.,O,3635.0,"Sensory scores for color , smell , flavor , aftertaste , moistness , and overall acceptability for fresh cookies were acceptable , yet lower for flavor and aftertaste in fat - free cookies than CTL ( P<.01 ) ."
104845,This,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104846,suggests,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104847,the,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104848,existence,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104849,of,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104850,common,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104851,antigenic,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104852,determinants,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104853,among,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104854,these,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104855,allergens,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104856,.,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
105018,All,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105019,three,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105020,chocolates,B-AG.01.n.17.a,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105021,provoked,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105022,a,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105023,sustained,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105024,rise,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105025,in,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105026,blood,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105027,glucose,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105028,",",O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105029,which,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105030,reached,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105031,a,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105032,maximum,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105033,at,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105034,90,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105035,min,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105036,after,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105037,ingestion,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105038,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105039,returned,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105040,to,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105041,baseline,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105042,values,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105043,by,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105044,5,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105045,h.,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105046,The,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105047,highest,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105048,blood,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105049,glucose,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105050,levels,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105051,occurred,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105052,after,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105053,conventional,B-AG.01.n.17.a,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105054,chocolate,I-AG.01.n.17.a,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105055,",",O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105056,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105057,differences,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105058,were,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105059,statistically,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105060,significant,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105061,at,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105062,60,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105063,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105064,90,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105065,min,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105066,(,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105067,P,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105068,less,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105069,than,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105070,0.05,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105071,),O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105072,.,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105073,The,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105074,area,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105075,under,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105076,the,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105077,glycaemic,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105078,curve,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105079,for,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105080,isomalt,B-AG.01.n.17.a,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105081,chocolate,I-AG.01.n.17.a,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105082,was,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105083,36,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105084,%,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105085,smaller,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105086,than,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105087,that,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105088,for,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105089,conventional,B-AG.01.n.17.a,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105090,chocolate,I-AG.01.n.17.a,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105091,(,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105092,P,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105093,less,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105094,than,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105095,0.05,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105096,),O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105097,",",O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105098,and,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105099,there,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105100,were,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105101,differences,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105102,in,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105103,insulin,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105104,and,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105105,lactate,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105106,levels,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105107,",",O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105108,consistent,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105109,with,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105110,the,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105111,lower,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105112,glycaemic,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105113,effect,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105114,.,O,3655.0,"The area under the glycaemic curve for isomalt chocolate was 36 % smaller than that for conventional chocolate ( P less than 0.05 ) , and there were differences in insulin and lactate levels , consistent with the lower glycaemic effect ."
105191,Although,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105192,the,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105193,Japanese,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105194,diet,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105195,is,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105196,associated,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105197,with,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105198,higher,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105199,sodium,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105200,intake,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105201,and,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105202,lower,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105203,potassium,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105204,intake,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105205,",",O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105206,few,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105207,studies,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105208,have,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105209,examined,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105210,the,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105211,source,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105212,foods,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105213,quantitatively,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105214,.,O,3660.0,"Although the Japanese diet is associated with higher sodium intake and lower potassium intake , few studies have examined the source foods quantitatively ."
105655,The,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105656,gluten,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105657,protein,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105658,of,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105659,wheat,B-AG.01.i,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105660,triggers,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105661,an,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105662,immunological,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105663,reaction,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105664,in,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105665,some,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105666,gluten,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105667,-,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105668,sensitive,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105669,people,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105670,with,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105671,HLA,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105672,-,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105673,DQ2/8,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105674,genotypes,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105675,",",O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105676,which,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105677,leads,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105678,to,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105679,Celiac,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105680,disease,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105681,(,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105682,CD,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105683,),O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105684,with,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105685,symptomatic,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105686,damage,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105687,in,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105688,the,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105689,small,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105690,intestinal,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105691,villi,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105692,.,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105908,Lifestyle,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105909,factors,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105910,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105911,including,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105912,nutrition,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105913,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105914,play,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105915,an,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105916,important,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105917,role,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105918,in,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105919,the,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105920,etiology,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105921,of,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105922,Cardiovascular,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105923,Disease,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105924,(,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105925,CVD,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105926,),O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105927,.,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
106056,Supplements,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106057,reviewed,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106058,in,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106059,the,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106060,third,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106061,section,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106062,include,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106063,salt,B-AG.01.l.01,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106064,and,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106065,sodium,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106066,",",O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106067,omega-3,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106068,and,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106069,fish,B-AG.01.f,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106070,oil,I-AG.01.f,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106071,",",O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106072,phytosterols,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106073,",",O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106074,antioxidants,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106075,",",O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106076,vitamin,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106077,D,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106078,",",O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106079,magnesium,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106080,",",O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106081,homocysteine,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106082,-,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106083,reducing,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106084,agents,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106085,",",O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106086,and,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106087,coenzyme,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106088,Q10,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106089,.,O,3688.0,"Supplements reviewed in the third section include salt and sodium , omega-3 and fish oil , phytosterols , antioxidants , vitamin D , magnesium , homocysteine - reducing agents , and coenzyme Q10 ."
106809,Observational,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106810,studies,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106811,support,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106812,the,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106813,role,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106814,of,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106815,modifying,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106816,lifestyle,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106817,-,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106818,related,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106819,risk,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106820,factors,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106821,such,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106822,as,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106823,diet,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106824,",",O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106825,physical,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106826,activity,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106827,and,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106828,alcohol,B-AG.01.y.01,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106829,use,B-X,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106830,in,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106831,stroke,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106832,prevention,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106833,.,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106887,Consumption,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106888,of,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106889,a,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106890,diet,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106891,rich,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106892,in,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106893,fruits,B-AG.01.h.01,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106894,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106895,vegetables,B-AG.01.h.02,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106896,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106897,folate,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106898,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106899,K,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106900,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106901,Ca,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106902,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106903,Mg,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106904,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106905,dietary,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106906,fibre,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106907,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106908,fish,B-AG.01.d.07,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106909,and,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106910,milk,B-AG.01.e,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106911,may,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106912,protect,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106913,against,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106914,stroke,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106915,.,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
107224,Metabolic,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107225,B12,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107226,deficiency,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107227,is,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107228,common,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107229,and,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107230,usually,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107231,missed,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107232,.,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107382,The,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107383,potato,B-AG.01.h.02.a,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107384,(,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107385,200,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107386,g,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107387,raw,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107388,wt,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107389,),O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107390,with,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107391,bolognese,B-AG.01.n.06,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107392,sauce,I-AG.01.n.06,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107393,(,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107394,167,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107395,g,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107396,),O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107397,and,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107398,spaghetti,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107399,(,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107400,50,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107401,g,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107402,raw,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107403,wt,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107404,),O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107405,with,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107406,bolognese,B-AG.01.n.06,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107407,sauce,I-AG.01.n.06,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107408,(,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107409,167,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107410,g,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107411,),O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107412,had,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107413,approximately,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107414,identical,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107415,caloric,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107416,content,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107417,(,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107418,435,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107419,and,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107420,447,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107421,kcal,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107422,",",O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107423,respectively,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107424,),O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107425,",",O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107426,fat,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107427,(,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107428,18,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107429,g,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107430,each,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107431,),O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107432,",",O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107433,protein,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107434,(,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107435,23,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107436,and,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107437,26,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107438,g,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107439,",",O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107440,respectively,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107441,),O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107442,",",O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107443,and,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107444,carbohydrate,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107445,(,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107446,47,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107447,and,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107448,48,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107449,g,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107450,",",O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107451,respectively,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107452,),O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107453,.,O,3734.0,"The potato ( 200 g raw wt ) with bolognese sauce ( 167 g ) and spaghetti ( 50 g raw wt ) with bolognese sauce ( 167 g ) had approximately identical caloric content ( 435 and 447 kcal , respectively ) , fat ( 18 g each ) , protein ( 23 and 26 g , respectively ) , and carbohydrate ( 47 and 48 g , respectively ) ."
107561,Ochratoxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107562,A,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107563,(,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107564,OTA,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107565,),O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107566,is,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107567,a,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107568,mycotoxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107569,",",O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107570,or,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107571,fungal,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107572,toxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107573,",",O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107574,that,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107575,contaminates,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107576,multiple,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107577,foodstuffs,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107578,worldwide,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107579,.,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107580,Affected,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107581,commodities,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107582,include,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107583,oats,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107584,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107585,wheat,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107586,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107587,maize,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107588,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107589,barley,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107590,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107591,raisins,B-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107592,and,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107593,other,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107594,dried,B-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107595,vine,I-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107596,fruits,I-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107597,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107598,wine,B-AG.01.y.01.a,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107599,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107600,beer,B-AG.01.y.01.b,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107601,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107602,coffee,B-AG.01.ad,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107603,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107604,and,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107605,cocoa,B-FOOD,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107606,.,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
108468,For,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108469,most,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108470,studies,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108471,",",O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108472,an,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108473,independent,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108474,effect,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108475,of,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108476,a,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108477,vegetable,B-AG.01.f,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108478,oil,I-AG.01.f,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108479,or,I-AG.01.f,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108480,fat,I-AG.01.f,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108481,could,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108482,not,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108483,be,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108484,ascertained,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108485,because,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108486,there,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108487,was,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108488,no,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108489,neutral,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108490,control,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108491,and,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108492,at,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108493,least,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108494,two,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108495,of,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108496,the,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108497,test,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108498,oils,B-AG.01.f,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108499,or,I-AG.01.f,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108500,fats,I-AG.01.f,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108501,were,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108502,varied,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108503,.,O,3770.0,"For most studies , an independent effect of a vegetable oil or fat could not be ascertained because there was no neutral control and at least two of the test oils or fats were varied ."
108620,Stearic,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108621,acid,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108622,(,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108623,18:0,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108624,),O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108625,appears,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108626,to,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108627,be,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108628,neutral,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108629,in,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108630,its,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108631,LDL,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108632,-,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108633,C,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108634,-,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108635,raising,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108636,potential,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108637,and,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108638,how,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108639,it,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108640,affects,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108641,LDL,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108642,metabolism,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108643,.,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108966,In,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108967,the,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108968,21st,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108969,century,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108970,",",O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108971,the,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108972,protection,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108973,provided,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108974,by,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108975,cranberry,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108976,phytochemicals,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108977,against,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108978,cancer,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108979,and,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108980,vascular,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108981,diseases,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108982,has,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108983,drawn,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108984,more,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108985,attention,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108986,from,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108987,researchers,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108988,.,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
109154,It,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109155,is,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109156,well,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109157,known,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109158,that,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109159,variations,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109160,in,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109161,MEC,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109162,number,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109163,are,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109164,due,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109165,to,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109166,cell,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109167,proliferation,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109168,and,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109169,apoptosis,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109170,.,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109315,Other,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109316,animal,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109317,models,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109318,were,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109319,designed,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109320,to,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109321,investigate,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109322,the,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109323,endocrine,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109324,control,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109325,of,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109326,the,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109327,exfoliation,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109328,process,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109329,and,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109330,its,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109331,link,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109332,with,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109333,milk,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109334,production,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109335,.,O,3807.0,Other animal models were designed to investigate the endocrine control of the exfoliation process and its link with milk production .
109505,The,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109506,dietary,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109507,habits,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109508,were,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109509,defined,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109510,through,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109511,the,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109512,"""",O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109513,Lifestyle,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109514,Assessment,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109515,Questionnaire,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109516,"""",O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109517,.,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109870,Moreover,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109871,",",O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109872,the,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109873,water,B-AG.01.z,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109874,intake,B-X,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109875,should,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109876,be,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109877,increased,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109878,and,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109879,the,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109880,actual,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109881,need,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109882,to,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109883,consume,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109884,iodized,B-AG.01.l.01,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109885,salt,I-AG.01.l.01,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109886,should,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109887,be,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109888,verified,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109889,for,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109890,each,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109891,subject,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109892,/,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109893,area,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109894,.,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
110230,This,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110231,paper,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110232,will,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110233,review,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110234,the,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110235,characteristics,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110236,of,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110237,cereal,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110238,anthocyanins,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110239,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110240,and,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110241,assess,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110242,their,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110243,prevalence,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110244,in,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110245,various,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110246,commercially,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110247,relevant,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110248,crops,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110249,including,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110250,wheat,B-AG.01.i,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110251,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110252,barley,B-AG.01.i,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110253,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110254,maize,B-AG.01.i,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110255,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110256,and,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110257,rice,B-AG.01.i,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110258,.,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110526,Borderline,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110527,statistically,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110528,significant,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110529,lower,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110530,bladder,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110531,cancer,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110532,risks,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110533,were,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110534,found,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110535,among,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110536,never,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110537,smokers,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110538,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110539,increased,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110540,consumption,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110541,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110542,fruit,B-AG.01.h,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110543,and,I-AG.01.h,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110544,vegetables,I-AG.01.h,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110545,combined,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110546,(,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110547,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110548,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110549,0.94,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110550,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110551,:,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110552,0.87,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110553,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110554,1.00,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110555,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110556,increments,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110557,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110558,100,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110559,g,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110560,/,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110561,day,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110562,;,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110563,calibrated,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110564,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110565,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110566,0.92,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110567,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110568,0.79,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110569,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110570,1.06,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110571,),O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110572,and,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110573,increased,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110574,consumption,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110575,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110576,apples,B-AG.01.h.01.c,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110577,and,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110578,pears,B-AG.01.h.01.d,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110579,(,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110580,hard,B-AG.01.h.01,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110581,fruit,I-AG.01.h.01,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110582,;,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110583,calibrated,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110584,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110585,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110586,0.90,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110587,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110588,:,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110589,0.82,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110590,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110591,0.98,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110592,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110593,increments,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110594,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110595,25,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110596,g,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110597,/,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110598,day,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110599,),O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110600,.,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110638,In,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110639,recent,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110640,history,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110641,",",O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110642,some,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110643,dietary,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110644,recommendations,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110645,have,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110646,treated,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110647,dairy,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110648,fat,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110649,as,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110650,an,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110651,unnecessary,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110652,source,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110653,of,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110654,calories,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110655,and,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110656,saturated,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110657,fat,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110658,in,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110659,the,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110660,human,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110661,diet,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110662,.,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110992,Uptake,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110993,of,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110994,dairy,B-AG.01.e,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110995,products,I-AG.01.e,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110996,of,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110997,Bos,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110998,taurus,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110999,-,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111000,derived,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111001,milk,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111002,cattle,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111003,",",O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111004,particularly,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111005,consumed,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111006,at,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111007,early,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111008,age,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111009,",",O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111010,is,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111011,suggested,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111012,to,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111013,represent,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111014,one,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111015,of,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111016,the,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111017,main,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111018,risk,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111019,factors,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111020,for,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111021,the,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111022,development,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111023,of,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111024,breast,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111025,cancer,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111026,.,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111368,Five,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111369,settlements,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111370,had,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111371,higher,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111372,As,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111373,intake,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111374,than,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111375,the,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111376,BMDL0.5,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111377,.,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111453,Four,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111454,hundred,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111455,and,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111456,thirty,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111457,-,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111458,eight,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111459,cases,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111460,were,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111461,frequency,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111462,matched,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111463,to,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111464,438,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111465,controls,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111466,by,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111467,age,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111468,(,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111469,5,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111470,-,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111471,year,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111472,interval,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111473,),O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111474,and,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111475,residence,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111476,(,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111477,rural,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111478,/,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111479,urban,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111480,),O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111481,.,O,3887.0,Four hundred and thirty - eight cases were frequency matched to 438 controls by age ( 5 - year interval ) and residence ( rural / urban ) .
111482,Dietary,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111483,intake,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111484,was,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111485,assessed,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111486,by,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111487,face,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111488,-,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111489,to,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111490,-,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111491,face,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111492,interviews,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111493,using,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111494,a,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111495,validated,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111496,food,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111497,frequency,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111498,questionnaire,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111499,.,O,3888.0,Dietary intake was assessed by face - to - face interviews using a validated food frequency questionnaire .
111696,For,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111697,this,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111698,purpose,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111699,",",O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111700,histopathological,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111701,analysis,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111702,and,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111703,immunohistochemistry,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111704,for,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111705,RUNX-2,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111706,and,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111707,RANK,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111708,-,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111709,L,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111710,were,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111711,investigated,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111712,in,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111713,this,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111714,setting,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111715,.,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
112210,After,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112211,41,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112212,wk,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112213,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112214,cumulative,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112215,survival,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112216,of,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112217,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112218,mice,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112219,given,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112220,20,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112221,mg,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112222,ethyl,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112223,carbamate,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112224,/,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112225,kg,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112226,in,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112227,water,B-AG.01.z,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112228,was,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112229,depressed,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112230,compared,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112231,with,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112232,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112233,mice,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112234,drinking,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112235,wines,B-AG.01.y.01.a,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112236,or,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112237,ethanol,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112238,solution,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112239,with,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112240,this,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112241,ethyl,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112242,carbamate,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112243,level,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112244,.,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112533,Dietary,O,3927.0,Dietary data were obtained from 24 - h recalls .
112534,data,O,3927.0,Dietary data were obtained from 24 - h recalls .
112535,were,O,3927.0,Dietary data were obtained from 24 - h recalls .
112536,obtained,O,3927.0,Dietary data were obtained from 24 - h recalls .
112537,from,O,3927.0,Dietary data were obtained from 24 - h recalls .
112538,24,O,3927.0,Dietary data were obtained from 24 - h recalls .
112539,-,O,3927.0,Dietary data were obtained from 24 - h recalls .
112540,h,O,3927.0,Dietary data were obtained from 24 - h recalls .
112541,recalls,O,3927.0,Dietary data were obtained from 24 - h recalls .
112542,.,O,3927.0,Dietary data were obtained from 24 - h recalls .
112822,When,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112823,compared,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112824,with,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112825,data,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112826,from,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112827,non,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112828,-,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112829,drinkers,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112830,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112831,the,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112832,cumulative,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112833,lifetime,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112834,consumption,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112835,of,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112836,all,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112837,types,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112838,of,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112839,alcohol,B-AG.01.y.01,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112840,in,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112841,grams,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112842,of,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112843,ethanol,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112844,(,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112845,ORs,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112846,1.00,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112847,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112848,0.97,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112849,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112850,0.93,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112851,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112852,1.25,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112853,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112854,p,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112855,trend,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112856,0.55,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112857,),O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112858,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112859,beer,B-AG.01.y.01.b,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112860,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112861,spirits,B-AG.01.y.01,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112862,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112863,red,B-AG.01.y.01.a,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112864,wine,I-AG.01.y.01.a,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112865,and,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112866,fortified,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112867,wine,B-AG.01.y.01.a,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112868,was,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112869,not,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112870,related,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112871,to,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112872,risk,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112873,.,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
113148,Diet,B-AG.01.aa,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113149,soda,I-AG.01.aa,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113150,and,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113151,orange,B-AG.01.ab,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113152,juice,I-AG.01.ab,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113153,-,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113154,a,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113155,100,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113156,%,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113157,juice,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113158,with,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113159,a,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113160,1:1,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113161,fructose,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113162,:,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113163,glucose,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113164,ratio,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113165,-,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113166,were,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113167,included,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113168,for,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113169,comparison,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113170,.,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113422,Strawberries,B-AG.01.h.01.b,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113423,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113424,a,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113425,rich,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113426,source,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113427,of,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113428,phytochemicals,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113429,(,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113430,ellagic,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113431,acid,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113432,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113433,anthocyanins,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113434,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113435,quercetin,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113436,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113437,and,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113438,catechin,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113439,),O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113440,and,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113441,vitamins,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113442,(,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113443,ascorbic,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113444,acid,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113445,and,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113446,folic,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113447,acid,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113448,),O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113449,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113450,have,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113451,been,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113452,highly,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113453,ranked,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113454,among,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113455,dietary,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113456,sources,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113457,of,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113458,polyphenols,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113459,and,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113460,antioxidant,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113461,capacity,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113462,.,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113957,Individuals,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113958,with,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113959,celiac,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113960,disease,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113961,generally,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113962,are,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113963,advised,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113964,to,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113965,follow,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113966,a,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113967,lifelong,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113968,gluten,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113969,-,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113970,free,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113971,diet,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113972,and,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113973,avoid,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113974,consumption,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113975,of,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113976,the,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113977,prolamins,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113978,gliadin,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113979,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113980,wheat,B-AG.01.i,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113981,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113982,",",O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113983,secalin,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113984,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113985,rye,B-AG.01.i,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113986,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113987,",",O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113988,and,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113989,hordein,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113990,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113991,barley,B-AG.01.i,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113992,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113993,.,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
114305,Recent,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114306,studies,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114307,have,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114308,shown,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114309,that,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114310,consumption,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114311,of,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114312,dairy,B-AG.01.e,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114313,products,I-AG.01.e,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114314,appears,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114315,to,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114316,be,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114317,beneficial,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114318,in,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114319,muscle,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114320,building,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114321,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114322,lowering,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114323,blood,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114324,pressure,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114325,and,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114326,low,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114327,-,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114328,density,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114329,lipoprotein,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114330,cholesterol,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114331,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114332,and,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114333,preventing,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114334,tooth,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114335,decay,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114336,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114337,diabetes,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114338,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114339,cancer,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114340,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114341,and,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114342,obesity,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114343,.,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114568,We,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114569,defined,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114570,sepsis,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114571,events,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114572,as,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114573,hospital,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114574,admission,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114575,for,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114576,serious,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114577,infection,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114578,and,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114579,at,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114580,least,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114581,two,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114582,systematic,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114583,inflammatory,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114584,response,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114585,syndrome,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114586,criteria,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
114587,.,O,3990.0,We defined sepsis events as hospital admission for serious infection and at least two systematic inflammatory response syndrome criteria .
115082,The,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115083,Mediterranean,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115084,diet,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115085,includes,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115086,the,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115087,consumption,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115088,of,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115089,large,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115090,amounts,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115091,of,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115092,olive,B-AG.01.f,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115093,oil,I-AG.01.f,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115094,.,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115275,This,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115276,review,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115277,summarizes,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115278,the,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115279,antioxidant,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115280,abilities,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115281,;,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115282,the,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115283,scavenging,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115284,abilities,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115285,and,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115286,the,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115287,biological,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115288,fates,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115289,of,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115290,hydroxytyrosol,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115291,",",O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115292,oleuropein,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115293,and,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115294,tyrosol,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115295,which,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115296,have,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115297,been,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115298,published,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115299,in,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115300,recent,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115301,years,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115302,.,O,4018.0,"This review summarizes the antioxidant abilities ; the scavenging abilities and the biological fates of hydroxytyrosol , oleuropein and tyrosol which have been published in recent years ."
115627,Trans,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115628,isomers,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115629,of,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115630,fatty,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115631,acids,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115632,",",O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115633,formed,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115634,by,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115635,the,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115636,partial,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115637,hydrogenation,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115638,of,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115639,vegetable,B-AG.01.f,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115640,oils,I-AG.01.f,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115641,to,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115642,produce,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115643,margarine,B-AG.01.f,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115644,and,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115645,vegetable,B-AG.01.f,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115646,shortening,I-AG.01.f,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115647,",",O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115648,increase,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115649,the,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115650,ratio,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115651,of,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115652,plasma,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115653,low,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115654,-,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115655,density,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115656,-,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115657,lipoprotein,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115658,to,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115659,high,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115660,-,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115661,density,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115662,-,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115663,lipoprotein,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115664,cholesterol,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115665,",",O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115666,so,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115667,it,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115668,is,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115669,possible,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115670,that,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115671,they,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115672,adversely,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115673,influence,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115674,risk,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115675,of,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115676,coronary,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115677,heart,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115678,disease,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115679,(,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115680,CHD,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115681,),O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115682,.,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
116000,Participants,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116001,also,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116002,listed,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116003,their,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116004,emotional,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116005,conceptualisations,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116006,upon,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116007,consumption,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116008,and,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116009,were,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116010,assessed,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116011,on,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116012,emotional,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116013,eating,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116014,behaviour,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116015,and,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116016,health,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116017,and,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116018,taste,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116019,attitudes,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116020,.,O,4042.0,Participants also listed their emotional conceptualisations upon consumption and were assessed on emotional eating behaviour and health and taste attitudes .
116077,In,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116078,conclusion,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116079,",",O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116080,dark,B-AG.01.n.17.a,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116081,chocolate,I-AG.01.n.17.a,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116082,with,I-AG.01.n.17.a,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116083,tagatose,I-AG.01.n.17.a,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116084,did,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116085,not,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116086,significantly,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116087,differ,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116088,from,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116089,sugar,B-AG.01.l.02,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116090,in,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116091,overall,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116092,liking,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116093,",",O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116094,most,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116095,sensory,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116096,attributes,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116097,and,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116098,emotional,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116099,conceptualisation,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116100,.,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116109,In,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116110,virtually,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116111,every,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116112,early,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116113,civilization,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116114,known,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116115,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116116,such,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116117,as,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116118,ancient,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116119,India,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116120,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116121,Egypt,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116122,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116123,Rome,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116124,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116125,China,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116126,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116127,and,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116128,Japan,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116129,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116130,garlic,B-AG.01.h.02.e,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116131,was,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116132,part,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116133,of,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116134,the,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116135,therapeutic,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116136,regimen,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116137,for,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116138,a,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116139,variety,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116140,of,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116141,maladies,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116142,.,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116570,Therefore,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116571,because,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116572,hyperlipidemia,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116573,is,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116574,a,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116575,major,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116576,etiopathological,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116577,factor,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116578,for,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116579,atherosclerosis,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116580,",",O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116581,garlic,B-AG.01.h.02.e,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116582,may,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116583,play,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116584,an,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116585,important,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116586,role,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116587,in,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116588,the,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116589,prevention,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116590,of,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116591,atherosclerosis,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116592,.,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116808,There,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116809,are,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116810,even,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116811,factors,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116812,in,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116813,milk,B-AG.01.e,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116814,and,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116815,milk,B-AG.01.e,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116816,products,I-AG.01.e,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116817,which,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116818,may,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116819,actively,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116820,protect,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116821,from,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116822,this,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116823,condition,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116824,by,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116825,improving,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116826,several,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116827,risk,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116828,factors,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116829,.,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116949,By,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116950,virtue,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116951,of,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116952,their,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116953,unique,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116954,composition,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116955,",",O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116956,nuts,B-AG.01.h.01.f,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116957,are,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116958,likely,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116959,to,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116960,beneficially,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116961,impact,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116962,health,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116963,outcomes,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116964,.,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
117355,When,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117356,a,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117357,single,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117358,logistic,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117359,model,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117360,was,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117361,fitted,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117362,including,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117363,all,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117364,food,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117365,items,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117366,significant,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117367,in,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117368,univariate,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117369,analysis,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117370,",",O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117371,the,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117372,3,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117373,items,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117374,remaining,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117375,statistically,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117376,significant,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117377,were,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117378,green,B-AG.01.h.02,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117379,vegetables,I-AG.01.h.02,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117380,(,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117381,relative,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117382,risk,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117383,",",O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117384,RR,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117385,=,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117386,0.27,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117387,for,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117388,upper,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117389,vs.,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117390,lower,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117391,tertile,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117392,),O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117393,",",O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117394,polenta,B-AG.01.n.10,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117395,(,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117396,RR,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117397,=,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117398,2.32,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117399,),O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117400,and,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117401,ham,B-AG.01.d,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117402,(,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117403,RR,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117404,=,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117405,1.60,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117406,),O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117407,.,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117408,Indices,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117409,of,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117410,beta,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117411,-,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117412,carotene,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117413,and,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117414,ascorbate,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117415,intake,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117416,were,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117417,negatively,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117418,and,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117419,strongly,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117420,related,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117421,with,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117422,gastric,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117423,cancer,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117424,risk,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117425,",",O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117426,but,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117427,the,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117428,association,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117429,with,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117430,these,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117431,micronutrients,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117432,was,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117433,no,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117434,longer,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117435,evident,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117436,after,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117437,simultaneous,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117438,allowance,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117439,for,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117440,various,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117441,food,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117442,items,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117443,.,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117467,This,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117468,paper,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117469,describes,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117470,composition,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117471,of,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117472,dried,B-AG.01.n.08,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117473,plums,I-AG.01.n.08,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117474,and,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117475,their,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117476,products,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117477,(,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117478,prune,B-AG.01.ab,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117479,juice,I-AG.01.ab,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117480,and,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117481,dried,B-AG.01.n.08,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117482,plum,I-AG.01.n.08,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117483,powder,I-AG.01.n.08,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117484,),O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117485,with,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117486,special,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117487,attention,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117488,to,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117489,possibly,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117490,bioactive,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117491,compounds,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117492,.,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
118154,Extensive,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118155,research,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118156,within,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118157,the,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118158,past,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118159,two,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118160,decades,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118161,has,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118162,revealed,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118163,that,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118164,obesity,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118165,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118166,a,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118167,major,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118168,risk,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118169,factor,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118170,for,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118171,type,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118172,2,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118173,diabetes,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118174,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118175,atherosclerosis,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118176,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118177,cancer,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118178,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118179,and,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118180,other,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118181,chronic,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118182,diseases,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118183,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118184,is,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118185,a,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118186,proinflammatory,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118187,disease,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118188,.,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118189,Several,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118190,spices,B-AG.01.l.03,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118191,have,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118192,been,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118193,shown,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118194,to,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118195,exhibit,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118196,activity,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118197,against,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118198,obesity,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118199,through,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118200,antioxidant,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118201,and,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118202,anti,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118203,-,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118204,inflammatory,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118205,mechanisms,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118206,.,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118344,These,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118345,curcumin,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118346,-,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118347,induced,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118348,alterations,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118349,reverse,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118350,insulin,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118351,resistance,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118352,",",O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118353,hyperglycemia,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118354,",",O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118355,hyperlipidemia,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118356,",",O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118357,and,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118358,other,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118359,symptoms,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118360,linked,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118361,to,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118362,obesity,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118363,.,O,4127.0,"These curcumin - induced alterations reverse insulin resistance , hyperglycemia , hyperlipidemia , and other symptoms linked to obesity ."
118875,A,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118876,diet,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118877,based,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118878,on,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118879,rice,B-AG.01.i,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118880,and,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118881,beans,B-AG.01.h.02.g,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118882,may,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118883,have,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118884,a,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118885,protective,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118886,role,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118887,against,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118888,weight,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118889,gain,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118890,in,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118891,women,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
118892,.,O,4144.0,A diet based on rice and beans may have a protective role against weight gain in women .
119173,The,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119174,aims,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119175,of,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119176,the,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119177,present,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119178,study,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119179,were,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119180,to,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119181,calculate,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119182,DED,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119183,estimates,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119184,for,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119185,the,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119186,Irish,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119187,population,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119188,and,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119189,to,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119190,identify,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119191,dietary,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119192,determinants,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119193,of,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119194,DED,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119195,.,O,4156.0,The aims of the present study were to calculate DED estimates for the Irish population and to identify dietary determinants of DED .
119307,Determinants,O,4159.0,Determinants of DED did not vary by the calculation method used .
119308,of,O,4159.0,Determinants of DED did not vary by the calculation method used .
119309,DED,O,4159.0,Determinants of DED did not vary by the calculation method used .
119310,did,O,4159.0,Determinants of DED did not vary by the calculation method used .
119311,not,O,4159.0,Determinants of DED did not vary by the calculation method used .
119312,vary,O,4159.0,Determinants of DED did not vary by the calculation method used .
119313,by,O,4159.0,Determinants of DED did not vary by the calculation method used .
119314,the,O,4159.0,Determinants of DED did not vary by the calculation method used .
119315,calculation,O,4159.0,Determinants of DED did not vary by the calculation method used .
119316,method,O,4159.0,Determinants of DED did not vary by the calculation method used .
119317,used,O,4159.0,Determinants of DED did not vary by the calculation method used .
119318,.,O,4159.0,Determinants of DED did not vary by the calculation method used .
119490,These,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119491,estimates,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119492,and,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119493,determinants,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119494,serve,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119495,as,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119496,a,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119497,baseline,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119498,for,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119499,comparison,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119500,for,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119501,other,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119502,works,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119503,and,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119504,public,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119505,health,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119506,campaigns,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119507,.,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119876,Wives,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119877,",",O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119878,responding,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119879,as,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119880,surrogates,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119881,for,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119882,both,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119883,cases,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119884,and,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119885,controls,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119886,",",O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119887,were,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119888,interviewed,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119889,by,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119890,telephone,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119891,and,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119892,completed,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119893,",",O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119894,alone,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119895,",",O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119896,a,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119897,food,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119898,frequency,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119899,questionnaire,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
119900,.,O,4177.0,"Wives , responding as surrogates for both cases and controls , were interviewed by telephone and completed , alone , a food frequency questionnaire ."
120384,As,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120385,with,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120386,other,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120387,noninfectious,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120388,diseases,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120389,",",O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120390,the,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120391,diet,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120392,has,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120393,an,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120394,important,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120395,effect,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120396,on,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120397,the,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120398,prevention,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120399,and,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120400,treatment,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120401,of,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120402,metabolic,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120403,syndrome,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120404,.,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120579,In,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120580,this,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120581,review,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120582,",",O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120583,based,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120584,on,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120585,the,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120586,clinical,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120587,studies,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120588,conducted,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120589,to,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120590,date,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120591,",",O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120592,and,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120593,the,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120594,nutrient,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120595,content,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120596,of,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120597,yogurt,B-AG.01.e,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120598,",",O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120599,possible,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120600,mechanisms,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120601,of,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120602,these,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120603,contradictory,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120604,results,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120605,are,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120606,investigated,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120607,.,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120664,Results,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120665,indicated,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120666,that,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120667,Western,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120668,style,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120669,diet,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120670,such,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120671,as,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120672,expenditure,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120673,of,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120674,meat,B-AG.01.d,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120675,",",O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120676,milk,B-AG.01.e,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120677,and,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120678,egg,B-AG.01.g,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120679,and,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120680,bread,B-AG.01.n.11,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120681,had,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120682,negative,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120683,association,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120684,with,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120685,SMR,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120686,.,O,4205.0,"Results indicated that Western style diet such as expenditure of meat , milk and egg and bread had negative association with SMR ."
120719,Consumption,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120720,of,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120721,constituents,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120722,of,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120723,the,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120724,traditional,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120725,Japanese,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120726,diet,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120727,",",O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120728,such,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120729,as,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120730,rice,B-AG.01.i,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120731,and,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120732,other,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120733,cereals,B-AG.01.i,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120734,",",O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120735,certain,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120736,seasonings,B-AG.01.l.03,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120737,",",O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120738,salted,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120739,and,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120740,dried,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120741,fish,B-AG.01.d.07,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120742,showed,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120743,a,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120744,positive,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120745,association,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120746,with,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120747,SMR,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120748,.,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
121102,In,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121103,this,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121104,study,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121105,",",O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121106,we,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121107,aimed,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121108,to,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121109,explore,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121110,the,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121111,proteomic,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121112,profile,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121113,of,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121114,milk,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121115,sEV,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121116,from,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121117,BLV,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121118,-,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121119,infected,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121120,cattle,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121121,compared,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121122,with,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121123,those,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121124,from,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121125,uninfected,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121126,cattle,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121127,.,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121355,A,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121356,random,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121357,sample,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121358,of,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121359,1153,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121360,individuals,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121361,",",O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121362,aged,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121363,18,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121364,-,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121365,69,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121366,years,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121367,",",O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121368,was,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121369,recruited,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121370,to,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121371,participate,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121372,in,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121373,the,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121374,cross,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121375,-,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121376,sectional,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121377,Observation,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121378,of,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121379,Cardiovascular,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121380,Risk,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121381,Factors,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121382,in,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121383,Luxembourg,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121384,study,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121385,.,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121490,After,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121491,excluding,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121492,subjects,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121493,taking,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121494,antidiabetic,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121495,medications,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121496,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121497,higher,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121498,chocolate,B-AG.01.n.17.a,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121499,consumption,B-X,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121500,was,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121501,associated,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121502,with,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121503,lower,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121504,HOMA,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121505,-,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121506,IR,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121507,(,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121508,β=-0·16,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121509,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121510,P=0·004,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121511,),O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121512,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121513,serum,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121514,insulin,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121515,levels,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121516,(,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121517,β=-0·16,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121518,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121519,P=0·003,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121520,),O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121521,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121522,γ,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121523,-,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121524,GT,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121525,(,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121526,β=-0·12,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121527,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121528,P=0·009,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121529,),O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121530,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121531,ALT,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121532,(,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121533,β=-0·09,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121534,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121535,P=0·004,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121536,),O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121537,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121538,after,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121539,adjustment,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121540,for,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121541,age,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121542,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121543,sex,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121544,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121545,education,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121546,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121547,lifestyle,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121548,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121549,dietary,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121550,confounding,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121551,factors,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121552,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121553,including,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121554,intakes,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121555,of,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121556,fruits,B-AG.01.h.01,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121557,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121558,vegetables,B-AG.01.h.02,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121559,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121560,alcohol,B-AG.01.y.01,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121561,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121562,polyphenol,B-AG.01.ad,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121563,-,I-AG.01.ad,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121564,rich,I-AG.01.ad,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121565,coffee,I-AG.01.ad,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121566,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121567,tea,B-AG.01.ac,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121568,.,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121974,They,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121975,received,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121976,by,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121977,force-,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121978,feeding,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121979,7.14,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121980,mL/(kg,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121981,.,O,4249.0,They received by force- feeding 7.14 mL/(kg .
122510,Likewise,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122511,",",O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122512,tea,B-AG.01.ac,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122513,consumption,B-X,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122514,in,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122515,non,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122516,-,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122517,cigarette,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122518,smokers,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122519,increased,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122520,bladder,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122521,cancer,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122522,risk,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122523,(,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122524,OR,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122525,=,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122526,2.25,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122527,),O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122528,.,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122550,Furthermore,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122551,",",O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122552,it,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122553,is,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122554,hypothesized,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122555,that,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122556,the,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122557,dietary,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122558,components,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122559,of,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122560,these,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122561,beverages,B-AG.01.y,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122562,may,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122563,be,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122564,related,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122565,to,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122566,the,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122567,development,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122568,of,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122569,bladder,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122570,cancer,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122571,.,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122643,After,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122644,random,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122645,split,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122646,of,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122647,our,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122648,study,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122649,population,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122650,",",O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122651,we,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122652,derived,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122653,a,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122654,dietary,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122655,pattern,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122656,in,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122657,the,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122658,training,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122659,set,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122660,using,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122661,RRR,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122662,with,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122663,adiponectin,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122664,",",O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122665,HDL,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122666,-,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122667,cholesterol,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122668,and,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122669,triglycerides,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122670,as,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122671,responses,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122672,and,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122673,35,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122674,food,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122675,items,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122676,as,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122677,predictors,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122678,.,O,4273.0,"After random split of our study population , we derived a dietary pattern in the training set using RRR with adiponectin , HDL - cholesterol and triglycerides as responses and 35 food items as predictors ."
122755,The,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122756,multivariate,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122757,-,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122758,adjusted,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122759,odds,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122760,ratio,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122761,of,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122762,type,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122763,2,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122764,diabetes,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122765,for,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122766,the,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122767,highest,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122768,quintile,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122769,compared,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122770,to,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122771,the,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122772,lowest,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122773,was,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122774,4.43,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122775,(,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122776,95,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122777,%,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122778,confidence,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122779,interval,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122780,:,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122781,1.87,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122782,-,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122783,10.50,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122784,",",O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122785,p,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122786,for,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122787,trend,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122788,<,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122789,0.001,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122790,),O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122791,.,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
123015,The,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123016,"""",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123017,traditional,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123018,"""",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123019,DP,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123020,(,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123021,bread,B-AG.01.n.11,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123022,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123023,potatoes,B-AG.01.h.02.a,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123024,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123025,milk,B-AG.01.e,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123026,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123027,vegetables,B-AG.01.h.02,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123028,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123029,butter,B-AG.01.e.01,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123030,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123031,stock,B-AG.01.n.02,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123032,),O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123033,was,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123034,positively,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123035,associated,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123036,with,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123037,age,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123038,and,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123039,negatively,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123040,associated,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123041,with,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123042,being,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123043,a,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123044,former,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123045,/,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123046,current,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123047,smoker,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123048,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123049,education,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123050,(,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123051,men,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123052,),O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123053,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123054,and,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123055,residing,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123056,in,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123057,an,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123058,urban,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123059,/,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123060,semi,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123061,-,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123062,urban,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123063,area,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123064,.,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123347,Colonic,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123348,DNA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123349,strand,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123350,breakage,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123351,was,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123352,positively,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123353,associated,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123354,with,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123355,circulating,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123356,leptin,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123357,and,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123358,MDA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123359,concentrations,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123360,as,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123361,well,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123362,as,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123363,tissue,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123364,MDA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123365,concentrations,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123366,and,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123367,negatively,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123368,associated,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123369,with,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123370,plasma,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123371,TIMP-2,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123372,concentration,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123373,.,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123374,MMP-2,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123375,and,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123376,TIMP-2,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123377,positively,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123378,correlated,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123379,with,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123380,hepatic,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123381,portal,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123382,butyrate,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123383,levels,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123384,but,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123385,leptin,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123386,concentrations,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123387,correlated,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123388,negatively,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123389,.,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123926,In,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123927,conclusion,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123928,",",O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123929,the,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123930,present,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123931,study,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123932,confirms,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123933,the,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123934,presence,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123935,of,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123936,a,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123937,moderate,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123938,adverse,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123939,effect,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123940,of,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123941,high,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123942,intake,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123943,of,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123944,foods,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123945,of,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123946,animal,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123947,origin,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123948,",",O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123949,chiefly,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123950,milk,B-AG.01.e,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123951,",",O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123952,while,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123953,it,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123954,suggests,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123955,that,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123956,a,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123957,diet,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123958,rich,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123959,in,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123960,fresh,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123961,fruit,B-AG.01.h.01,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123962,and,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123963,vegetables,B-AG.01.h.02,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123964,does,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123965,not,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123966,convey,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123967,a,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123968,protection,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
123969,.,O,4319.0,"In conclusion , the present study confirms the presence of a moderate adverse effect of high intake of foods of animal origin , chiefly milk , while it suggests that a diet rich in fresh fruit and vegetables does not convey a protection ."
124042,Many,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124043,of,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124044,the,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124045,ACE,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124046,-,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124047,I,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124048,peptides,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124049,formed,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124050,during,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124051,milk,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124052,fermentation,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124053,are,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124054,resistant,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124055,to,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124056,gastrointestinal,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124057,digestion,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124058,and,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124059,inhibit,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124060,angiotensin,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124061,converting,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124062,enzyme,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124063,(,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124064,ACE,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124065,),O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124066,in,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124067,the,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124068,rennin,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124069,angiotension,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124070,system,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124071,(,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124072,RAS,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124073,),O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124074,.,O,4324.0,Many of the ACE - I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme ( ACE ) in the rennin angiotension system ( RAS ) .
124402,Olive,B-AG.01.f,4338.0,Olive oil reportedly has cardioprotective effects .
124403,oil,I-AG.01.f,4338.0,Olive oil reportedly has cardioprotective effects .
124404,reportedly,O,4338.0,Olive oil reportedly has cardioprotective effects .
124405,has,O,4338.0,Olive oil reportedly has cardioprotective effects .
124406,cardioprotective,O,4338.0,Olive oil reportedly has cardioprotective effects .
124407,effects,O,4338.0,Olive oil reportedly has cardioprotective effects .
124408,.,O,4338.0,Olive oil reportedly has cardioprotective effects .
124579,Dietary,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124580,histories,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124581,concerned,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124582,the,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124583,frequency,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124584,of,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124585,consumption,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124586,per,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124587,week,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124588,of,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124589,alcohol,B-AG.01.y.01,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124590,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124591,beverages,B-AG.01.y,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124592,that,I-AG.01.y,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124593,contain,I-AG.01.y,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124594,methylxanthine,I-AG.01.y,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124595,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124596,and,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124597,14,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124598,select,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124599,food,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124600,items,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124601,or,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124602,groups,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124603,of,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124604,foods,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124605,(,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124606,including,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124607,major,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124608,sources,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124609,of,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124610,proteins,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124611,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124612,fat,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124613,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124614,fibers,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124615,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124616,and,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124617,vitamin,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124618,A,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124619,in,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124620,the,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124621,Italian,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124622,diet,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124623,),O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124624,.,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
125012,Here,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125013,we,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125014,review,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125015,how,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125016,Westernized,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125017,high,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125018,-,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125019,fat,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125020,diets,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125021,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125022,excessive,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125023,alcohol,B-AG.01.y.01,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125024,intake,B-X,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125025,can,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125026,influence,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125027,inflammation,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125028,within,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125029,the,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125030,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125031,microenvironment,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125032,",",O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125033,stimulating,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125034,both,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125035,primary,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125036,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125037,metastatic,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125038,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125039,tumorigenesis,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125040,.,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125213,Replacing,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125214,fatty,B-AG.01.d.07,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125215,fish,I-AG.01.d.07,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125216,with,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125217,vegetables,B-AG.01.h.02,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125218,was,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125219,associated,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125220,with,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125221,a,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125222,higher,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125223,risk,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125224,of,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125225,MI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125226,(,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125227,HR,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125228,1·23,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125229,;,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125230,95,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125231,%,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125232,CI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125233,1·05,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125234,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125235,1·45,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125236,),O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125237,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125238,whereas,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125239,an,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125240,inverse,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125241,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125242,statistically,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125243,non,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125244,-,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125245,significant,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125246,association,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125247,was,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125248,found,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125249,for,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125250,lean,B-AG.01.d.07,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125251,fish,I-AG.01.d.07,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125252,(,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125253,HR,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125254,0·93,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125255,;,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125256,95,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125257,%,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125258,CI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125259,0·83,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125260,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125261,1·05,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125262,),O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125263,.,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125658,During,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125659,13.4,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125660,years,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125661,of,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125662,follow,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125663,-,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125664,up,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125665,122,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125666,women,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125667,developed,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125668,RCC,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125669,.,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
126366,Dietary,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126367,habits,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126368,during,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126369,the,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126370,year,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126371,before,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126372,sigmoidoscopy,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126373,and,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126374,when,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126375,subjects,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126376,were,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126377,30,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126378,yr,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126379,old,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126380,were,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126381,collected,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126382,using,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126383,a,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126384,food,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126385,-,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126386,frequency,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126387,questionnaire,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126388,.,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126389,Change,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126390,in,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126391,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126392,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126393,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126394,during,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126395,adulthood,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126396,was,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126397,calculated,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126398,by,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126399,subtracting,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126400,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126401,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126402,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126403,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126404,specific,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126405,foods,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126406,or,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126407,food,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126408,groups,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126409,at,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126410,age,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126411,30,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126412,yr,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126413,from,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126414,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126415,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126416,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126417,during,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126418,the,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126419,previous,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126420,year,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126421,(,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126422,recent,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126423,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126424,),O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126425,.,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
127110,Anthropometric,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127111,measurements,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127112,",",O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127113,assessments,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127114,of,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127115,body,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127116,composition,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127117,",",O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127118,and,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127119,blood,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127120,sample,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127121,analysis,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127122,were,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127123,performed,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127124,at,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127125,baseline,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127126,and,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127127,at,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127128,follow,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127129,-,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127130,up,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127131,four,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127132,years,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127133,later,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127134,.,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127355,Consequently,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127356,",",O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127357,this,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127358,information,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127359,could,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127360,be,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127361,of,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127362,value,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127363,to,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127364,obesity-,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127365,and,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127366,metabolic,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127367,disease,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127368,-,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127369,prevention,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127370,strategies,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127371,.,O,4430.0,"Consequently , this information could be of value to obesity- and metabolic disease - prevention strategies ."
127994,Administration,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127995,of,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127996,PG,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127997,did,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127998,not,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127999,affect,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128000,dry,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128001,matter,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128002,intake,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128003,or,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128004,milk,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128005,yield,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128006,and,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128007,composition,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128008,during,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128009,the,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128010,first,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128011,3,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128012,wk,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128013,postpartum,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128014,;,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128015,however,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128016,",",O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128017,cows,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128018,drenched,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128019,with,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128020,fat,B-AG.01.f,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128021,tended,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128022,to,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128023,have,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128024,lower,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128025,dry,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128026,matter,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128027,intake,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128028,and,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128029,milk,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128030,yield,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128031,during,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128032,the,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128033,first,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128034,3,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128035,wk,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128036,of,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128037,lactation,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128038,.,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128087,The,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128088,relationships,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128089,between,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128090,areal,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128091,differences,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128092,in,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128093,mortality,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128094,from,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128095,six,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128096,digestive,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128097,-,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128098,tract,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128099,cancers,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128100,and,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128101,consumption,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128102,of,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128103,selected,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128104,foods,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128105,in,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128106,46,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128107,of,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128108,the,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128109,47,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128110,Japanese,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128111,prefectures,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128112,(,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128113,Okinawa,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128114,being,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128115,excluded,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128116,),O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128117,were,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128118,analyzed,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128119,.,O,4457.0,The relationships between areal differences in mortality from six digestive - tract cancers and consumption of selected foods in 46 of the 47 Japanese prefectures ( Okinawa being excluded ) were analyzed .
128683,However,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128684,",",O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128685,recent,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128686,human,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128687,studies,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128688,have,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128689,proven,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128690,that,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128691,chocolate,B-AG.01.n.17.a,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128692,has,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128693,beneficial,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128694,effects,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128695,on,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128696,some,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128697,pathogenic,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128698,mechanisms,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128699,of,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128700,heart,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128701,disease,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128702,such,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128703,as,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128704,endothelial,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128705,function,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128706,and,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128707,blood,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128708,pressure,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128709,.,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128816,Conversely,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128817,",",O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128818,the,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128819,fat,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128820,from,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128821,chocolate,B-AG.01.n.17.a,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128822,alone,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128823,is,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128824,a,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128825,pro,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128826,-,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128827,oxidant,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128828,in,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128829,this,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128830,model,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128831,.,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
129254,About,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129255,50,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129256,%,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129257,of,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129258,those,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129259,studied,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129260,ate,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129261,meat,B-AG.01.d,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129262,products,I-AG.01.d,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129263,<,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129264,1,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129265,time,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129266,/,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129267,wk,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129268,or,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129269,not,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129270,at,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129271,all,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129272,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129273,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129274,vegetarians,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129275,consumed,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129276,more,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129277,tomatoes,B-AG.01.h.02.f,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129278,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129279,legumes,B-AG.01.h.02.g,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129280,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129281,nuts,B-AG.01.h.01.f,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129282,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129283,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129284,fruit,B-AG.01.h.01,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129285,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129286,but,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129287,less,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129288,coffee,B-AG.01.ad,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129289,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129290,doughnuts,B-AG.01.n.13,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129291,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129292,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129293,eggs,B-AG.01.g,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129294,than,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129295,did,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129296,nonvegetarians,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129297,.,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129571,Although,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129572,acute,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129573,trials,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129574,show,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129575,reductions,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129576,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129577,postprandial,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129578,glycemia,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129579,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129580,healthy,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129581,individuals,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129582,ingesting,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129583,60,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129584,to,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129585,90,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129586,g,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129587,almonds,B-AG.01.h.01.f,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129588,",",O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129589,trials,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129590,have,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129591,not,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129592,been,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129593,conducted,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129594,using,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129595,a,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129596,single,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129597,serving,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129598,of,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129599,almonds,B-AG.01.h.01.f,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129600,(,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129601,28,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129602,g,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129603,),O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129604,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129605,individuals,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129606,with,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129607,type,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129608,2,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129609,diabetes,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129610,mellitus,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129611,.,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
130241,Both,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130242,aqueous,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130243,and,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130244,organic,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130245,extractions,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130246,of,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130247,ginger,B-AG.01.l.03,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130248,significantly,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130249,inhibited,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130250,the,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130251,growth,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130252,of,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130253,one,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130254,or,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130255,both,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130256,E.,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130257,coli,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130258,strains,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130259,",",O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130260,respectively,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130261,(,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130262,also,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130263,at,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130264,the,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130265,1:50,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130266,dilution,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130267,),O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130268,.,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130466,The,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130467,majority,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130468,of,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130469,previous,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130470,oil,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130471,dosing,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130472,studies,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130473,conducted,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130474,on,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130475,wild,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130476,-,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130477,caught,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130478,birds,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130479,used,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130480,gavage,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130481,methods,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130482,to,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130483,dose,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130484,birds,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130485,with,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130486,oil,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130487,and,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130488,determine,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130489,toxicity,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130490,.,O,4538.0,The majority of previous oil dosing studies conducted on wild - caught birds used gavage methods to dose birds with oil and determine toxicity .
130988,However,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130989,",",O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130990,the,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130991,effect,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130992,of,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130993,consumption,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130994,of,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130995,raw,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130996,tomatoes,B-AG.01.h.02.f,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130997,and,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130998,tomato,B-AG.01.l.04,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130999,sauces,I-AG.01.l.04,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131000,on,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131001,inflammation,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131002,biomarkers,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131003,and,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131004,adhesion,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131005,molecules,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131006,related,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131007,to,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131008,atherosclerosis,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131009,remains,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131010,unknown,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131011,.,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131012,The,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131013,aim,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131014,of,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131015,this,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131016,study,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131017,was,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131018,to,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131019,test,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131020,the,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131021,postprandial,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131022,effects,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131023,of,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131024,a,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131025,single,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131026,dose,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131027,of,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131028,raw,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131029,tomatoes,B-AG.01.h.02.f,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131030,(,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131031,RT,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131032,),O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131033,",",O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131034,tomato,B-AG.01.l.04,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131035,sauce,I-AG.01.l.04,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131036,(,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131037,TS,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131038,),O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131039,and,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131040,tomato,B-AG.01.l.04,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131041,sauce,I-AG.01.l.04,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131042,with,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131043,refined,B-AG.01.f,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131044,olive,I-AG.01.f,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131045,oil,I-AG.01.f,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131046,(,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131047,TSOO,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131048,),O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131049,on,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131050,cardiovascular,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131051,disease,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131052,risk,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131053,factors,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131054,.,O,4556.0,"The aim of this study was to test the postprandial effects of a single dose of raw tomatoes ( RT ) , tomato sauce ( TS ) and tomato sauce with refined olive oil ( TSOO ) on cardiovascular disease risk factors ."
131333,Histone,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131334,deacetylase,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131335,inhibitors,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131336,(,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131337,HDACi,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131338,),O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131339,regulate,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131340,the,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131341,activity,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131342,of,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131343,HDACs,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131344,and,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131345,are,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131346,being,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131347,used,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131348,in,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131349,cancer,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131350,treatment,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131351,either,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131352,alone,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131353,or,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131354,in,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131355,combination,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131356,with,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131357,other,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131358,chemotherapeutic,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131359,drugs,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131360,/,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131361,radiotherapy,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131362,.,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131395,Several,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131396,other,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131397,HDACi,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131398,of,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131399,natural,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131400,and,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131401,synthetic,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131402,origin,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131403,are,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131404,under,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131405,clinical,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131406,trial,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131407,for,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131408,the,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131409,evaluation,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131410,of,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131411,efficiency,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131412,and,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131413,side,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131414,-,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131415,effects,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131416,.,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131455,Several,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131456,HDACi,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131457,of,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131458,natural,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131459,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131460,dietary,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131461,origin,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131462,are,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131463,butein,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131464,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131465,protocatechuic,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131466,aldehyde,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131467,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131468,kaempferol,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131469,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131470,grapes,B-AG.01.h.01.b,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131471,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131472,green,B-AG.01.ac,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131473,tea,I-AG.01.ac,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131474,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131475,tomatoes,B-AG.01.h.02.f,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131476,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131477,potatoes,B-AG.01.h.02.a,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131478,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131479,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131480,onions,B-AG.01.h.02.e,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131481,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131482,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131483,resveratrol,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131484,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131485,grapes,B-AG.01.h.01.b,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131486,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131487,red,B-AG.01.y.01.a,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131488,wine,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131489,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131490,blueberries,B-AG.01.h.01.b,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131491,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131492,peanuts,B-AG.01.h.01.f,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131493,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131494,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131495,sinapinic,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131496,acid,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131497,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131498,wine,B-AG.01.y.01.a,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131499,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131500,vinegar,B-AG.01.ae.01,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131501,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131502,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131503,diallyl,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131504,disulfide,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131505,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131506,garlic,B-AG.01.h.02.e,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131507,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131508,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131509,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131510,zerumbone,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131511,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131512,ginger,B-AG.01.l.03,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131513,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131514,.,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131691,The,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131692,bread,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131693,quality,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131694,parameters,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131695,measured,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131696,were,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131697,specific,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131698,volume,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131699,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131700,dry,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131701,matter,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131702,of,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131703,bread,B-AG.01.n.11,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131704,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131705,crust,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131706,color,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131707,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131708,crumb,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131709,hardness,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131710,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131711,and,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131712,gas,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131713,cell,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131714,size,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131715,distribution,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131716,.,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131806,Bread,B-AG.01.n.11,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131807,with,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131808,1.9,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131809,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131810,guar,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131811,gum,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131812,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131813,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131814,/,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131815,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131816,",",O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131817,total,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131818,flour,B-AG.01.k,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131819,basis,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131820,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131821,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131822,5,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131823,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131824,buckwheat,B-AG.01.k,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131825,flour,I-AG.01.k,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131826,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131827,of,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131828,all,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131829,flours,B-AG.01.k,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131830,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131831,substitutes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131832,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131833,mimicked,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131834,French,B-AG.01.n.11,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131835,bread,I-AG.01.n.11,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131836,quality,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131837,attributes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131838,.,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
132130,Treatments,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132131,did,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132132,not,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132133,affect,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132134,the,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132135,enzyme,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132136,activity,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132137,of,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132138,lactate,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132139,dehydrogenase,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132140,and,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132141,N,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132142,-,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132143,acetyl,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132144,-,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132145,beta,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132146,-,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132147,d,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132148,-,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132149,glucosaminidase,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132150,in,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132151,milk,B-AG.01.e,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132152,or,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132153,the,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132154,activity,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132155,of,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132156,isocitrate,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132157,dehydrogenase,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132158,and,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132159,malate,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132160,dehydrogenase,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132161,in,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132162,blood,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132163,plasma,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
132164,.,O,4593.0,Treatments did not affect the enzyme activity of lactate dehydrogenase and N - acetyl - beta - d - glucosaminidase in milk or the activity of isocitrate dehydrogenase and malate dehydrogenase in blood plasma .
